<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><channel rdf:about="http://onlinelibrary.wiley.com/rss/journal/10.1002/(ISSN)1097-4598" xmlns="http://purl.org/rss/1.0/"><title>Muscle &amp; Nerve</title><description> Wiley Online Library : Muscle &amp; Nerve</description><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2F%28ISSN%291097-4598</link><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc</dc:publisher><dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">en</dc:language><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">© 2013 Wiley Periodicals, Inc.</dc:rights><prism:issn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">0148-639X</prism:issn><prism:eIssn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1097-4598</prism:eIssn><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-06-01T00:00:00-05:00</dc:date><prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">June 2013</prism:coverDisplayDate><prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">47</prism:volume><prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">6</prism:number><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">789</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">951</prism:endingPage><image rdf:resource="http://onlinelibrary.wiley.com/store/10.1002/mus.v47.6/asset/cover.gif?v=1&amp;s=917e29b3acedd9b7e653deb637ce894c1d67e1a4"/><items><rdf:Seq><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23912"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23906"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23900"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23901"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23902"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23904"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23903"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23905"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23898"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23899"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23897"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23895"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23896"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23894"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23891"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23892"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23893"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23890"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23888"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23889"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23882"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23881"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23883"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23884"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23885"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23886"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23887"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23880"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23878"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23879"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23877"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23875"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23876"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23874"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23873"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23872"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23870"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23869"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23868"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23867"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23866"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23865"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23864"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23863"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23862"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23861"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23860"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23859"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23858"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23856"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23857"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23855"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23854"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23853"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23851"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23852"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23849"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23850"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23847"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23848"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23845"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23843"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23844"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23841"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23842"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23840"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23837"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23838"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23835"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23836"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23834"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23833"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23832"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23827"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23829"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23830"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23828"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23825"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23824"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23823"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23826"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23822"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23821"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23820"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23819"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23818"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23817"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23816"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23815"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23811"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23812"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23809"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23810"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23805"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23804"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23769"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23770"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23768"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23775"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23766"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23772"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23795"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23793"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23791"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23789"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23788"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23787"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23785"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23784"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23786"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23781"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23780"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23803"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23802"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23801"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23800"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23798"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23797"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23765"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23762"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23761"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23760"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23758"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23757"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23756"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23753"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23752"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23750"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23749"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23748"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23744"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23739"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23740"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23729"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23767"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23771"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23745"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23799"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23731"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23807"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23724"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23794"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23790"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23871"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23735"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23808"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23725"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23806"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23726"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23792"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23722"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23839"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23717"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23719"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23700"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23831"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23699"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23721"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23846"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23712"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23746"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23734"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23351"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.21394"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.20945"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23571"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23575"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23814"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23737"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23755"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23759"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23813"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23697"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23707"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23716"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23715"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23690"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23691"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23672"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23693"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23702"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23718"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23674"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23678"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23689"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23696"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23743"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23754"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23751"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23763"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23706"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23796"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23572"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23573"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23574"/></rdf:Seq></items></channel><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23912" xmlns="http://purl.org/rss/1.0/"><title>Normal values of median nerve cross sectional area obtained by ultrasound along its course in the arm with electrophysiological correlations, in 100 Asian subjects</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23912</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Normal values of median nerve cross sectional area obtained by ultrasound along its course in the arm with electrophysiological correlations, in 100 Asian subjects</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lokesh Bathala, Pavan Kumar, Krishna Kumar, Ahammad Basha Shaik, Leo H. Visser</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-23T18:10:20.765678-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23912</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23912</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23912</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective:</b> To obtain normative cross sectional area (CSA) values for median nerve by ultrasound at predetermined sites and correlate them with electrophysiological variables in healthy Asian subjects.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Materials and methods:</b> The median nerve was examined ultrasonographically in 100 healthy volunteers, mean age 39 years (range, 18–75 years). CSA of the median nerve was measured at wrist, mid-forearm, mid-arm and axilla. All subjects underwent simultaneous standardized nerve conduction studies.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> The mean median nerve CSAs ± standard deviation at the distal wrist crease was 7.2±1 mm2; mid-forearm 4.8±0.9 mm2; mid-arm 6.1±1mm2; axilla 5.9±0.9 mm2. The CSA at the wrist was the largest compared to other levels (p&lt;0.001) and it increased with advancing age (p&lt;0.002).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions:</b> The normative data obtained from this study show that median nerve CSA is not uniform along its length. There are differences between gender, and values increase with advancing age. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Objective: To obtain normative cross sectional area (CSA) values for median nerve by ultrasound at predetermined sites and correlate them with electrophysiological variables in healthy Asian subjects.
Materials and methods: The median nerve was examined ultrasonographically in 100 healthy volunteers, mean age 39 years (range, 18–75 years). CSA of the median nerve was measured at wrist, mid-forearm, mid-arm and axilla. All subjects underwent simultaneous standardized nerve conduction studies.
Results: The mean median nerve CSAs ± standard deviation at the distal wrist crease was 7.2±1 mm2; mid-forearm 4.8±0.9 mm2; mid-arm 6.1±1mm2; axilla 5.9±0.9 mm2. The CSA at the wrist was the largest compared to other levels (p&lt;0.001) and it increased with advancing age (p&lt;0.002).
Conclusions: The normative data obtained from this study show that median nerve CSA is not uniform along its length. There are differences between gender, and values increase with advancing age. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23906" xmlns="http://purl.org/rss/1.0/"><title>Molecular diagnosis of dystrophinopathies using a multi-technique analysis algorithm</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23906</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Molecular diagnosis of dystrophinopathies using a multi-technique analysis algorithm</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Leonela N Luce, Daniela Ottaviani, Marcela Ferrer, Irene Szijan, Javier Cotignola, Florencia Giliberto</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-20T22:17:18.525383-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23906</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23906</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23906</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Dystrophinopathies are X-linked recessive neuromuscular diseases caused by mutations in the dystrophin gene. This study aimed to detect mutations within the dystrophin gene in DMD patients, to determine the carrier status of women, and to perform a prenatal diagnosis.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Methods: We analyzed 17 individuals from 2 unrelated families with a history of DMD. We used multiplex PCR, Multiplex Ligation-dependent Probe Amplification (MLPA), and Short Tandem-Repeat (STR) segregation analysis to accurately detect and characterize the mutations and to identify the at-risk haplotype.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results: The selected methodology allowed for the characterization of 2 single-exon out-of-frame deletions in the affected patients. 9/13 women and a fetus were excluded from being carriers. Three recombination events were found and suggested that germline mosaicism had occurred in both families.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Discussion: This methodology proved to be efficient for characterizing the disease-causing mutation in affected individuals and for assessing the carrier status in healthy relatives. These findings helped inform precise genetic counseling and contributed to characterization of the disease in the Argentine population. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Dystrophinopathies are X-linked recessive neuromuscular diseases caused by mutations in the dystrophin gene. This study aimed to detect mutations within the dystrophin gene in DMD patients, to determine the carrier status of women, and to perform a prenatal diagnosis.
Methods: We analyzed 17 individuals from 2 unrelated families with a history of DMD. We used multiplex PCR, Multiplex Ligation-dependent Probe Amplification (MLPA), and Short Tandem-Repeat (STR) segregation analysis to accurately detect and characterize the mutations and to identify the at-risk haplotype.
Results: The selected methodology allowed for the characterization of 2 single-exon out-of-frame deletions in the affected patients. 9/13 women and a fetus were excluded from being carriers. Three recombination events were found and suggested that germline mosaicism had occurred in both families.
Discussion: This methodology proved to be efficient for characterizing the disease-causing mutation in affected individuals and for assessing the carrier status in healthy relatives. These findings helped inform precise genetic counseling and contributed to characterization of the disease in the Argentine population. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23900" xmlns="http://purl.org/rss/1.0/"><title>Neuromuscular ultrasound in common entrapment neuropathies</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23900</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Neuromuscular ultrasound in common entrapment neuropathies</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michael S. Cartwright, Francis O. Walker</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T07:42:17.206848-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23900</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23900</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23900</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">AANEM Minimonograph</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Neuromuscular ultrasound involves the use of high-resolution ultrasound to image the peripheral nervous system of patients with suspected neuromuscular diseases. It complements electrodiagnostic studies well by providing anatomic information regarding nerves, muscles, vessels, tendons, ligaments, bones, and other structures that cannot be obtained with nerve conduction studies and electromyography. Neuromuscular ultrasound has been studied closely over the past 10 years and has been used most often in the assessment of entrapment neuropathies. This review focuses on the use of neuromuscular ultrasound in 4 of the most common entrapment neuropathies: carpal tunnel syndrome, ulnar neuropathy at the elbow and wrist, and fibular neuropathy at the knee. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Neuromuscular ultrasound involves the use of high-resolution ultrasound to image the peripheral nervous system of patients with suspected neuromuscular diseases. It complements electrodiagnostic studies well by providing anatomic information regarding nerves, muscles, vessels, tendons, ligaments, bones, and other structures that cannot be obtained with nerve conduction studies and electromyography. Neuromuscular ultrasound has been studied closely over the past 10 years and has been used most often in the assessment of entrapment neuropathies. This review focuses on the use of neuromuscular ultrasound in 4 of the most common entrapment neuropathies: carpal tunnel syndrome, ulnar neuropathy at the elbow and wrist, and fibular neuropathy at the knee. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23901" xmlns="http://purl.org/rss/1.0/"><title>Neurophysiological techniques to detect early small-fiber dysfunction in transthyretin amyloid polyneuropathy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23901</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Neurophysiological techniques to detect early small-fiber dysfunction in transthyretin amyloid polyneuropathy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Isabel Conceição, João Costa, José Castro, Mamede de Carvalho</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T07:32:10.088177-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23901</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23901</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23901</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Transthyretin familial amyloid polyneuropathy (TTR-FAP) is characterized by early selective involvement of small nerve fibers. Initial clinical diagnosis is complicated by psychosocial factors.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Objective: To evaluate diagnostic accuracy of sural sensory nerve action potentials, plantar sympathetic skin response (SSR), and cortical laser-evoked potentials (LEP) to dorsal foot stimulation in early diagnosis of TTR-FAP.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Methods: Sixty-three subjects with TTR-FAP (Val30Met) mutation were split into 2 groups (asymptomatic carriers and early-symptomatic patients) and compared with 33 healthy controls.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results: The diagnostic accuracy of plantar SSR amplitude and LEP N2 latency was similar; all had very high specificity (94 to 97%) but low sensitivity (22 to 32%) in distinguishing controls from carriers and early-symptomatic patients. No control had abnormal results on both tests.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Conclusions: Plantar SSR and LEPs have similar diagnostic performance in detecting small-fiber dysfunction in early TTR-FAP; we propose that both tests should be used to investigate this population. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Transthyretin familial amyloid polyneuropathy (TTR-FAP) is characterized by early selective involvement of small nerve fibers. Initial clinical diagnosis is complicated by psychosocial factors.
Objective: To evaluate diagnostic accuracy of sural sensory nerve action potentials, plantar sympathetic skin response (SSR), and cortical laser-evoked potentials (LEP) to dorsal foot stimulation in early diagnosis of TTR-FAP.
Methods: Sixty-three subjects with TTR-FAP (Val30Met) mutation were split into 2 groups (asymptomatic carriers and early-symptomatic patients) and compared with 33 healthy controls.
Results: The diagnostic accuracy of plantar SSR amplitude and LEP N2 latency was similar; all had very high specificity (94 to 97%) but low sensitivity (22 to 32%) in distinguishing controls from carriers and early-symptomatic patients. No control had abnormal results on both tests.
Conclusions: Plantar SSR and LEPs have similar diagnostic performance in detecting small-fiber dysfunction in early TTR-FAP; we propose that both tests should be used to investigate this population. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23902" xmlns="http://purl.org/rss/1.0/"><title>The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23902</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: Longitudinal natural history observations over 48 weeks from a multicenter study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Craig M McDonald, Erik K Henricson, R Ted Abresch, Julaine Florence, Michelle Eagle, Eduard Gappmaier, Allan M. Glanzman, , Robert Spiegel, Jay Barth, Gary Elfring, Allen Reha, Stuart Peltz</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T07:31:33.969028-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23902</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23902</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23902</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction:</b> Duchenne muscular dystrophy (DMD) subjects ≥5 years with nonsense mutations were followed for 48 weeks in a multicenter, randomized, double-blind, placebo-controlled trial of ataluren. Placebo arm data (N=57) provide insight into the natural history of the 6-minute walk test (6MWT) and other endpoints. <b>Methods</b>: Evaluations performed every 6 weeks included the 6 minute walk distance (6MWD), timed function tests (TFTs), and quantitative strength using hand-held myometry. <b>Results:</b> Baseline age (≥7 years), 6MWD, and selected TFT performance, are strong predictors of decline in ambulation (Δ 6MWD) and time to 10% worsening in 6MWD. A baseline 6MWD of &lt;350 meters was associated with greater functional decline, and loss of ambulation was only seen in those with baseline 6MWD &lt;325 meters. Only 1/42 (2.3%) subjects able to stand from supine lost ambulation. <b>Discussion:</b> Findings confirm the clinical meaningfulness of the 6MWD as the most accepted primary clinical endpoint in ambulatory DMD trials. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Duchenne muscular dystrophy (DMD) subjects ≥5 years with nonsense mutations were followed for 48 weeks in a multicenter, randomized, double-blind, placebo-controlled trial of ataluren. Placebo arm data (N=57) provide insight into the natural history of the 6-minute walk test (6MWT) and other endpoints. Methods: Evaluations performed every 6 weeks included the 6 minute walk distance (6MWD), timed function tests (TFTs), and quantitative strength using hand-held myometry. Results: Baseline age (≥7 years), 6MWD, and selected TFT performance, are strong predictors of decline in ambulation (Δ 6MWD) and time to 10% worsening in 6MWD. A baseline 6MWD of &lt;350 meters was associated with greater functional decline, and loss of ambulation was only seen in those with baseline 6MWD &lt;325 meters. Only 1/42 (2.3%) subjects able to stand from supine lost ambulation. Discussion: Findings confirm the clinical meaningfulness of the 6MWD as the most accepted primary clinical endpoint in ambulatory DMD trials. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23904" xmlns="http://purl.org/rss/1.0/"><title>SMA VALIANT Trial: A prospective, double-blind, placebo controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23904</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">SMA VALIANT Trial: A prospective, double-blind, placebo controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">John T. Kissel, Bakri Elsheikh, Wendy M. King, Miriam Freimer, Charles B. Scott, Stephen Kolb, Sandra P. Reyna, Thomas O. Crawford, Louise R. Simard, Kristin J. Krosschell, Gyula Acsadi, Mary K. Schroth, Guy D'Anjou, Bernard LaSalle, Thomas W. Prior, Susan Sorenson, Jo Anne Maczulski, Kathryn J. Swoboda, </dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T07:12:56.356563-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23904</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23904</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23904</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction:</b> An open label trial suggested that valproic acid (VPA) improved strength in adults with spinal muscular atrophy (SMA). We report a 12 month, double blind, crossover study of VPA in ambulatory SMA adults.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods:</b> There were 33 subjects aged 20-55 years. After baseline assessments subjects were randomized to receive VPA (10-20 mg/kg/daily) or placebo. At 6 months, patients were switched to the other group. Assessments were performed at 3, 6, and 12 months. The primary outcome was the 6-month change in maximum voluntary isometric contraction testing with pulmonary, electrophysiologic, and functional secondary outcomes.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> Thirty subjects completed the study. VPA was well tolerated, and compliance was good. There was no change in primary or secondary outcomes at 6 or 12 months.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions</b>: VPA did not improve strength or function in SMA adults. The outcomes used are feasible and reliable and can be employed in future trials in SMA adults. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: An open label trial suggested that valproic acid (VPA) improved strength in adults with spinal muscular atrophy (SMA). We report a 12 month, double blind, crossover study of VPA in ambulatory SMA adults.
Methods: There were 33 subjects aged 20-55 years. After baseline assessments subjects were randomized to receive VPA (10-20 mg/kg/daily) or placebo. At 6 months, patients were switched to the other group. Assessments were performed at 3, 6, and 12 months. The primary outcome was the 6-month change in maximum voluntary isometric contraction testing with pulmonary, electrophysiologic, and functional secondary outcomes.
Results: Thirty subjects completed the study. VPA was well tolerated, and compliance was good. There was no change in primary or secondary outcomes at 6 or 12 months.
Conclusions: VPA did not improve strength or function in SMA adults. The outcomes used are feasible and reliable and can be employed in future trials in SMA adults. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23903" xmlns="http://purl.org/rss/1.0/"><title>Muscle weakness, fatigue, and torque variability: Effects of age and mobility status</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23903</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Muscle weakness, fatigue, and torque variability: Effects of age and mobility status</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jane A. Kent-Braun, Damien M. Callahan, Jessica L. Fay, Stephen A. Foulis, John P. Buonaccorsi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-14T10:06:42.187121-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23903</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23903</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23903</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>INTRODUCTION. While deficits in muscle function, particularly power production, develop in old age and are risk factors for mobility impairment, a complete understanding of muscle fatigue during dynamic contractions is lacking. We tested hypotheses related to torque-producing capacity, fatigue resistance, and variability of torque production during repeated maximal contractions in healthy older, mobility-impaired older, and young women. METHODS. Knee extensor fatigue (decline in torque) was measured during 4 min of dynamic contractions. Torque variability was characterized using a novel 4-component logistic regression model. RESULTS. Young women produced more torque at baseline and during the protocol than older women (<em>P</em>&lt;0.001). While fatigue did not differ between groups (<em>P</em>=0.53), torque variability differed by group (<em>P</em>=0.022) and was greater in older impaired compared with young women (<em>P</em>=0.010). CONCLUSIONS. These results suggest that increased torque variability may combine with baseline muscle weakness to limit function, particularly in older adults with mobility impairments. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

INTRODUCTION. While deficits in muscle function, particularly power production, develop in old age and are risk factors for mobility impairment, a complete understanding of muscle fatigue during dynamic contractions is lacking. We tested hypotheses related to torque-producing capacity, fatigue resistance, and variability of torque production during repeated maximal contractions in healthy older, mobility-impaired older, and young women. METHODS. Knee extensor fatigue (decline in torque) was measured during 4 min of dynamic contractions. Torque variability was characterized using a novel 4-component logistic regression model. RESULTS. Young women produced more torque at baseline and during the protocol than older women (P&lt;0.001). While fatigue did not differ between groups (P=0.53), torque variability differed by group (P=0.022) and was greater in older impaired compared with young women (P=0.010). CONCLUSIONS. These results suggest that increased torque variability may combine with baseline muscle weakness to limit function, particularly in older adults with mobility impairments. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23905" xmlns="http://purl.org/rss/1.0/"><title>The 6-minute walk test and other clinical endpoints in Duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23905</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The 6-minute walk test and other clinical endpoints in Duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Craig M McDonald, Erik K Henricson, R Ted Abresch, Julaine Florence, Michelle Eagle, Eduard Gappmaier, Allan M. Glanzman, , Robert Spiegel, Jay Barth, Gary Elfring, Allen Reha, Stuart W. Peltz</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-14T10:04:46.816087-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23905</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23905</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23905</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction:</b> An international clinical trial enrolled 174 ambulatory males ≥5 years old with nonsense mutation Duchenne muscular dystrophy (nmDMD). Pre-treatment data provide insight into reliability, concurrent validity, and minimal clinically important differences (MCID) of the 6-minute walk test (6MWT) and other endpoints. <b>Methods</b>: Screening and baseline evaluations included the 6-minute walk distance (6MWD), timed function tests (TFTs), quantitative strength by myometry, the PedsQL<sup>TM</sup>, heart rate determined energy expenditure index, and other exploratory endpoints. <b>Results:</b> The 6MWT proved feasible and reliable in a multicenter context. Concurrent validity with other endpoints was excellent. The MCID for 6MWD was 28.5 and 31.7 meters based on 2 statistical distribution methods. <b>Discussion:</b> The ratio of MCID to baseline mean is lower for 6MWD than for other endpoints. The 6MWD is an optimal primary endpoint for Duchenne muscular dystrophy (DMD) clinical trials that are focused therapeutically on preservation of ambulation and slowing of disease progression. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: An international clinical trial enrolled 174 ambulatory males ≥5 years old with nonsense mutation Duchenne muscular dystrophy (nmDMD). Pre-treatment data provide insight into reliability, concurrent validity, and minimal clinically important differences (MCID) of the 6-minute walk test (6MWT) and other endpoints. Methods: Screening and baseline evaluations included the 6-minute walk distance (6MWD), timed function tests (TFTs), quantitative strength by myometry, the PedsQLTM, heart rate determined energy expenditure index, and other exploratory endpoints. Results: The 6MWT proved feasible and reliable in a multicenter context. Concurrent validity with other endpoints was excellent. The MCID for 6MWD was 28.5 and 31.7 meters based on 2 statistical distribution methods. Discussion: The ratio of MCID to baseline mean is lower for 6MWD than for other endpoints. The 6MWD is an optimal primary endpoint for Duchenne muscular dystrophy (DMD) clinical trials that are focused therapeutically on preservation of ambulation and slowing of disease progression. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23898" xmlns="http://purl.org/rss/1.0/"><title>Invasive fibroblasts: Fundamental difference between sporadic inclusion body myositis and polymyositis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23898</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Invasive fibroblasts: Fundamental difference between sporadic inclusion body myositis and polymyositis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kathrin Doppler, Georgios Pantazis, Alfred Lindner, Andreas Mack, Antje Bornemann</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-06T02:47:59.932478-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23898</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23898</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23898</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction:</em> Sporadic inclusion body myositis (sIBM) is a progressive disease that leads to extensive muscle weakness. The aim of this study was to determine whether the number and distribution of fibroblasts differ in sIBM when compared with polymyositis.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Methods:</em> Immunofluorescence double labelling was performed on 35 biopsies with antibodies directed against perlecan and CD90, procollagen I, CD34, and CD105. In addition, non-serial ultrathin sections were studied from 3 biopsies of each condition.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Results:</em> Fibroblasts expressing CD90 and CD34 accumulated in the endomysial compartment in polymyositis and sIBM. In addition, cells expressing CD90 were found beneath the basal lamina in both conditions. At the ultrastructural level in polymyositis, fibroblasts invaded the myofiber, with focal destruction of the basement membrane. In sIBM, by contrast, invasive fibroblasts were ensheathed by the intact myofiber basement membrane.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Discussion:</em> The impact of intruding fibroblasts on satellite cells remains to be established. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Sporadic inclusion body myositis (sIBM) is a progressive disease that leads to extensive muscle weakness. The aim of this study was to determine whether the number and distribution of fibroblasts differ in sIBM when compared with polymyositis.
Methods: Immunofluorescence double labelling was performed on 35 biopsies with antibodies directed against perlecan and CD90, procollagen I, CD34, and CD105. In addition, non-serial ultrathin sections were studied from 3 biopsies of each condition.
Results: Fibroblasts expressing CD90 and CD34 accumulated in the endomysial compartment in polymyositis and sIBM. In addition, cells expressing CD90 were found beneath the basal lamina in both conditions. At the ultrastructural level in polymyositis, fibroblasts invaded the myofiber, with focal destruction of the basement membrane. In sIBM, by contrast, invasive fibroblasts were ensheathed by the intact myofiber basement membrane.
Discussion: The impact of intruding fibroblasts on satellite cells remains to be established. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23899" xmlns="http://purl.org/rss/1.0/"><title>A simple electrodiagnostic method for morton neuroma</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23899</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A simple electrodiagnostic method for morton neuroma</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Elif Ilgaz Aydinlar, Metin Uzun, Burak Beksac, Vahit Emre Ozden, Ercan Karaarslan, A. Emre Oge</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-06T02:46:39.313988-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23899</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23899</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23899</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction:</b> We describe a simple and quickly applied electrodiagnostic method for confirming the diagnosis of interdigital neuropathy (IDN) caused by Morton neuroma (MN).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods:</b> Interdigital nerves II-III and III-IV were stimulated with surface electrodes simultaneously touching the lateral side of 1 toe and the medial side of the other. Recording was also made with surface electrodes. The results of 20 normal controls and 14 patients with MN were evaluated.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> The amplitude and peak latency values elicited in the patients as well as the interside differences revealed an acceptable abnormality rate between 57.1% and 71.4%.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion:</b> Although the most popular and effective method of MN diagnosis is clinical evaluation supported by imaging, electrophysiological studies can, in selected patients, provide valuable information © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We describe a simple and quickly applied electrodiagnostic method for confirming the diagnosis of interdigital neuropathy (IDN) caused by Morton neuroma (MN).
Methods: Interdigital nerves II-III and III-IV were stimulated with surface electrodes simultaneously touching the lateral side of 1 toe and the medial side of the other. Recording was also made with surface electrodes. The results of 20 normal controls and 14 patients with MN were evaluated.
Results: The amplitude and peak latency values elicited in the patients as well as the interside differences revealed an acceptable abnormality rate between 57.1% and 71.4%.
Conclusion: Although the most popular and effective method of MN diagnosis is clinical evaluation supported by imaging, electrophysiological studies can, in selected patients, provide valuable information © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23897" xmlns="http://purl.org/rss/1.0/"><title>CANOMAD – report of a case with a 40 year history and autopsy. Is this a sensory ganglionopathy with neuromuscular junction blockade?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23897</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">CANOMAD – report of a case with a 40 year history and autopsy. Is this a sensory ganglionopathy with neuromuscular junction blockade?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Penelope A. McKelvie, Peter C. Gates, Timothy Day</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-06T02:46:36.694264-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23897</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23897</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23897</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Case of the Month</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: An 80 year old man had a 40 year history of chronic sensory ataxic neuropathy and 11 years of relapsing/remitting episodes of rapid deterioration with perioral paresthesiae and weakness of bulbar, respiratory, and limb muscles. <b>Case report:</b> An IgM paraprotein was detected 12 years before death, and Waldenstrom's macroglobulinaemia was diagnosed on bone marrow biopsy 3 years before death. Chronic ataxic neuropathy with ophthalmoplegia, IgM paraprotein, cold agglutinins, and anti-disialyl antibodies (CANOMAD) was diagnosed. Comprehensive autopsy showed severe dorsal column atrophy and dorsal root ganglionopathy. A different pathology was identified in cranial and peripheral nerves, dorsal roots, and cauda equina, comprising infiltration of clonal B-lymphocytes within the endoneurium, perineurium, and leptomeninges. <b>Conclusion:</b> The autopsy provides evidence of the pathogenesis of the relapsing remitting component of CANOMAD, and we postulate that this may relate to the presence of clonal IgM anti-disiayl gangliosides secreting B-lymphocytes within nerves. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: An 80 year old man had a 40 year history of chronic sensory ataxic neuropathy and 11 years of relapsing/remitting episodes of rapid deterioration with perioral paresthesiae and weakness of bulbar, respiratory, and limb muscles. Case report: An IgM paraprotein was detected 12 years before death, and Waldenstrom's macroglobulinaemia was diagnosed on bone marrow biopsy 3 years before death. Chronic ataxic neuropathy with ophthalmoplegia, IgM paraprotein, cold agglutinins, and anti-disialyl antibodies (CANOMAD) was diagnosed. Comprehensive autopsy showed severe dorsal column atrophy and dorsal root ganglionopathy. A different pathology was identified in cranial and peripheral nerves, dorsal roots, and cauda equina, comprising infiltration of clonal B-lymphocytes within the endoneurium, perineurium, and leptomeninges. Conclusion: The autopsy provides evidence of the pathogenesis of the relapsing remitting component of CANOMAD, and we postulate that this may relate to the presence of clonal IgM anti-disiayl gangliosides secreting B-lymphocytes within nerves. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23895" xmlns="http://purl.org/rss/1.0/"><title>Subcutaneous immunoglobulin treatment of inclusion body myositis stabilizes dysphagia</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23895</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Subcutaneous immunoglobulin treatment of inclusion body myositis stabilizes dysphagia</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kaweh Pars, Niklas Garde, Thomas Skripuletz, Refik Pul, Reinhard Dengler, Martin Stangel</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-04T11:31:14.027069-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23895</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23895</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23895</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23896" xmlns="http://purl.org/rss/1.0/"><title>Muscle related differences in the MMG-force relationships are model dependent</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23896</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Muscle related differences in the MMG-force relationships are model dependent</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michael A. Cooper, Trent J. Herda</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-04T11:31:06.036202-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23896</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23896</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23896</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>INTRODUCTION:</b> We examined the mechanomyographic amplitude (MMG<sub>RMS</sub>)-force relationships with log-transform and polynomial regression models for the vastus lateralis (VL), rectus femoris (RF), and first dorsal interosseous (FDI) muscles. <b>METHODS:</b> Twelve healthy (age = 23 ± 3 yrs;) men performed isometric ramp contractions of the leg extensors and index finger from 10% to 80% of their maximal voluntary contraction (MVC) with MMG sensors positioned on the VL, RF, and FDI. Log-transform and polynomial regression models were fitted to the relationships. <b>RESULTS:</b> There were differences for the <em>a</em> terms (intercepts) and <em>b</em> terms (slopes) from the log-transform model between the FDI, VL, and RF, however, there were no consistent differences identified with the polynomial regression models. <b>DISCUSSION:</b> The log-transform model quantified differences in the patterns of responses between the FDI and the leg extensors, however, polynomial regression could not distinguish such differences. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

INTRODUCTION: We examined the mechanomyographic amplitude (MMGRMS)-force relationships with log-transform and polynomial regression models for the vastus lateralis (VL), rectus femoris (RF), and first dorsal interosseous (FDI) muscles. METHODS: Twelve healthy (age = 23 ± 3 yrs;) men performed isometric ramp contractions of the leg extensors and index finger from 10% to 80% of their maximal voluntary contraction (MVC) with MMG sensors positioned on the VL, RF, and FDI. Log-transform and polynomial regression models were fitted to the relationships. RESULTS: There were differences for the a terms (intercepts) and b terms (slopes) from the log-transform model between the FDI, VL, and RF, however, there were no consistent differences identified with the polynomial regression models. DISCUSSION: The log-transform model quantified differences in the patterns of responses between the FDI and the leg extensors, however, polynomial regression could not distinguish such differences. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23894" xmlns="http://purl.org/rss/1.0/"><title>Electromyography and neuromuscular disorders: Clinical-electrophysiologic correlations. 3rd edition</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23894</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Electromyography and neuromuscular disorders: Clinical-electrophysiologic correlations. 3rd edition</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Siddhartha Varma</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-04T11:31:00.9414-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23894</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23894</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23894</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Book Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23891" xmlns="http://purl.org/rss/1.0/"><title>Contribution of QSART to the diagnosis of small fiber neuropathy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23891</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Contribution of QSART to the diagnosis of small fiber neuropathy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Pariwat Thaisetthawatkul, J Americo M Fernandes Filho, David N Herrmann</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-04T00:56:39.077194-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23891</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23891</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23891</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b> We evaluated incorporation of quantitative sudomotor axon reflex test (QSART) into diagnostic criteria for small fiber neuropathy (SFN) as an addition to quantitative sensory testing (QST) and intraepidermal nerve fiber density (IENFD).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b> 101 patients with clinically suspected SFN underwent QSART, QST, and skin biopsy. The diagnostic yield of existing SFN criteria in these patients was compared to criteria incorporating QSART. The new combined diagnostic criteria were evaluated.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b> SFN was diagnosed in 38/101 patients (38%) using current criteria. Addition of QSART to existing SFN criteria resulted in an increased diagnostic yield of 67/101(66%). Applying new SFN criteria requiring abnormality in at least 2 assessments among QSART, QST, and IENFD resulted in a diagnosis of SFN in 57/101 (56%).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion</b> Assessment of both somatic and peripheral autonomic small nerve fibers enhances diagnostic criteria for SFN. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction We evaluated incorporation of quantitative sudomotor axon reflex test (QSART) into diagnostic criteria for small fiber neuropathy (SFN) as an addition to quantitative sensory testing (QST) and intraepidermal nerve fiber density (IENFD).
Methods 101 patients with clinically suspected SFN underwent QSART, QST, and skin biopsy. The diagnostic yield of existing SFN criteria in these patients was compared to criteria incorporating QSART. The new combined diagnostic criteria were evaluated.
Results SFN was diagnosed in 38/101 patients (38%) using current criteria. Addition of QSART to existing SFN criteria resulted in an increased diagnostic yield of 67/101(66%). Applying new SFN criteria requiring abnormality in at least 2 assessments among QSART, QST, and IENFD resulted in a diagnosis of SFN in 57/101 (56%).
Discussion Assessment of both somatic and peripheral autonomic small nerve fibers enhances diagnostic criteria for SFN. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23892" xmlns="http://purl.org/rss/1.0/"><title>X-linked charcot-marie-tooth disease predominates in a cohort of multi-ethnic Malaysian patients</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23892</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">X-linked charcot-marie-tooth disease predominates in a cohort of multi-ethnic Malaysian patients</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nortina Shahrizaila, Sarimah Samulong, Shelisa Tey, Liaw Chiew Suan, Lao Kah Meng, Khean Jin Goh, Azlina Ahmad-Annuar</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-04T00:10:49.524191-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23892</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23892</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23892</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23892-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Data regarding Charcot-Marie-Tooth disease is lacking in South-East Asian populations. We investigated the frequency of the common genetic mutations in a multi-ethnic Malaysian cohort.</p></div></div>
<div class="section" id="mus23892-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Patients with features of Charcot-Marie-Tooth disease or hereditary liability to pressure palsies were investigated for <em>PMP22</em> duplication, deletion, and point mutations and <em>GJB1, MPZ</em>, and <em>MFN2</em> point mutations.</p></div></div>
<div class="section" id="mus23892-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Over a period of 3 years, we identified 25 index patients. A genetic diagnosis was reached in 60%. The most common were point mutations in <em>GJB1</em>, accounting for X-linked Charcot-Marie-Tooth disease (24% of the total patient population), followed by <em>PMP22</em> duplication causing Charcot-Marie-Tooth disease type 1A (20%). We also discovered 2 novel <em>GJB1</em> mutations, c.521 C&gt;T (Proline174Leucine) and c.220G&gt;A (Valine74Methionine).</p></div></div>
<div class="section" id="mus23892-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Discussion</h4><div class="para"><p>This study revealed that X-linked Charcot-Marie-Tooth disease predominates in our patient cohort. We also found better phenotype/genotype correlation when applying a more recently recommended genetic approach to Charcot-Marie-Tooth disease. © 2013 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction
Data regarding Charcot-Marie-Tooth disease is lacking in South-East Asian populations. We investigated the frequency of the common genetic mutations in a multi-ethnic Malaysian cohort.


Methods
Patients with features of Charcot-Marie-Tooth disease or hereditary liability to pressure palsies were investigated for PMP22 duplication, deletion, and point mutations and GJB1, MPZ, and MFN2 point mutations.


Results
Over a period of 3 years, we identified 25 index patients. A genetic diagnosis was reached in 60%. The most common were point mutations in GJB1, accounting for X-linked Charcot-Marie-Tooth disease (24% of the total patient population), followed by PMP22 duplication causing Charcot-Marie-Tooth disease type 1A (20%). We also discovered 2 novel GJB1 mutations, c.521 C&gt;T (Proline174Leucine) and c.220G&gt;A (Valine74Methionine).


Discussion
This study revealed that X-linked Charcot-Marie-Tooth disease predominates in our patient cohort. We also found better phenotype/genotype correlation when applying a more recently recommended genetic approach to Charcot-Marie-Tooth disease. © 2013 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23893" xmlns="http://purl.org/rss/1.0/"><title>A differential pattern of gene expression in skeletal muscle of tumor-bearing rats reveals a dysregulation of excitation-contraction coupling together with additional muscle alterations</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23893</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A differential pattern of gene expression in skeletal muscle of tumor-bearing rats reveals a dysregulation of excitation-contraction coupling together with additional muscle alterations</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cibely Cristine Fontes-Oliveira, Sílvia Busquets, Gemma Fuster, Elisabet Ametller, Maite Figueras, Mireia Olivan, Míriam Toledo, Francisco J. López-Soriano, Xiaoyan Qu, Jeffrey Demuth, Paula Stevens, Alex Varbanov, Feng Wang, Robert J. Isfort, Josep M. Argilés</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-04T00:00:08.272721-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23893</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23893</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23893</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>BACKGROUND: Cachexia is a wasting condition that manifests in several types of cáncer. The main characteristic is a profound loss of muscle mass. METHODS: By using a micro-array system, the expression of several hundred genes was screened in skeletal muscle of rats bearing a cachexia-inducing tumor, the Yoshida AH-130 ascites hepatoma. This model induced a strong decrease in muscle mass in the tumor-bearing animals, as compared with their healthy counterparts. RESULTS: The results show important differences in gene expression in EDL skeletal muscle between tumor-bearing animals suffering from cachexia and control animals. CONCLUSIONS: The differences concern genes related to intracellular calcium homeostasis and genes involved in the control of mitochondrial oxidative phosphorylation and protein turnover, both at the level of protein synthesis and proteolysis. The stated differences may represent a useful tool for the design of novel therapeutic strategies to fight this devastating syndrome. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

BACKGROUND: Cachexia is a wasting condition that manifests in several types of cáncer. The main characteristic is a profound loss of muscle mass. METHODS: By using a micro-array system, the expression of several hundred genes was screened in skeletal muscle of rats bearing a cachexia-inducing tumor, the Yoshida AH-130 ascites hepatoma. This model induced a strong decrease in muscle mass in the tumor-bearing animals, as compared with their healthy counterparts. RESULTS: The results show important differences in gene expression in EDL skeletal muscle between tumor-bearing animals suffering from cachexia and control animals. CONCLUSIONS: The differences concern genes related to intracellular calcium homeostasis and genes involved in the control of mitochondrial oxidative phosphorylation and protein turnover, both at the level of protein synthesis and proteolysis. The stated differences may represent a useful tool for the design of novel therapeutic strategies to fight this devastating syndrome. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23890" xmlns="http://purl.org/rss/1.0/"><title>Reply: Surgical and postpartum hereditary brachial plexus attacks and prophylactic immunotherapy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23890</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Reply: Surgical and postpartum hereditary brachial plexus attacks and prophylactic immunotherapy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Christopher J Klein</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-29T01:49:03.582827-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23890</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23890</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23890</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Reply to Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23888" xmlns="http://purl.org/rss/1.0/"><title>Voluntary rate of torque development is impaired following a voluntary versus tetanic conditioning contraction</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23888</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Voluntary rate of torque development is impaired following a voluntary versus tetanic conditioning contraction</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cameron B. Smith, Matti D. Allen, Charles L. Rice</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-29T01:48:01.125667-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23888</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23888</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23888</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>INTRODUCTION</b>: Both voluntary and evoked conditioning contractions will potentiate muscle twitch contractile properties. The response of a voluntary contraction to each condition type is not well understood and may be a more functional model than evoked twitch potentiation. <b>METHODS</b>: Baseline measurements from tibialis anterior were: maximal isometric twitch torque and rate of torque development (RTD), maximal evoked 50Hz torque, and maximal voluntary ballistic RTD. Potentiation was induced by a 10s voluntary, or tetanic contraction (~78% MVC), followed by 2 twitches and 2 ballistic contractions. <b>RESULTS</b>: Twitch properties (torque, RTD) were potentiated equally following each conditioning contraction. Ballistic RTD was greater post-tetanus (390.2 Nm/s ± 59.3) than post-voluntary (356.4 Nm/s ± 69.1), but both were reduced from baseline (422.0 Nm/s ± 88.9). <b>CONCLUSIONS</b>: Twitch potentiation was similar between conditioning contraction types, however ballistic RTD was lower following post-tetanus than post-voluntary. These results indicate central inhibition or fatigue concurrent to peripheral potentiation. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

INTRODUCTION: Both voluntary and evoked conditioning contractions will potentiate muscle twitch contractile properties. The response of a voluntary contraction to each condition type is not well understood and may be a more functional model than evoked twitch potentiation. METHODS: Baseline measurements from tibialis anterior were: maximal isometric twitch torque and rate of torque development (RTD), maximal evoked 50Hz torque, and maximal voluntary ballistic RTD. Potentiation was induced by a 10s voluntary, or tetanic contraction (~78% MVC), followed by 2 twitches and 2 ballistic contractions. RESULTS: Twitch properties (torque, RTD) were potentiated equally following each conditioning contraction. Ballistic RTD was greater post-tetanus (390.2 Nm/s ± 59.3) than post-voluntary (356.4 Nm/s ± 69.1), but both were reduced from baseline (422.0 Nm/s ± 88.9). CONCLUSIONS: Twitch potentiation was similar between conditioning contraction types, however ballistic RTD was lower following post-tetanus than post-voluntary. These results indicate central inhibition or fatigue concurrent to peripheral potentiation. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23889" xmlns="http://purl.org/rss/1.0/"><title>Letter to the editor/ Author reply: “Surgical and postpartum hereditary brachial plexus attacks and prophylactic immunotherapy”</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23889</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Letter to the editor/ Author reply: “Surgical and postpartum hereditary brachial plexus attacks and prophylactic immunotherapy”</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jeroen JJ van Eijk, Nens van Alfen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-29T01:41:09.481999-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23889</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23889</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23889</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23882" xmlns="http://purl.org/rss/1.0/"><title>Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23882</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Emily Choi DeCroos, Lisa D. Hobson-Webb, Vern C. Juel, Janice M. Massey, Donald B. Sanders</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-27T10:40:24.021516-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23882</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23882</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23882</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Acetylcholine receptor (AChR) and striated muscle antibodies (StrAbs) are frequently found in myasthenia gravis (MG) patients with thymoma. This study aimed to determine the positive (PPV) and negative predictive value (NPV) of these antibodies for thymoma in patients with MG.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Methods: Antibody findings, thymic histology, and onset age were reviewed for 1141 patients with MG. PPV and NPV of these antibodies for thymoma were determined.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results: The PPV of AChR binding antibodies plus StrAbs was highest (50.0%) with onset before age 40. The PPV of all antibodies was low (&lt;9%) after age 40. Higher StrAb levels did not increase the PPV. The NPV of AChR binding antibodies was high (99.7%) for all ages.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Conclusion: Patients without AChR binding antibody are unlikely to have a thymoma. StrAbs and AChR binding antibodies are not diagnostic for thymoma, but in early onset MG, their presence should raise the clinical suspicion for thymoma. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Acetylcholine receptor (AChR) and striated muscle antibodies (StrAbs) are frequently found in myasthenia gravis (MG) patients with thymoma. This study aimed to determine the positive (PPV) and negative predictive value (NPV) of these antibodies for thymoma in patients with MG.
Methods: Antibody findings, thymic histology, and onset age were reviewed for 1141 patients with MG. PPV and NPV of these antibodies for thymoma were determined.
Results: The PPV of AChR binding antibodies plus StrAbs was highest (50.0%) with onset before age 40. The PPV of all antibodies was low (&lt;9%) after age 40. Higher StrAb levels did not increase the PPV. The NPV of AChR binding antibodies was high (99.7%) for all ages.
Conclusion: Patients without AChR binding antibody are unlikely to have a thymoma. StrAbs and AChR binding antibodies are not diagnostic for thymoma, but in early onset MG, their presence should raise the clinical suspicion for thymoma. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23881" xmlns="http://purl.org/rss/1.0/"><title>Natura non facit saltus in anti-ganglioside antibody-mediated neuropathies</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23881</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Natura non facit saltus in anti-ganglioside antibody-mediated neuropathies</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Antonino Uncini, Francesca Notturno, Margherita Capasso</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-27T10:40:20.575596-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23881</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23881</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23881</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Issues &amp; Opinions</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Natura non facit saltus</em> (Latin for “nature does not make jumps"). This maxim expresses the idea that natural things and properties change gradually, in a continuum, rather than suddenly. In biomedical sciences, for taxonomic purposes, we make jumps that emphasize differences more than similarities. In dysimmune neuropathies 2 disorders characterized by the presence of antibodies to gangliosides GM1 and GD1a and a peculiar exclusive motor involvement: acute motor axonal neuropathy (AMAN) and multifocal motor neuropathy (MMN) have been identified. However anti-GM1 or -GD1a antibodies are also associated with acute motor and sensory axonal motor neuropathy (AMSAN). We review the results of recent clinical and experimental studies which indicating that AMAN and MMN are not exclusively motor. We discuss the possible explanations of the greater resistance of sensory fibers to antibody attack to finally suggest that AMAN, AMSAN, and MMN belong to a continuous spectrum with a common pathophysiological mechanism. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Natura non facit saltus (Latin for “nature does not make jumps"). This maxim expresses the idea that natural things and properties change gradually, in a continuum, rather than suddenly. In biomedical sciences, for taxonomic purposes, we make jumps that emphasize differences more than similarities. In dysimmune neuropathies 2 disorders characterized by the presence of antibodies to gangliosides GM1 and GD1a and a peculiar exclusive motor involvement: acute motor axonal neuropathy (AMAN) and multifocal motor neuropathy (MMN) have been identified. However anti-GM1 or -GD1a antibodies are also associated with acute motor and sensory axonal motor neuropathy (AMSAN). We review the results of recent clinical and experimental studies which indicating that AMAN and MMN are not exclusively motor. We discuss the possible explanations of the greater resistance of sensory fibers to antibody attack to finally suggest that AMAN, AMSAN, and MMN belong to a continuous spectrum with a common pathophysiological mechanism. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23883" xmlns="http://purl.org/rss/1.0/"><title>Neuromuscular electrical stimulation alters gene expression and delays quadriceps muscle atrophy of rats after anterior cruciate ligament transection</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23883</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Neuromuscular electrical stimulation alters gene expression and delays quadriceps muscle atrophy of rats after anterior cruciate ligament transection</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">João L. Q. Durigan, Gabriel B. Delfino, Sabrina M. Peviani, Thiago L. Russo, Carolina Ramírez, André D. B. da Silva Gomes, Tania F. Salvini</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-27T09:02:33.443054-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23883</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23883</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23883</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Neuromuscular electrical stimulation (NMES) is used to improve quadriceps mass after anterior cruciate ligament (ACL) injury. We studied the effect of NMES on mRNA levels of atrophy genes in the quadriceps muscle of rats after ACL transection. Methods: mRNA levels of atrogin-1, MuRF-1, myostatin were assessed by quantitative PCR and the polyubiquitinated proteins by Western Blot at 1, 2, 3, 7, and 15 days post-injury. Results: NMES minimized the accumulation of atrogenes and myostatin according to time period. NMES prevented a reduction in muscle mass in all muscles of the ACLES group at 3 days. Conclusion: NMES decreased the accumulation of atrogenes and myostatin mRNA in the quadriceps muscles, inhibiting the early atrophy at 3 days, although it did not prevent atrophy at 7 and 15 days after ACL transection. This study indicates the importance of therapeutic NMES interventions in the acute phase after ACL transection. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Neuromuscular electrical stimulation (NMES) is used to improve quadriceps mass after anterior cruciate ligament (ACL) injury. We studied the effect of NMES on mRNA levels of atrophy genes in the quadriceps muscle of rats after ACL transection. Methods: mRNA levels of atrogin-1, MuRF-1, myostatin were assessed by quantitative PCR and the polyubiquitinated proteins by Western Blot at 1, 2, 3, 7, and 15 days post-injury. Results: NMES minimized the accumulation of atrogenes and myostatin according to time period. NMES prevented a reduction in muscle mass in all muscles of the ACLES group at 3 days. Conclusion: NMES decreased the accumulation of atrogenes and myostatin mRNA in the quadriceps muscles, inhibiting the early atrophy at 3 days, although it did not prevent atrophy at 7 and 15 days after ACL transection. This study indicates the importance of therapeutic NMES interventions in the acute phase after ACL transection. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23884" xmlns="http://purl.org/rss/1.0/"><title>Muscular adaptations and insulin-like growth factor-I (IGF-I) responses to resistance training are stretch-mediated</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23884</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Muscular adaptations and insulin-like growth factor-I (IGF-I) responses to resistance training are stretch-mediated</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gerard McMahon, Christopher I Morse, Adrian Burden, Keith Winwood, Gladys Leopoldine Onambélé</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-27T07:33:08.073385-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23884</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23884</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23884</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction:</b> Modulation of muscle characteristics was attempted through altering muscle stretch during resistance training. We hypothesized that stretch would enhance muscle responses. <b>Methods:</b> Participants trained for 8 weeks, loading the quadriceps in a shortened (SL-0-50<sup>o</sup> knee flexion; n=10) or lengthened (LL- 40-90<sup>o</sup>; n=11) position, followed by 4 weeks detraining. Controls (CON; n=10) were untrained. Quadriceps strength, <em>Vastus Lateralis</em> architecture, anatomical cross-sectional area (aCSA), and serum IGF-I (insulin-like growth factor 1) were measured at weeks 0, 8, 10, and 12. <b>Results:</b> Increases in fascicle length (29±4% vs. 14±4%), distal aCSA (53±12% vs. 18±8%), strength (26±6% vs. 7±3%), and IGF-I (31±6% vs. 7±6%) were greater in LL compared to SL (<em>P</em>&lt;0.05). No changes occurred in CON. Detraining decrements in strength and aCSA were greater in SL than LL (<em>P</em>&lt;0.05). <b>Discussion:</b> Enhanced muscle <em>in vivo</em> (and somewhat IGF-I) adaptations to resistance training are concurrent with muscle stretch, which warrants its inclusion within training. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Modulation of muscle characteristics was attempted through altering muscle stretch during resistance training. We hypothesized that stretch would enhance muscle responses. Methods: Participants trained for 8 weeks, loading the quadriceps in a shortened (SL-0-50o knee flexion; n=10) or lengthened (LL- 40-90o; n=11) position, followed by 4 weeks detraining. Controls (CON; n=10) were untrained. Quadriceps strength, Vastus Lateralis architecture, anatomical cross-sectional area (aCSA), and serum IGF-I (insulin-like growth factor 1) were measured at weeks 0, 8, 10, and 12. Results: Increases in fascicle length (29±4% vs. 14±4%), distal aCSA (53±12% vs. 18±8%), strength (26±6% vs. 7±3%), and IGF-I (31±6% vs. 7±6%) were greater in LL compared to SL (P&lt;0.05). No changes occurred in CON. Detraining decrements in strength and aCSA were greater in SL than LL (P&lt;0.05). Discussion: Enhanced muscle in vivo (and somewhat IGF-I) adaptations to resistance training are concurrent with muscle stretch, which warrants its inclusion within training. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23885" xmlns="http://purl.org/rss/1.0/"><title>Schwann cells seeded in acellular nerve grafts improve functional recovery</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23885</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Schwann cells seeded in acellular nerve grafts improve functional recovery</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nithya J. Jesuraj, Katherine B. Santosa, Matthew R. MacEwan, Amy M. Moore, Rahul Kasukurthi, Wilson Z. Ray, Eric R. Flagg, Daniel A. Hunter, Gregory H. Borschel, Philip J. Johnson, Susan E. Mackinnon, Shelly E. Sakiyama-Elbert</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-26T12:05:20.624585-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23885</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23885</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23885</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction:</b> This study evaluated whether Schwann cells (SCs) from different nerve sources transplanted into cold-preserved acellular nerve grafts (CP-ANGs) would improve functional regeneration compared to nerve isografts.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods:</b> SCs isolated and expanded from motor and sensory branches of rat femoral and sciatic nerves were seeded into 14mm CP-ANGs. Growth factor expression, axonal regeneration, and functional recovery were evaluated in a14 mm rat sciatic injury model and compared to isografts.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> At 14 days, motor or sensory-derived SCs increased expression of growth factors in CP-ANGs versus isografts. After 42 days, histomorphometric analysis found CP-ANGs with SCs and isografts had similar numbers of regenerating nerve fibers. At 84 days, muscle force generation was similar for CP-ANGs with SCs and isografts. SC source did not affect nerve fiber counts or muscle force generation.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion</b>: SCs transplanted into CP-ANGs increase functional regeneration to isograft levels; however SC nerve source did not have an effect. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: This study evaluated whether Schwann cells (SCs) from different nerve sources transplanted into cold-preserved acellular nerve grafts (CP-ANGs) would improve functional regeneration compared to nerve isografts.
Methods: SCs isolated and expanded from motor and sensory branches of rat femoral and sciatic nerves were seeded into 14mm CP-ANGs. Growth factor expression, axonal regeneration, and functional recovery were evaluated in a14 mm rat sciatic injury model and compared to isografts.
Results: At 14 days, motor or sensory-derived SCs increased expression of growth factors in CP-ANGs versus isografts. After 42 days, histomorphometric analysis found CP-ANGs with SCs and isografts had similar numbers of regenerating nerve fibers. At 84 days, muscle force generation was similar for CP-ANGs with SCs and isografts. SC source did not affect nerve fiber counts or muscle force generation.
Discussion: SCs transplanted into CP-ANGs increase functional regeneration to isograft levels; however SC nerve source did not have an effect. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23886" xmlns="http://purl.org/rss/1.0/"><title>Functional implications of impaired control of submaximal hip flexion following stroke</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23886</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Functional implications of impaired control of submaximal hip flexion following stroke</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Allison S. Hyngstrom, Henry R. Kuhnen, Kiersten M. Kirking, Sandra K. Hunter</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-26T11:07:40.836158-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23886</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23886</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23886</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: We quantified sub-maximal torque regulation during low to moderate intensity isometric hip flexion contractions in individuals with stroke and the associations with leg function. Methods: 10 participants with chronic stroke and 10 controls performed isometric hip flexion contractions at 5%, 10%, 15%, 20%, and 40% of maximal voluntary contraction (MVC) in paretic, non-paretic, and control legs. Results: Participants with stroke had larger torque fluctuations (coefficient of variation, CV), for both the paretic and non-paretic legs, than controls (<em>P</em>&lt;0.05) with the largest CV at 5% MVC in the paretic leg (P&lt;0.05). The paretic CV correlated with walking speed (<em>r</em><sup>2</sup> =0.45) and Berg Balance Score (r<sup>2</sup>=0.38). At 5% MVC, there were larger torque fluctuations in the contralateral leg during paretic contractions compared with the control leg. Conclusions: Impaired low-force regulation of paretic leg hip flexion can be functionally relevant and related to control versus strength deficits post stroke. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We quantified sub-maximal torque regulation during low to moderate intensity isometric hip flexion contractions in individuals with stroke and the associations with leg function. Methods: 10 participants with chronic stroke and 10 controls performed isometric hip flexion contractions at 5%, 10%, 15%, 20%, and 40% of maximal voluntary contraction (MVC) in paretic, non-paretic, and control legs. Results: Participants with stroke had larger torque fluctuations (coefficient of variation, CV), for both the paretic and non-paretic legs, than controls (P&lt;0.05) with the largest CV at 5% MVC in the paretic leg (P&lt;0.05). The paretic CV correlated with walking speed (r2 =0.45) and Berg Balance Score (r2=0.38). At 5% MVC, there were larger torque fluctuations in the contralateral leg during paretic contractions compared with the control leg. Conclusions: Impaired low-force regulation of paretic leg hip flexion can be functionally relevant and related to control versus strength deficits post stroke. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23887" xmlns="http://purl.org/rss/1.0/"><title>Non-genomic actions of progesterone and 17β-estradiol on the chloride conductance of skeletal muscle</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23887</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Non-genomic actions of progesterone and 17β-estradiol on the chloride conductance of skeletal muscle</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">James A Burge, Michael G Hanna, Stephanie Schorge</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-26T10:45:42.15943-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23887</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23887</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23887</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="mus23887-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Myotonia congenita, caused by mutations in <em>ClC-1</em>, tends to be more severe in men and is often exacerbated by pregnancy.</p></div></div>
<div class="section" id="mus23887-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>We did whole cell patch clamp of mouse muscle chloride currents in the absence/presence of 100 µM progesterone or 17ß-estradiol.</p></div></div>
<div class="section" id="mus23887-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>100 µM progesterone rapidly and reversibly shifted the ClC-1 activation curve of mouse skeletal muscle (V50 changed from -52.6 ± 9.3 to +35.5 ± 6.7, <em>P</em>&lt;0.01) and markedly reduced chloride currents at depolarized potentials. 17ß-estradiol at the same concentration had a similar but smaller effect (V50 change from -57.2 ± 7.6 to -40.5 ± 9.8, <em>P</em>&lt;0.05). 1 µM progesterone produced no significant effect.</p></div></div>
<div class="section" id="mus23887-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Discussion</h4><div class="para"><p>While the data support the existence of a non-genomic mechanism in mammalian skeletal muscle through which sex hormones at high concentration can rapidly modulate ClC-1, the influence of hormones on muscle excitability <em>in vivo</em> remains an open question. © 2013 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction
Myotonia congenita, caused by mutations in ClC-1, tends to be more severe in men and is often exacerbated by pregnancy.


Methods
We did whole cell patch clamp of mouse muscle chloride currents in the absence/presence of 100 µM progesterone or 17ß-estradiol.


Results
100 µM progesterone rapidly and reversibly shifted the ClC-1 activation curve of mouse skeletal muscle (V50 changed from -52.6 ± 9.3 to +35.5 ± 6.7, P&lt;0.01) and markedly reduced chloride currents at depolarized potentials. 17ß-estradiol at the same concentration had a similar but smaller effect (V50 change from -57.2 ± 7.6 to -40.5 ± 9.8, P&lt;0.05). 1 µM progesterone produced no significant effect.


Discussion
While the data support the existence of a non-genomic mechanism in mammalian skeletal muscle through which sex hormones at high concentration can rapidly modulate ClC-1, the influence of hormones on muscle excitability in vivo remains an open question. © 2013 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23880" xmlns="http://purl.org/rss/1.0/"><title>Stretch activated signaling is modulated by stretch magnitude and contraction</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23880</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Stretch activated signaling is modulated by stretch magnitude and contraction</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jonathan M. Van Dyke, James L. W. Bain, Danny A. Riley</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-26T04:00:54.26083-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23880</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23880</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23880</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Stretch therapy is commonly utilized to prevent shortening maladaptation of skeletal muscle. Stretch in combination with isometric contraction prevents shortening, but the signaling mechanisms are not understood.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: Using a soleus tenotomy+stretch rat model, the phosphorylation-activation of mechanosensitive kinases (Akt, p70<sup>S6K</sup>, p38 MAPK, and ERK1/2) were measured for various stretch magnitudes, set relative to optimal soleus length (Lo).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: The kinases were not activated by passive stretch until it exceeded the normal physiological range. Stretch+isometric contraction resulted in relatively strong phosphorylation, even at short lengths.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion</b>: While passive stretch results in kinase phosphorylation only during extreme lengthening, isometric contraction generated pronounced phosphorylation of kinases at Lo and Lo+25%, indicating stimulation of pathways that lead to the preservation or increase of muscle length.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Relevance</b>: Understanding the effects of passive and active stretch with respect to Lo and contraction is essential for predicting therapeutic outcomes and influencing optimal muscle length. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Stretch therapy is commonly utilized to prevent shortening maladaptation of skeletal muscle. Stretch in combination with isometric contraction prevents shortening, but the signaling mechanisms are not understood.
Methods: Using a soleus tenotomy+stretch rat model, the phosphorylation-activation of mechanosensitive kinases (Akt, p70S6K, p38 MAPK, and ERK1/2) were measured for various stretch magnitudes, set relative to optimal soleus length (Lo).
Results: The kinases were not activated by passive stretch until it exceeded the normal physiological range. Stretch+isometric contraction resulted in relatively strong phosphorylation, even at short lengths.
Discussion: While passive stretch results in kinase phosphorylation only during extreme lengthening, isometric contraction generated pronounced phosphorylation of kinases at Lo and Lo+25%, indicating stimulation of pathways that lead to the preservation or increase of muscle length.
Relevance: Understanding the effects of passive and active stretch with respect to Lo and contraction is essential for predicting therapeutic outcomes and influencing optimal muscle length. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23878" xmlns="http://purl.org/rss/1.0/"><title>Application of ultrasound to the median sensory and the ulnar motor nerve conduction studies</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23878</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Application of ultrasound to the median sensory and the ulnar motor nerve conduction studies</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hamilton Chen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-26T04:00:37.722217-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23878</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23878</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23878</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23879" xmlns="http://purl.org/rss/1.0/"><title>MR imaging in Duchenne muscular dystrophy: Longitudinal assessment of natural history over 18 months</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23879</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">MR imaging in Duchenne muscular dystrophy: Longitudinal assessment of natural history over 18 months</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">K.G. Hollingsworth, P. Garrood, M Eagle, K Bushby, V Straub</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-26T04:00:32.891552-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23879</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23879</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23879</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Purpose</b>: In Duchenne muscular dystrophy (DMD), fat replacement of muscle may be a useful endpoint in trials of therapy, though progression in different muscle groups is uneven. This study assesses the progression in fat replacement by T<sub>1</sub>-weighted imaging over 2 9-month periods.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: 8 ambulant, corticosteroid-treated boys with DMD were imaged at 3 Tesla at 3 time points (baseline, 9 and 18 months) with T<sub>1</sub> weighted imaging to measure fat replacement.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: The greatest increase in fat content was measured in the biceps femoris long head, vastus lateralis, and rectus femoris, while the biceps femoris short head, and gluteus maximus progressed more slowly. None of the lower leg muscles studied changed significantly.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusion:</b> MRI can measure specific changes in fat replacement of muscle over time, demonstrating the variability in rates of natural progression between muscle groups and identifying those muscles suitable for use as biomarkers in clinical trials. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Purpose: In Duchenne muscular dystrophy (DMD), fat replacement of muscle may be a useful endpoint in trials of therapy, though progression in different muscle groups is uneven. This study assesses the progression in fat replacement by T1-weighted imaging over 2 9-month periods.
Methods: 8 ambulant, corticosteroid-treated boys with DMD were imaged at 3 Tesla at 3 time points (baseline, 9 and 18 months) with T1 weighted imaging to measure fat replacement.
Results: The greatest increase in fat content was measured in the biceps femoris long head, vastus lateralis, and rectus femoris, while the biceps femoris short head, and gluteus maximus progressed more slowly. None of the lower leg muscles studied changed significantly.
Conclusion: MRI can measure specific changes in fat replacement of muscle over time, demonstrating the variability in rates of natural progression between muscle groups and identifying those muscles suitable for use as biomarkers in clinical trials. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23877" xmlns="http://purl.org/rss/1.0/"><title>Reg3G gene expression in regenerating skeletal muscle and corresponding nerve</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23877</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Reg3G gene expression in regenerating skeletal muscle and corresponding nerve</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gordana Starcevic Klasan, Danijel Ivanac, Dubravka Jurisic Erzen, Anne Picard, Shin Takasawa, Stanislav Peharec, Juraj Arbanas, Dean Girotto, Romana Jerkovic</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-16T03:00:42.125568-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23877</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23877</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23877</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction— The <em>Reg</em> genes play an important role in the regeneration of various tissues, however no reports have been published regarding the expression of the <em>Reg3G</em> gene in skeletal muscle. We have investigated the expression of <em>Reg3G</em> gene in regeneration of rat skeletal muscle and injured nerves.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Methods— We used three experimental models of muscle and nerve injury. RT-PCR and Western blot analysis was performed for the detection of Reg3G in regenerating muscle and nerve.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results— We found transcriptional activation of the <em>Reg3G</em> gene in the soleus and extensor digitorum longus muscles and in their corresponding nerves after both muscle and nerve injury in different time periods, respectively.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Conclusions— These results suggest that the <em>Reg3G</em> gene plays an important role in communication between injured axons and muscle and may play a significant role in skeletal muscle and peripheral nerve regeneration. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction— The Reg genes play an important role in the regeneration of various tissues, however no reports have been published regarding the expression of the Reg3G gene in skeletal muscle. We have investigated the expression of Reg3G gene in regeneration of rat skeletal muscle and injured nerves.
Methods— We used three experimental models of muscle and nerve injury. RT-PCR and Western blot analysis was performed for the detection of Reg3G in regenerating muscle and nerve.
Results— We found transcriptional activation of the Reg3G gene in the soleus and extensor digitorum longus muscles and in their corresponding nerves after both muscle and nerve injury in different time periods, respectively.
Conclusions— These results suggest that the Reg3G gene plays an important role in communication between injured axons and muscle and may play a significant role in skeletal muscle and peripheral nerve regeneration. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23875" xmlns="http://purl.org/rss/1.0/"><title>Sihler staining study of anastomosis between the facial and trigeminal nerves in the ocular area and its clinical implications</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23875</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Sihler staining study of anastomosis between the facial and trigeminal nerves in the ocular area and its clinical implications</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hun-Mu Yang, Sung-Yoon Won, Hee-Jin Kim, Kyung-Seok Hu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-16T03:00:29.736706-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23875</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23875</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23875</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: The trigeminal nerve (CN V) supplies mostly sensory innervation to the face, and the facial nerve (CN VII) conveys primarily motor fibers. The aim of this study was to elucidate their distributions and anastomoses.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: Fourteen specimens of hemisectioned faces were gathered from human cadavers and stained with Sihler staining.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: The temporal (Tbr), zygomatic (Zbr), and buccal (Bbr) branches of CN VII formed trigeminofacial anastomoses in the ocular area. Communications were observed between the supraorbital nerve and the Tbr (85.7%), the infraorbital nerve and the Bbr (100%) and Zbr (28.6%), and the zygomaticofacial nerve and the Zbr (41.7%). Anastomoses were formed between the supratrochlear nerve and the Tbr (57.1%) and Bbr (50%), and the infratrochlear nerve and the Bbr (85.7%).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion</b>: Motor and sensory axons to the face contribute to trigeminofacial anastomoses, which may play key roles in subtle movements of muscles of facial expression. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: The trigeminal nerve (CN V) supplies mostly sensory innervation to the face, and the facial nerve (CN VII) conveys primarily motor fibers. The aim of this study was to elucidate their distributions and anastomoses.
Methods: Fourteen specimens of hemisectioned faces were gathered from human cadavers and stained with Sihler staining.
Results: The temporal (Tbr), zygomatic (Zbr), and buccal (Bbr) branches of CN VII formed trigeminofacial anastomoses in the ocular area. Communications were observed between the supraorbital nerve and the Tbr (85.7%), the infraorbital nerve and the Bbr (100%) and Zbr (28.6%), and the zygomaticofacial nerve and the Zbr (41.7%). Anastomoses were formed between the supratrochlear nerve and the Tbr (57.1%) and Bbr (50%), and the infratrochlear nerve and the Bbr (85.7%).
Discussion: Motor and sensory axons to the face contribute to trigeminofacial anastomoses, which may play key roles in subtle movements of muscles of facial expression. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23876" xmlns="http://purl.org/rss/1.0/"><title>Motor nerve impairment in diabetic patients with symmetrical distal sensory polyneuropathy: A single nerve fiber conduction velocity study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23876</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Motor nerve impairment in diabetic patients with symmetrical distal sensory polyneuropathy: A single nerve fiber conduction velocity study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gulin Sunter, Kayihan Uluc, Celal Salcini, Cagri Mesut Temucin, Orhan Yilmaz, Tulin Tanridag, Onder Us, Luca Padua</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-16T03:00:25.926598-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23876</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23876</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23876</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: We investigated the clinical utility of single fiber conduction velocity (SF-CV) testing in the evaluation of motor nerve function in diabetic patients with signs and symptoms of symmetrical distal sensory polyneuropathy (DSP). SF-CV findings were compared with conventional nerve conduction studies (NCS).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: Twenty eight consecutive type-2 diabetic patients with clinically diagnosed DSP were studied.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: SF-CV testing of the tibial nerve was abnormal in 16 (57.1%) patients. Twelve patients with normal conventional motor NCS had abnormal findings by tibial SF-CV. SF-CV testing of the tibial nerve was significantly superior to all other motor NCS.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions</b>: SF-CV testing of the tibial nerve often demonstrates motor nerve impairment in diabetic patients with sensory DSP when conventional NCS are normal. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We investigated the clinical utility of single fiber conduction velocity (SF-CV) testing in the evaluation of motor nerve function in diabetic patients with signs and symptoms of symmetrical distal sensory polyneuropathy (DSP). SF-CV findings were compared with conventional nerve conduction studies (NCS).
Methods: Twenty eight consecutive type-2 diabetic patients with clinically diagnosed DSP were studied.
Results: SF-CV testing of the tibial nerve was abnormal in 16 (57.1%) patients. Twelve patients with normal conventional motor NCS had abnormal findings by tibial SF-CV. SF-CV testing of the tibial nerve was significantly superior to all other motor NCS.
Conclusions: SF-CV testing of the tibial nerve often demonstrates motor nerve impairment in diabetic patients with sensory DSP when conventional NCS are normal. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23874" xmlns="http://purl.org/rss/1.0/"><title>Internodal mechanism of pathological afterdischarges in myelinated axons</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23874</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Internodal mechanism of pathological afterdischarges in myelinated axons</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alexander G. Dimitrov, Nonna A. Dimitrova</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-12T04:10:54.947514-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23874</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23874</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23874</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Recent optical recordings of transmembrane potentials in the axons of pyramidal neurons show that the internodal action potentials (APs) predicted in our previous studies do exist. These novel processes are not well understood. We aim to clarify electrical phenomena in peripheral myelinated axons (MAs). <b>Methods</b>: We used a multi-cable Hodgkin-Huxley-type model to simulate MAs with potassium channels that were either normal or inhibited along a short region of the internodal membrane. A brief stimulus was applied to the first node. <b>Results</b>: We demonstrated peculiarities in the internodal APs induced by a saltatory AP: They existed across internodal membranes, were detectable in periaxonal space but not in intracellular space, propagated continuously and then collided near the mid-internodes, and produced internodal sources of afterdischarges. <b>Conclusion</b>: Our results highlight the importance of the MA internodal regions as new therapeutic targets for avoiding afterdischarges provoked by reduced axonal fast potassium channel expression. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Recent optical recordings of transmembrane potentials in the axons of pyramidal neurons show that the internodal action potentials (APs) predicted in our previous studies do exist. These novel processes are not well understood. We aim to clarify electrical phenomena in peripheral myelinated axons (MAs). Methods: We used a multi-cable Hodgkin-Huxley-type model to simulate MAs with potassium channels that were either normal or inhibited along a short region of the internodal membrane. A brief stimulus was applied to the first node. Results: We demonstrated peculiarities in the internodal APs induced by a saltatory AP: They existed across internodal membranes, were detectable in periaxonal space but not in intracellular space, propagated continuously and then collided near the mid-internodes, and produced internodal sources of afterdischarges. Conclusion: Our results highlight the importance of the MA internodal regions as new therapeutic targets for avoiding afterdischarges provoked by reduced axonal fast potassium channel expression. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23873" xmlns="http://purl.org/rss/1.0/"><title>Vascular access for therapeutic plasma exchange</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23873</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Vascular access for therapeutic plasma exchange</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bhupendra Khatri, John Kramer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-11T00:58:51.301362-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23873</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23873</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23873</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23872" xmlns="http://purl.org/rss/1.0/"><title>Andersen-Tawil syndrome presenting as a fixed myopathy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23872</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Andersen-Tawil syndrome presenting as a fixed myopathy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nicholas D. Child, James C. Cleland, Richard H. Roxburgh</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-09T04:07:21.509838-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23872</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23872</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23872</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23870" xmlns="http://purl.org/rss/1.0/"><title>Fluoxetine prevents acetylcholine-induced excitotoxicity blocking human endplate acetylcholine receptor</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23870</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Fluoxetine prevents acetylcholine-induced excitotoxicity blocking human endplate acetylcholine receptor</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cristina Deflorio, Myriam Catalano, Sergio Fucile, Cristina Limatola, Francesca Grassi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-05T03:40:35.379396-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23870</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23870</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23870</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction:</em> Fluoxetine is an open channel blocker of fetal muscle acetylcholine (ACh) receptor (AChR) and slow-channel mutant AChRs. It is used commonly to treat patients with slow-channel congenital myasthenic syndromes. Fluoxetine effects on adult wild-type endplate AChR are less characterized, although muscle AChR isoforms are differentially modulated by some drugs.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Methods:</em> Excitotoxicity assays and patch clamp recordings were performed in HEK cells expressing wild-type or slow-channel mutant human AChRs.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Results:</em> Fluoxetine (2–10 μM) abolished ACh-induced death and decreased ACh-activated whole-cell currents in cells expressing all AChR types. In outside-out patches, fluoxetine rapidly curtailed ACh-evoked unitary activity and macroscopic currents. The effect was increased if fluoxetine was applied before ACh.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Conclusions</em>: Fluoxetine is an open channel blocker, but it also affects AChR in the closed state. AChR blockade likely underlies the rescue of HEK cells from ACh-induced death. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Fluoxetine is an open channel blocker of fetal muscle acetylcholine (ACh) receptor (AChR) and slow-channel mutant AChRs. It is used commonly to treat patients with slow-channel congenital myasthenic syndromes. Fluoxetine effects on adult wild-type endplate AChR are less characterized, although muscle AChR isoforms are differentially modulated by some drugs.
Methods: Excitotoxicity assays and patch clamp recordings were performed in HEK cells expressing wild-type or slow-channel mutant human AChRs.
Results: Fluoxetine (2–10 μM) abolished ACh-induced death and decreased ACh-activated whole-cell currents in cells expressing all AChR types. In outside-out patches, fluoxetine rapidly curtailed ACh-evoked unitary activity and macroscopic currents. The effect was increased if fluoxetine was applied before ACh.
Conclusions: Fluoxetine is an open channel blocker, but it also affects AChR in the closed state. AChR blockade likely underlies the rescue of HEK cells from ACh-induced death. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23869" xmlns="http://purl.org/rss/1.0/"><title>West nile virus infection and myasthenia gravis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23869</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">West nile virus infection and myasthenia gravis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Arturo Leis, Gabriella Szatmary, Mark A. Ross, Dobrivoje S. Stokic</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-05T03:40:34.242032-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23869</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23869</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23869</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Viruses are commonly cited as triggers for autoimmune disease. It is unclear if West Nile virus (WNV) initiates autoimmunity.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Methods: We describe 6 cases of myasthenia gravis (MG) that developed several months after WNV infection. All patients had serologically confirmed WNV neuroinvasive disease. None had evidence of MG prior to WNV.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results: All patients had stable neurological deficits when they developed new symptoms of MG 3-to-7 months after WNV infection. However, residual deficits from WNV confounded or delayed MG diagnosis. All patients had elevated acetylcholine receptor (Ach-R) antibodies, and 1 had thymoma. Treatment varied, but 4 patients required acetylcholinesterase inhibitors, multiple immunosuppressive drugs, and intravenous immune globulin (IVIG) or plasmapheresis for recurrent MG crises.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Discussion: The pathogenic mechanism of MG following WNV remains uncertain. We hypothesize that WNV-triggered autoimmunity breaks immunological self-tolerance to initiate MG, possibly through molecular mimicry between virus antigens and Ach-R subunits or other autoimmune mechanisms. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Viruses are commonly cited as triggers for autoimmune disease. It is unclear if West Nile virus (WNV) initiates autoimmunity.
Methods: We describe 6 cases of myasthenia gravis (MG) that developed several months after WNV infection. All patients had serologically confirmed WNV neuroinvasive disease. None had evidence of MG prior to WNV.
Results: All patients had stable neurological deficits when they developed new symptoms of MG 3-to-7 months after WNV infection. However, residual deficits from WNV confounded or delayed MG diagnosis. All patients had elevated acetylcholine receptor (Ach-R) antibodies, and 1 had thymoma. Treatment varied, but 4 patients required acetylcholinesterase inhibitors, multiple immunosuppressive drugs, and intravenous immune globulin (IVIG) or plasmapheresis for recurrent MG crises.
Discussion: The pathogenic mechanism of MG following WNV remains uncertain. We hypothesize that WNV-triggered autoimmunity breaks immunological self-tolerance to initiate MG, possibly through molecular mimicry between virus antigens and Ach-R subunits or other autoimmune mechanisms. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23868" xmlns="http://purl.org/rss/1.0/"><title>A case diagnosed with MG at onset and LEMS 20 years later</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23868</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A case diagnosed with MG at onset and LEMS 20 years later</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Semiha G. Kurt, Ferah Kizilay, Gwendolyn Claussen, Shin J. Oh</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-05T03:40:33.044085-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23868</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23868</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23868</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23867" xmlns="http://purl.org/rss/1.0/"><title>High resolution ultrasound in posterior interosseous nerve syndrom</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23867</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">High resolution ultrasound in posterior interosseous nerve syndrom</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tanja Djurdjevic, Alexander Loizides, Wolfgang Löscher, Hannes Gruber, Michaela Plaikner, Siegfried Peer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-05T03:40:26.791733-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23867</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23867</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23867</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="mus23867-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Posterior interosseous nerve (PIN) syndrome is a rare compression neuropathy of the PIN in the region of the supinator muscle, most common by the arcade of Frohse. We aimed to specify ultrasonographic findings in patients with PIN-syndrome in comparison to healthy volunteers.</p></div></div>
<div class="section" id="mus23867-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Materials and Methods</h4><div class="para"><p>Ultrasound images and clinical data of 13 patients with PIN-syndrome confirmed by neurological examination and electrophysiological testing were evaluated retrospectively. Antero-posterior nerve diameters measured at the arcade of Frohse were compared with those of 20 healthy volunteers. The echotexture and the presence of a caliber change of the PIN were additionally assessed.</p></div></div>
<div class="section" id="mus23867-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Enlargement of the PIN was seen in all patients with PIN-syndrome, but not in volunteers (statistically significant difference in mean diameter p &lt; 0.05). Furthermore, edema and caliber change of the PIN were present in all patients.</p></div></div>
<div class="section" id="mus23867-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>High resolution ultrasound allows for differentiation of patients with PIN-syndrome and healthy volunteers. © 2013 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction
Posterior interosseous nerve (PIN) syndrome is a rare compression neuropathy of the PIN in the region of the supinator muscle, most common by the arcade of Frohse. We aimed to specify ultrasonographic findings in patients with PIN-syndrome in comparison to healthy volunteers.


Materials and Methods
Ultrasound images and clinical data of 13 patients with PIN-syndrome confirmed by neurological examination and electrophysiological testing were evaluated retrospectively. Antero-posterior nerve diameters measured at the arcade of Frohse were compared with those of 20 healthy volunteers. The echotexture and the presence of a caliber change of the PIN were additionally assessed.


Results
Enlargement of the PIN was seen in all patients with PIN-syndrome, but not in volunteers (statistically significant difference in mean diameter p &lt; 0.05). Furthermore, edema and caliber change of the PIN were present in all patients.


Conclusion
High resolution ultrasound allows for differentiation of patients with PIN-syndrome and healthy volunteers. © 2013 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23866" xmlns="http://purl.org/rss/1.0/"><title>Muscle size, activation and coactivation in adults with cerebral palsy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23866</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Muscle size, activation and coactivation in adults with cerebral palsy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ayser W. Hussain, Gladys L. Onambele, Alun G. Williams, Christopher I. Morse</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-05T03:40:22.643667-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23866</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23866</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23866</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction.</b> Muscle weakness is present in the paretic limbs of individuals with cerebral palsy (CP). We aimed to determine what neuromuscular factors contribute to weakness in adults with CP during isometric maximal voluntary contractions (iMVC).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Method.</b> Gastrocnemius anatomical cross sectional area (ACSA) and agonist and antagonist activation were measured in 11 CP and 11 control adult men during plantarflexion iMVC.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results.</b> Plantarflexion iMVC torque of the paretic leg was 42% and 52% less than the non-paretic and control limbs, respectively. The paretic gastrocnemius ACSA was smaller than the control group only. Paretic agonist activation was less than the non-paretic and control groups, whereas antagonist coactivation was higher. Multiple regression analysis revealed muscle activation accounted for 57% of variation in paretic plantarflexion iMVC torque.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion.</b> This demonstrates that in individuals with CP, muscle weakness in the paretic limb is attributed primarily to impaired neural activation and, to a lesser degree, ACSA. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction. Muscle weakness is present in the paretic limbs of individuals with cerebral palsy (CP). We aimed to determine what neuromuscular factors contribute to weakness in adults with CP during isometric maximal voluntary contractions (iMVC).
Method. Gastrocnemius anatomical cross sectional area (ACSA) and agonist and antagonist activation were measured in 11 CP and 11 control adult men during plantarflexion iMVC.
Results. Plantarflexion iMVC torque of the paretic leg was 42% and 52% less than the non-paretic and control limbs, respectively. The paretic gastrocnemius ACSA was smaller than the control group only. Paretic agonist activation was less than the non-paretic and control groups, whereas antagonist coactivation was higher. Multiple regression analysis revealed muscle activation accounted for 57% of variation in paretic plantarflexion iMVC torque.
Discussion. This demonstrates that in individuals with CP, muscle weakness in the paretic limb is attributed primarily to impaired neural activation and, to a lesser degree, ACSA. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23865" xmlns="http://purl.org/rss/1.0/"><title>Correlates of care for young men with duchenne and becker muscular dystrophy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23865</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Correlates of care for young men with duchenne and becker muscular dystrophy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jennifer G. Andrews, Melinda F. Davis, F. John Meaney</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-05T03:40:20.339786-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23865</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23865</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23865</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: In progressive conditions such as Duchenne and Becker muscular dystrophy (DBMD), the need for care may outpace care use. We examined correlates that contribute to utilization of needed care. Sample: Structured interviews were conducted on use of care among 34 young men with DBMD born before 1982. <em>Results</em>: Disease severity, per capita income, and presence of other relatives with DBMD predicted greater use of services. Race/ethnicity, acculturation, and level of caregiver education did not significantly predict service utilization. <em>Conclusions</em>: We identified disparities in receipt of healthcare and related services in adult men with DBMD that can affect quality of life. Despite the high disease severity identified in this population, these men utilized only half of the services available to individuals with significant progressive conditions. Providers should be aware of low service utilization and focus on awareness and assistance to ensure access to available care. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: In progressive conditions such as Duchenne and Becker muscular dystrophy (DBMD), the need for care may outpace care use. We examined correlates that contribute to utilization of needed care. Sample: Structured interviews were conducted on use of care among 34 young men with DBMD born before 1982. Results: Disease severity, per capita income, and presence of other relatives with DBMD predicted greater use of services. Race/ethnicity, acculturation, and level of caregiver education did not significantly predict service utilization. Conclusions: We identified disparities in receipt of healthcare and related services in adult men with DBMD that can affect quality of life. Despite the high disease severity identified in this population, these men utilized only half of the services available to individuals with significant progressive conditions. Providers should be aware of low service utilization and focus on awareness and assistance to ensure access to available care. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23864" xmlns="http://purl.org/rss/1.0/"><title>C7 nerve root sensory distribution in peripheral nerves: A BOLD fMRI investigation at 9.4T</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23864</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">C7 nerve root sensory distribution in peripheral nerves: A BOLD fMRI investigation at 9.4T</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rupeng Li, Jacques A Machol, Xiping Liu, Patrick C Hettinger, Nicholas A Flugstad, Ji-Geng Yan, Hani S Matloub, James S Hyde</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-05T03:39:57.4333-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23864</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23864</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23864</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction:</em> We aimed to elucidate the linear makeup of each major nerve of the upper limb by the C7 root through sensory stimulation and functional MRI in a rat model. <em>Methods:</em> The C7 nerve root and major nerves of the right forelimb were stimulated electrically. Blood oxygen level dependent functional magnetic resonance imaging (BOLD fMRI) was performed concurrently. Voxel overlap within the primary sensory cortex was calculated. <em>Results:</em> C7 comprises sensation in less than 1% in the musculocutaneous nerve, 6% in the ulnar nerve, 16% in the radial nerve, and 19% in the median nerve (<em>P</em>&lt;0.005 for each). <em>Conclusions:</em> The overlap is always under 25% for each major nerve. <em>Clinical relevance:</em> This study helps explain why C7 is a suitable donor for brachial plexus injury treatment and why there is only a transient sensory deficit after transfer. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We aimed to elucidate the linear makeup of each major nerve of the upper limb by the C7 root through sensory stimulation and functional MRI in a rat model. Methods: The C7 nerve root and major nerves of the right forelimb were stimulated electrically. Blood oxygen level dependent functional magnetic resonance imaging (BOLD fMRI) was performed concurrently. Voxel overlap within the primary sensory cortex was calculated. Results: C7 comprises sensation in less than 1% in the musculocutaneous nerve, 6% in the ulnar nerve, 16% in the radial nerve, and 19% in the median nerve (P&lt;0.005 for each). Conclusions: The overlap is always under 25% for each major nerve. Clinical relevance: This study helps explain why C7 is a suitable donor for brachial plexus injury treatment and why there is only a transient sensory deficit after transfer. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23863" xmlns="http://purl.org/rss/1.0/"><title>Platelet-rich plasma limits the nerve injury caused by 10% dextrose in the rabbit median nerve</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23863</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Platelet-rich plasma limits the nerve injury caused by 10% dextrose in the rabbit median nerve</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gi-Young Park, Dong Rak Kwon</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-05T03:39:49.158937-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23863</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23863</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23863</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: We evaluated the effect of platelet-rich plasma (PRP) injection in a rabbit model of dextrose-induced median nerve injury.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Methods: New Zealand white rabbits (n = 15) were randomly divided into 3 groups. Three different regimens (Group 1: 0.1 mL saline; Group 2: 10% dextrose with PRP; Group 3: 10% dextrose with saline) were injected within the carpal tunnel. Electrophysiological and histological findings were evaluated at 12 weeks after the injection.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results: The mean median motor latency in group 3 was significantly longer than that in groups 1 and 2. The cross sectional area of the median nerve and subsynovial connective tissue thickness in group 3 were significantly larger than those in groups 1 and 2.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Conclusion: PRP injection may be effective in controlling median nerve injury, as demonstrated by improvement in electrophysiological and histological findings at 12 weeks after the dextrose injection. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We evaluated the effect of platelet-rich plasma (PRP) injection in a rabbit model of dextrose-induced median nerve injury.
Methods: New Zealand white rabbits (n = 15) were randomly divided into 3 groups. Three different regimens (Group 1: 0.1 mL saline; Group 2: 10% dextrose with PRP; Group 3: 10% dextrose with saline) were injected within the carpal tunnel. Electrophysiological and histological findings were evaluated at 12 weeks after the injection.
Results: The mean median motor latency in group 3 was significantly longer than that in groups 1 and 2. The cross sectional area of the median nerve and subsynovial connective tissue thickness in group 3 were significantly larger than those in groups 1 and 2.
Conclusion: PRP injection may be effective in controlling median nerve injury, as demonstrated by improvement in electrophysiological and histological findings at 12 weeks after the dextrose injection. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23862" xmlns="http://purl.org/rss/1.0/"><title>Novel GNE compound heterozygous mutations in a GNE myopathy patient</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23862</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Novel GNE compound heterozygous mutations in a GNE myopathy patient</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Huaying Cai, Ichiro Yabe, Shinichi Shirai, Hiroaki Nishmura, Makoto Hirotani, Takahiro Kano, Hideki Houzen, Kazuto Yoshida, Hidenao Sasaki</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-05T03:39:44.537502-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23862</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23862</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23862</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Case of the Month</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction:</em> Molecular studies have revealed that some patients with myopathies with rimmed vacuoles have pathogenic mutations in UDP-<em>N</em>-acetylglucosamine-2-epimerase/<em>N</em>-acetylmannosamine kinase (<em>GNE</em>) and Z-band alternatively spliced PDZ motif-containing protein (<em>ZASP</em>) genes. <em>Methods</em>: We investigated a patient with distal myopathy with rimmed vacuoles by muscle biopsy and sequencing of 6 candidate genes. <em>Results</em>: The patient carried <em>GNE</em> compound heterozygous missense mutations (p.V421A and p.N635K) and a <em>ZASP</em> variant (p.D673N). This patient presented with distal weakness sparing the quadriceps muscles and had atypical results for Z-band-associated protein immunostaining. This indicates that the <em>GNE</em> mutations are pathogenic, and the diagnosis is compatible with GNE myopathy. <em>Conclusions</em>: By combining pathological studies and candidate gene screening, we identified a patient with GNE myopathy due to novel <em>GNE</em> compound heterozygous mutations. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Molecular studies have revealed that some patients with myopathies with rimmed vacuoles have pathogenic mutations in UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase (GNE) and Z-band alternatively spliced PDZ motif-containing protein (ZASP) genes. Methods: We investigated a patient with distal myopathy with rimmed vacuoles by muscle biopsy and sequencing of 6 candidate genes. Results: The patient carried GNE compound heterozygous missense mutations (p.V421A and p.N635K) and a ZASP variant (p.D673N). This patient presented with distal weakness sparing the quadriceps muscles and had atypical results for Z-band-associated protein immunostaining. This indicates that the GNE mutations are pathogenic, and the diagnosis is compatible with GNE myopathy. Conclusions: By combining pathological studies and candidate gene screening, we identified a patient with GNE myopathy due to novel GNE compound heterozygous mutations. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23861" xmlns="http://purl.org/rss/1.0/"><title>The relationship between passive stiffness and muscle power output: Influence of muscle CSA normalization</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23861</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The relationship between passive stiffness and muscle power output: Influence of muscle CSA normalization</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ty B. Palmer, Nathaniel D.M. Jenkins, Brennan J. Thompson, Douglas B. Smith, Joel T. Cramer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-05T03:39:33.062815-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23861</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23861</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23861</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: We examined the relationship between passive stiffness of the posterior hip and thigh muscles and muscle power output prior to and following normalization of passive stiffness to muscle cross-sectional area (CSA). <em>Methods</em>: Pearson correlation coefficients (<em>r</em>) were used to assess the relationships between the normalized and non-normalized slopes of the initial (phase 1) and final (phase 2) portions of the angle-torque curve and peak power output (Pmax). <em>Results</em>: A significant positive relationship was observed between the non-normalized slope of phase 1 and Pmax (<em>r</em>=0.723; <em>P</em>≤0.001); however, no correlations were observed between the normalized slope of phase 1 and Pmax (<em>r</em>=0.244; <em>P</em>=0.299) nor between Pmax and the normalized and non-normalized slopes of phase 2 (<em>r</em>=-0.159-0.418; <em>P</em>=0.067-0.504). <em>Conclusions</em>: These findings suggested that muscle size, rather than stiffness, accounted for a significant portion of the variance in muscle power output. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We examined the relationship between passive stiffness of the posterior hip and thigh muscles and muscle power output prior to and following normalization of passive stiffness to muscle cross-sectional area (CSA). Methods: Pearson correlation coefficients (r) were used to assess the relationships between the normalized and non-normalized slopes of the initial (phase 1) and final (phase 2) portions of the angle-torque curve and peak power output (Pmax). Results: A significant positive relationship was observed between the non-normalized slope of phase 1 and Pmax (r=0.723; P≤0.001); however, no correlations were observed between the normalized slope of phase 1 and Pmax (r=0.244; P=0.299) nor between Pmax and the normalized and non-normalized slopes of phase 2 (r=-0.159-0.418; P=0.067-0.504). Conclusions: These findings suggested that muscle size, rather than stiffness, accounted for a significant portion of the variance in muscle power output. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23860" xmlns="http://purl.org/rss/1.0/"><title>Local anesthetic effects on gene transcription in human skeletal muscle biopsies</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23860</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Local anesthetic effects on gene transcription in human skeletal muscle biopsies</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Todd A. Trappe, Robert A. Standley, Sophia Liu, Bozena Jemiolo, Scott W. Trappe, Matthew P. Harber</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-02T04:56:11.855911-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23860</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23860</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23860</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: We examined if epinephrine in the local anesthetic to help control incision-related bleeding interferes with molecular measurements obtained with the Duchenne-Bergström percutaneous needle biopsy technique for sampling human skeletal muscle. <em>Methods</em>: Three groups received 2.5-3.0ml of 1%-lidocaine in 2 injections: 1) 0.5-1.0ml superficially that varied among the groups: i) <em>-Epi</em>: intra- and subcutaneous without epinephrine; ii) <em>+Epi-Fascia</em>: intra- and subcutaneous with epinephrine, avoiding the fascia; iii) <em>+Epi+Fascia</em>: intra- and subcutaneous with epinephrine, directing a small amount (~0.2ml) into the fascia area; and 2) ~2.0ml without epinephrine into the fascia area for all subjects. A muscle biopsy was obtained 5-10min later for IL-6 and MuRF-1 mRNA levels. <em>Results</em>: IL-6 mRNA levels were low in -Epi and +Epi-Fascia, but ~300 fold higher in +Epi+Fascia. MuRF-1 mRNA levels were similar among groups. <em>Conclusion</em>: Lidocaine with epinephrine can confound intramuscular measurements from needle biopsies, but this can be avoided with a careful injection approach. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We examined if epinephrine in the local anesthetic to help control incision-related bleeding interferes with molecular measurements obtained with the Duchenne-Bergström percutaneous needle biopsy technique for sampling human skeletal muscle. Methods: Three groups received 2.5-3.0ml of 1%-lidocaine in 2 injections: 1) 0.5-1.0ml superficially that varied among the groups: i) -Epi: intra- and subcutaneous without epinephrine; ii) +Epi-Fascia: intra- and subcutaneous with epinephrine, avoiding the fascia; iii) +Epi+Fascia: intra- and subcutaneous with epinephrine, directing a small amount (~0.2ml) into the fascia area; and 2) ~2.0ml without epinephrine into the fascia area for all subjects. A muscle biopsy was obtained 5-10min later for IL-6 and MuRF-1 mRNA levels. Results: IL-6 mRNA levels were low in -Epi and +Epi-Fascia, but ~300 fold higher in +Epi+Fascia. MuRF-1 mRNA levels were similar among groups. Conclusion: Lidocaine with epinephrine can confound intramuscular measurements from needle biopsies, but this can be avoided with a careful injection approach. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23859" xmlns="http://purl.org/rss/1.0/"><title>The utility of skin biopsy in management of small fiber neuropathy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23859</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The utility of skin biopsy in management of small fiber neuropathy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Scott A. Boruchow, Christopher H. Gibbons</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-29T09:26:40.43259-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23859</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23859</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23859</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: We examined the role of skin biopsy in the evaluation and management of patients with suspected small fiber neuropathy (SFN).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Methods</em>: A retrospective chart review was performed among all patients who underwent skin biopsy for evaluation of SFN at our institution between March, 2008 and March, 2011. Change in management was defined as a new diagnosis or change in treatment in response to both positive and negative skin biopsies.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Results</em>: Among 69 patients who underwent skin biopsy, 25 had pathological evidence of an SFN, and 9 had evidence of a borderline SFN. Change in management or diagnosis occurred in 14 of 25 patients with definite SFN, 6 of 9 patients with borderline SFN, and 16 of 35 biopsy negative patients.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Conclusions</em>: Skin biopsy changed management or diagnosis in 52% of patients evaluated for a possible SFN and appears to play a valuable role in the workup of these patients. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We examined the role of skin biopsy in the evaluation and management of patients with suspected small fiber neuropathy (SFN).
Methods: A retrospective chart review was performed among all patients who underwent skin biopsy for evaluation of SFN at our institution between March, 2008 and March, 2011. Change in management was defined as a new diagnosis or change in treatment in response to both positive and negative skin biopsies.
Results: Among 69 patients who underwent skin biopsy, 25 had pathological evidence of an SFN, and 9 had evidence of a borderline SFN. Change in management or diagnosis occurred in 14 of 25 patients with definite SFN, 6 of 9 patients with borderline SFN, and 16 of 35 biopsy negative patients.
Conclusions: Skin biopsy changed management or diagnosis in 52% of patients evaluated for a possible SFN and appears to play a valuable role in the workup of these patients. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23858" xmlns="http://purl.org/rss/1.0/"><title>Suramin attenuates dystrophin-deficient cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23858</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Suramin attenuates dystrophin-deficient cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Drielen de Oliveira Moreira, Juliano Alves Pereira, Ana Paula Tiemi Taniguti, Cíntia Yuri Matsumura, Luis Alberto Ferreira Ramos, Miguel Arcanjo Areas, Humberto Santo Neto, Maria Julia Marques</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-28T03:55:10.381714-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23858</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23858</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23858</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: To evaluate the effects of suramin, an antifibrotic agent, on the cardiac function and remodeling in the <em>mdx</em> mice.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Methods: <em>mdx</em> mice (8 months old) received intraperitoneal injections of suramin twice a week for 3 months. Control <em>mdx</em> mice (8 months old) were injected with saline.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results: Suramin improved the electrocardiography profile with main corrections seen in S/R wave ratio, PR interval, Q amplitude with a significant decrease in the cardiomyopathy index. Suramin decreased myocardial fibrosis, inflammation, and myonecrosis.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Discussion - These findings suggest that the antifibrotic drug suramin may be a potential new adjunctive therapy to help improve cardiomyopathy in DMD. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: To evaluate the effects of suramin, an antifibrotic agent, on the cardiac function and remodeling in the mdx mice.
Methods: mdx mice (8 months old) received intraperitoneal injections of suramin twice a week for 3 months. Control mdx mice (8 months old) were injected with saline.
Results: Suramin improved the electrocardiography profile with main corrections seen in S/R wave ratio, PR interval, Q amplitude with a significant decrease in the cardiomyopathy index. Suramin decreased myocardial fibrosis, inflammation, and myonecrosis.
Discussion - These findings suggest that the antifibrotic drug suramin may be a potential new adjunctive therapy to help improve cardiomyopathy in DMD. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23856" xmlns="http://purl.org/rss/1.0/"><title>Twitch and M-wave potentiation induced by intermittent maximal voluntary quadriceps contractions: Differences between direct quadriceps and femoral nerve stimulation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23856</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Twitch and M-wave potentiation induced by intermittent maximal voluntary quadriceps contractions: Differences between direct quadriceps and femoral nerve stimulation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Javier Rodriguez-Falces, Nicola A. Maffiuletti, Nicolas Place</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-28T03:34:42.37102-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23856</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23856</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23856</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: To investigate differences in twitch and M-wave potentiation in the quadriceps femoris when electrical stimulation is applied over the quadriceps muscle belly versus the femoral nerve trunk.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: M-waves and mechanical twitches were evoked using direct quadriceps muscle and femoral nerve stimulation between 48 successive isometric maximal voluntary contractions (MVC) from 10 young, healthy subjects. Potentiation was investigated by analyzing the changes in M-wave amplitude recorded from the vastus medialis (VM) and vastus lateralis (VL) muscles and in quadriceps peak twitch force.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: Potentiation of twitch, VM M-wave, and VL M-wave were greater for femoral nerve than for direct quadriceps stimulation (<em>P</em>&lt;0.05). Despite a 50% decrease in MVC force, the amplitude of the M-waves increased significantly during exercise.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions</b>: In addition to enhanced electrogenic Na<sup>+</sup>-K<sup>+</sup> pumping, other factors (such as synchronization in activation of muscle fibers and muscle architectural properties) might significantly influence the magnitude of M-wave enlargement. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: To investigate differences in twitch and M-wave potentiation in the quadriceps femoris when electrical stimulation is applied over the quadriceps muscle belly versus the femoral nerve trunk.
Methods: M-waves and mechanical twitches were evoked using direct quadriceps muscle and femoral nerve stimulation between 48 successive isometric maximal voluntary contractions (MVC) from 10 young, healthy subjects. Potentiation was investigated by analyzing the changes in M-wave amplitude recorded from the vastus medialis (VM) and vastus lateralis (VL) muscles and in quadriceps peak twitch force.
Results: Potentiation of twitch, VM M-wave, and VL M-wave were greater for femoral nerve than for direct quadriceps stimulation (P&lt;0.05). Despite a 50% decrease in MVC force, the amplitude of the M-waves increased significantly during exercise.
Conclusions: In addition to enhanced electrogenic Na+-K+ pumping, other factors (such as synchronization in activation of muscle fibers and muscle architectural properties) might significantly influence the magnitude of M-wave enlargement. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23857" xmlns="http://purl.org/rss/1.0/"><title>The accuracy of the ice test in the diagnosis of myasthenia gravis in patients with ptosis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23857</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The accuracy of the ice test in the diagnosis of myasthenia gravis in patients with ptosis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Omeed Fakiri, Dénes L.J. Tavy, Ako Dara Hama-Amin, Paul W. Wirtz</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-28T03:34:30.967526-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23857</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23857</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23857</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Several studies have reported high diagnostic sensitivity and specificity for the ice test in myasthenia gravis. All of the studies employed a case–control design, in which the diagnosis was already known at the time of the test for both patients and controls, leading to case selection bias. This suggests that the available literature substantially overestimates the diagnostic utility of these tests.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: A retrospective cohort study without selection bias was performed to examine the sensitivity and specificity of the ice test. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the ice test were determined by means of a 2x2 table.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: The ice test has a sensitivity of 0.92 (95% CI, 0.62-1.00), specificity of 0.79 (95%CI, 0.56-1.00), PPV of 0.73 ( 95%CI, 0.48-0.90) and a NPV of 0.94 (95%CI, 0.70-1.00).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion</b>: Due to its high negative predictive value the ice test still is a reliable and useful bed-side test. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Several studies have reported high diagnostic sensitivity and specificity for the ice test in myasthenia gravis. All of the studies employed a case–control design, in which the diagnosis was already known at the time of the test for both patients and controls, leading to case selection bias. This suggests that the available literature substantially overestimates the diagnostic utility of these tests.
Methods: A retrospective cohort study without selection bias was performed to examine the sensitivity and specificity of the ice test. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the ice test were determined by means of a 2x2 table.
Results: The ice test has a sensitivity of 0.92 (95% CI, 0.62-1.00), specificity of 0.79 (95%CI, 0.56-1.00), PPV of 0.73 ( 95%CI, 0.48-0.90) and a NPV of 0.94 (95%CI, 0.70-1.00).
Discussion: Due to its high negative predictive value the ice test still is a reliable and useful bed-side test. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23855" xmlns="http://purl.org/rss/1.0/"><title>Peripheral neuropathy: Assessment of proximal nerve integrity by diffusion tensor imaging (DTI)</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23855</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Peripheral neuropathy: Assessment of proximal nerve integrity by diffusion tensor imaging (DTI)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Christian Mathys, Joel Aissa, Gerd Meyer zu Hörste, Dorothea C. Reichelt, Gerald Antoch, Bernd Turowski, Hans-Peter Hartung, Kazim A. Sheikh, Helmar C. Lehmann</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-26T05:41:43.334661-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23855</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23855</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23855</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Objectives: We investigated the utility of diffusion tensor imaging (DTI) for detecting neuropathic changes in proximal nerve segments in patients with peripheral neuropathy.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Methods: Twenty-one individuals with (n=11) and without (n=10) peripheral neuropathy underwent DTI of a defined sciatic nerve segment. Patients and controls were evaluated by clinical examination and nerve conduction studies at baseline and six months after the initial DTI scan.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results: The mean fractional anisotropy (FA) value was significantly lower in sciatic nerves from patients with peripheral neuropathy as compared to controls. Sciatic nerve FA values correlated with clinical disability scores and electrophysiological parameters of axonal damage at baseline and 6 months after MRI scan.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Conclusions: DTI-derived FA values are a sensitive measure to discriminate healthy from functionally impaired human sciatic nerve segments. DTI of proximal nerve segments might be useful for estimating the proximal axonal degeneration burden in patients with peripheral neuropathies. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Objectives: We investigated the utility of diffusion tensor imaging (DTI) for detecting neuropathic changes in proximal nerve segments in patients with peripheral neuropathy.
Methods: Twenty-one individuals with (n=11) and without (n=10) peripheral neuropathy underwent DTI of a defined sciatic nerve segment. Patients and controls were evaluated by clinical examination and nerve conduction studies at baseline and six months after the initial DTI scan.
Results: The mean fractional anisotropy (FA) value was significantly lower in sciatic nerves from patients with peripheral neuropathy as compared to controls. Sciatic nerve FA values correlated with clinical disability scores and electrophysiological parameters of axonal damage at baseline and 6 months after MRI scan.
Conclusions: DTI-derived FA values are a sensitive measure to discriminate healthy from functionally impaired human sciatic nerve segments. DTI of proximal nerve segments might be useful for estimating the proximal axonal degeneration burden in patients with peripheral neuropathies. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23854" xmlns="http://purl.org/rss/1.0/"><title>Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies: A review</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23854</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies: A review</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Payam Mohassel, Andrew L. Mammen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-21T04:16:04.302329-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23854</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23854</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23854</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Invited Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Statins are among the most commonly prescribed medications that significantly reduce cardiovascular risk in selected individuals. However, these drugs can also be associated with muscle symptoms ranging from mild myalgias to severe rhabdomyolysis. While statin myotoxicity is usually self-limited, in some instances statin-exposed subjects can develop an autoimmune myopathy typically characterized by progressive weakness, muscle enzyme elevations, a necrotizing myopathy on muscle biopsy, and autoantibodies that recognize 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), the pharmacologic target of statins. These antibodies are also found in some autoimmune myopathy patients without statin exposure. Importantly, anti-HMGCR antibodies are not found in the vast majority of statin-exposed subjects without autoimmune myopathy, including those with self-limited statin intolerance. Thus, testing for these antibodies may help differentiate those with self-limited statin myopathy who recover after statin discontinuation from those with a progressive statin-associated autoimmune myopathy who typically require immunosuppressive therapy. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Statins are among the most commonly prescribed medications that significantly reduce cardiovascular risk in selected individuals. However, these drugs can also be associated with muscle symptoms ranging from mild myalgias to severe rhabdomyolysis. While statin myotoxicity is usually self-limited, in some instances statin-exposed subjects can develop an autoimmune myopathy typically characterized by progressive weakness, muscle enzyme elevations, a necrotizing myopathy on muscle biopsy, and autoantibodies that recognize 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), the pharmacologic target of statins. These antibodies are also found in some autoimmune myopathy patients without statin exposure. Importantly, anti-HMGCR antibodies are not found in the vast majority of statin-exposed subjects without autoimmune myopathy, including those with self-limited statin intolerance. Thus, testing for these antibodies may help differentiate those with self-limited statin myopathy who recover after statin discontinuation from those with a progressive statin-associated autoimmune myopathy who typically require immunosuppressive therapy. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23853" xmlns="http://purl.org/rss/1.0/"><title>RE: An algorithm for the safety of costal diaphragm electromyography derived from ultrasound</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23853</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">RE: An algorithm for the safety of costal diaphragm electromyography derived from ultrasound</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Peter B Saadeh, Pierre B Saadeh</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:23:38.651719-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23853</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23853</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23853</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23851" xmlns="http://purl.org/rss/1.0/"><title>Guillain-Barré-like syndrome associated with lung adenocarcinoma and CASPR2 antibodies</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23851</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Guillain-Barré-like syndrome associated with lung adenocarcinoma and CASPR2 antibodies</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Erdem Tüzün, Demet Kınay, Yael Hacohen, Fikret Aysal, Angela Vincent</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:23:34.126353-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23851</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23851</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23851</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23852" xmlns="http://purl.org/rss/1.0/"><title>Response to saadeh and saadeh</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23852</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Response to saadeh and saadeh</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nasim Amirjani, Simon C Gandevia</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:23:21.940069-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23852</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23852</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23852</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Reply to Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23849" xmlns="http://purl.org/rss/1.0/"><title>3-Dimensional morphometric mapping of rat muscle fibers</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23849</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">3-Dimensional morphometric mapping of rat muscle fibers</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ioannis P Kalpidis, Dorothea Kapoukranidou, Nicolas Charalambakis, Athanasios Chatzisotiriou, Maria Albani</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:23:11.434351-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23849</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23849</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23849</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Quantitative descriptions of fiber type organization in hindlimb muscles are incomplete or rare. Methods: Fiber morphometrics for both rat tibialis anterior (TA) muscles were measured in 3 dimensions. Results: Slow oxidative fiber area and perimeter varied in all zones. Fast oxidative glycolytic fibers (FOG) were predominant in the mediolateral and posterior zones, and fast glycolytic fibers (FG) predominated in the anterior zone. The mean area of FOG and succinate dehydrogenase intermediate fibers was lowest in the anterior zone. Mean area of FG was highest in the proximal and distal parts of the muscle. The area and perimeter of fast fibers differed significantly between the right and left limbs in the medial zone. In the middle and lateral zones, they differed at the proximal and distal parts. Discussion: Our detailed analysis in a high resolution, 3-dimensional map provides an essential tool for understanding the structure and function of TA muscles. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Quantitative descriptions of fiber type organization in hindlimb muscles are incomplete or rare. Methods: Fiber morphometrics for both rat tibialis anterior (TA) muscles were measured in 3 dimensions. Results: Slow oxidative fiber area and perimeter varied in all zones. Fast oxidative glycolytic fibers (FOG) were predominant in the mediolateral and posterior zones, and fast glycolytic fibers (FG) predominated in the anterior zone. The mean area of FOG and succinate dehydrogenase intermediate fibers was lowest in the anterior zone. Mean area of FG was highest in the proximal and distal parts of the muscle. The area and perimeter of fast fibers differed significantly between the right and left limbs in the medial zone. In the middle and lateral zones, they differed at the proximal and distal parts. Discussion: Our detailed analysis in a high resolution, 3-dimensional map provides an essential tool for understanding the structure and function of TA muscles. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23850" xmlns="http://purl.org/rss/1.0/"><title>Phrenic nerve stimulation protects against mechanical ventilation-induced diaphragm dysfunction in rats</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23850</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Phrenic nerve stimulation protects against mechanical ventilation-induced diaphragm dysfunction in rats</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Meirong Yang, Haitao Wang, Guangwei Han, Lianhua Chen, Lina Huang, Jihong Jiang, Shitong Li</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:22:58.658115-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23850</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23850</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23850</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: We investigated a novel application of phrenic nerve stimulation (PNS) in diaphragm dysfunction induced by mechanical ventilation (MV). Methods: Twenty-one Sprague-Dawley rats were randomly assigned to 3 groups: spontaneous breathing, 18-h controlled MV, and 18-h controlled MV with PNS. Upon completion of the experimental protocol, diaphragm contractility, gene expression of insulin-like growth factor-1 (IGF-1) and ubiquitin ligases, and serum IGF-1 levels were analyzed. Results: Compared with the spontaneously breathing rats, impaired diaphragm contractile function, including force-related properties and force-frequency responses, were pronounced with MV. Furthermore, MV suppressed IGF-1 and induced muscle ring finger 1 mRNA expression in the diaphragm. In contrast, PNS counteracted MV-induced gene expression changes in the diaphragm and restored diaphragm function. Conclusion: PNS exerted a protective effect against MV-induced diaphragm dysfunction by counteracting altered expression of IGF-1 and ubiquitin ligase in the diaphragm. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We investigated a novel application of phrenic nerve stimulation (PNS) in diaphragm dysfunction induced by mechanical ventilation (MV). Methods: Twenty-one Sprague-Dawley rats were randomly assigned to 3 groups: spontaneous breathing, 18-h controlled MV, and 18-h controlled MV with PNS. Upon completion of the experimental protocol, diaphragm contractility, gene expression of insulin-like growth factor-1 (IGF-1) and ubiquitin ligases, and serum IGF-1 levels were analyzed. Results: Compared with the spontaneously breathing rats, impaired diaphragm contractile function, including force-related properties and force-frequency responses, were pronounced with MV. Furthermore, MV suppressed IGF-1 and induced muscle ring finger 1 mRNA expression in the diaphragm. In contrast, PNS counteracted MV-induced gene expression changes in the diaphragm and restored diaphragm function. Conclusion: PNS exerted a protective effect against MV-induced diaphragm dysfunction by counteracting altered expression of IGF-1 and ubiquitin ligase in the diaphragm. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23847" xmlns="http://purl.org/rss/1.0/"><title>Pure ocular anti-MuSK myasthenia under no immunosuppressive treatment</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23847</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Pure ocular anti-MuSK myasthenia under no immunosuppressive treatment</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Vasiliki Zouvelou, Athanasios Papathanasiou, Christos Koros, Michael Rentzos, Thomas Zambelis, Eleftherios Stamboulis</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:22:57.515386-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23847</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23847</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23847</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23848" xmlns="http://purl.org/rss/1.0/"><title>A fast skeletal muscle troponin activator in the dy2J muscular dystrophy model</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23848</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A fast skeletal muscle troponin activator in the dy2J muscular dystrophy model</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jessica J. Miciak, Leigh C. Warsing, Maria E. Tibbs, Jeffrey R. Jasper, Sarah B. Jampel, Fady I. Malik, Clarke Tankersley, Kathryn R. Wagner</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:22:54.525241-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23848</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23848</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23848</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Tirasemtiv is a novel small molecule activator of the fast skeletal muscle troponin complex that produces sensitization of the sarcomere to calcium. Tirasemtiv is currently in Phase II clinical trials for neuromuscular diseases.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Methods: We conducted a blinded, randomized, placebo-controlled preclinical study of the effect of tirasemtiv on forearm grip strength, endurance, respiratory physiology, and muscle pathology in adequate sample sizes of the <em>Lama2<sup>dy-2J</sup></em> mouse model of congenital muscular dystrophy.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results: Mice receiving a high dose of tirasemtiv had significantly higher muscle fiber cross sectional area and respiratory response to CO<sub>2</sub> stimulation at 16 weeks than mice on low dose or placebo. There were no changes in muscle pathology, serum creatine kinase, strength, endurance, or respiration following long-term treatment.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Discussion: We conclude that tirasemtiv influences the structure of the skeletal muscle fiber in this model of muscular dystrophy but does not impact muscle function, as evaluated in this study. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Tirasemtiv is a novel small molecule activator of the fast skeletal muscle troponin complex that produces sensitization of the sarcomere to calcium. Tirasemtiv is currently in Phase II clinical trials for neuromuscular diseases.
Methods: We conducted a blinded, randomized, placebo-controlled preclinical study of the effect of tirasemtiv on forearm grip strength, endurance, respiratory physiology, and muscle pathology in adequate sample sizes of the Lama2dy-2J mouse model of congenital muscular dystrophy.
Results: Mice receiving a high dose of tirasemtiv had significantly higher muscle fiber cross sectional area and respiratory response to CO2 stimulation at 16 weeks than mice on low dose or placebo. There were no changes in muscle pathology, serum creatine kinase, strength, endurance, or respiration following long-term treatment.
Discussion: We conclude that tirasemtiv influences the structure of the skeletal muscle fiber in this model of muscular dystrophy but does not impact muscle function, as evaluated in this study. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23845" xmlns="http://purl.org/rss/1.0/"><title>Ultrasound diagnosis of bony nerve entrapment: Case series and literature review</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23845</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Ultrasound diagnosis of bony nerve entrapment: Case series and literature review</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Carmen Erra, Giuseppe Granata, Giovanna Liotta, Simon Podnar, Mauro Giannini, Hani Kushlaf, Lisa D. Hobson-Webb, Fraser J. Leversedge, Carlo Martinoli, Luca Padua</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:22:41.768491-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23845</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23845</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23845</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Case of the Month</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Nerve entrapment due to osseous callus formation is a rare complication after bone fractures. Electrodiagnostic studies and routine radiographic imaging often fail to demonstrate the pathology. The diagnosis is difficult and is often made incidentally upon surgical exploration. Nerve ultrasonography has not been used routinely used to assess such lesions.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Case report</b>: We report 5 cases of nerve entrapment in osseous callus following fractures which were seen in 2011 and 2012. The diagnosis was made by ultrasound (US). We then performed a review of the relevant literature.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions</b>: US is becoming an invaluable tool for diagnosing peripheral nerve entrapments. The current cases suggest that nerve US should be strongly considered as an adjunctive diagnostic tool for nerve palsies developing after trauma. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Nerve entrapment due to osseous callus formation is a rare complication after bone fractures. Electrodiagnostic studies and routine radiographic imaging often fail to demonstrate the pathology. The diagnosis is difficult and is often made incidentally upon surgical exploration. Nerve ultrasonography has not been used routinely used to assess such lesions.
Case report: We report 5 cases of nerve entrapment in osseous callus following fractures which were seen in 2011 and 2012. The diagnosis was made by ultrasound (US). We then performed a review of the relevant literature.
Conclusions: US is becoming an invaluable tool for diagnosing peripheral nerve entrapments. The current cases suggest that nerve US should be strongly considered as an adjunctive diagnostic tool for nerve palsies developing after trauma. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23843" xmlns="http://purl.org/rss/1.0/"><title>Long-term outcome in CIDP patients treated with IVIg: A retrospective study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23843</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Long-term outcome in CIDP patients treated with IVIg: A retrospective study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Luis Querol, Ricard Rojas-Garcia, Carlos Casasnovas, Maria Jose Sedano, Jose Luis Muñoz-Blanco, Maria Antonia Alberti, Carmen Paradas, Teresa Sevilla, Julio Pardo, Jose Luis Capablo, Rafael Sivera, Antonio Guerrero, Eduardo Gutierrez-Rivas, Isabel Illa</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:22:31.709294-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23843</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23843</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23843</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>BACKGROUND: The objective of this retrospective study was to describe the short- and long-term patterns of IVIg use, safety, and response to treatment in CIDP patients. METHODS: Response to therapy was defined as an improvement of at least 1 point on the Modified Rankin Score at short- and mid-term visits. Patient status at long term was classified as remission, stability, or non-responder. RESULTS: 86 patients were included; 60.5% responded at short term and 54.6% at mid term. At long term, 25.6% of patients were in remission, 65.1% were stable, and 9.3% were non-responders. The only variable associated with remission was a better response during the first 6 months of follow-up. CONCLUSIONS: A significant percentage of patients did not require any additional drugs in the long term. This suggests that treatment effect or disease outcome may be stable over time, and treatment regimens should therefore be individualized to avoid overtreatment. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

BACKGROUND: The objective of this retrospective study was to describe the short- and long-term patterns of IVIg use, safety, and response to treatment in CIDP patients. METHODS: Response to therapy was defined as an improvement of at least 1 point on the Modified Rankin Score at short- and mid-term visits. Patient status at long term was classified as remission, stability, or non-responder. RESULTS: 86 patients were included; 60.5% responded at short term and 54.6% at mid term. At long term, 25.6% of patients were in remission, 65.1% were stable, and 9.3% were non-responders. The only variable associated with remission was a better response during the first 6 months of follow-up. CONCLUSIONS: A significant percentage of patients did not require any additional drugs in the long term. This suggests that treatment effect or disease outcome may be stable over time, and treatment regimens should therefore be individualized to avoid overtreatment. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23844" xmlns="http://purl.org/rss/1.0/"><title>Role of TRPM2 cation channels in dorsal root ganglion of rats following experimental spinal cord injury</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23844</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Role of TRPM2 cation channels in dorsal root ganglion of rats following experimental spinal cord injury</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mustafa Nazıroğlu, Abdülhadi Cihangir Uğuz, Özgür İsmailoğlu, Bilal Çiğ, Cemil Özgül, Muhammed Borcak</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:20:48.693845-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23844</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23844</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23844</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: We sought to determine the contribution of oxidative stress-dependent activation of TRPM2 and L-type voltage-gated Ca<sup>2+</sup> channels (VGCC) in dorsal root ganglion (DRG) neurons of rats following spinal cord injury (SCI).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Methods</em>: The rats were divided into 4 groups: control, sham control, SCI, and SCI+nimodipine groups. The neurons of the SCI groups were also incubated with non-specific TRPM2 channel blockers, 2-aminoethoxydiphenyl borate (2-APB) and N-(p-amylcinnamoyl)anthranilic acid (ACA) before H<sub>2</sub>O<sub>2</sub> stimulation.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Results</em>: The [Ca<sup>2+</sup>]<sub>i</sub> concentrations were higher in the SCI group than in the control groups, although their concentrations were decreased by nimodipine and 2-APB. The H<sub>2</sub>O<sub>2</sub>-induced TRPM2 current densities in patch-clamp experiments were decreased by ACA and 2-APB incubation. In the nimodipine group, the TRPM2 channels of neurons were not activated by H<sub>2</sub>O<sub>2</sub> or cumene hydroperoxide.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Conclusions</em>: Increased Ca<sup>2+</sup> influx and currents in DRG neurons following spinal injury indicated TRPM2 and voltage-gated Ca<sup>2+</sup> channel activation. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We sought to determine the contribution of oxidative stress-dependent activation of TRPM2 and L-type voltage-gated Ca2+ channels (VGCC) in dorsal root ganglion (DRG) neurons of rats following spinal cord injury (SCI).
Methods: The rats were divided into 4 groups: control, sham control, SCI, and SCI+nimodipine groups. The neurons of the SCI groups were also incubated with non-specific TRPM2 channel blockers, 2-aminoethoxydiphenyl borate (2-APB) and N-(p-amylcinnamoyl)anthranilic acid (ACA) before H2O2 stimulation.
Results: The [Ca2+]i concentrations were higher in the SCI group than in the control groups, although their concentrations were decreased by nimodipine and 2-APB. The H2O2-induced TRPM2 current densities in patch-clamp experiments were decreased by ACA and 2-APB incubation. In the nimodipine group, the TRPM2 channels of neurons were not activated by H2O2 or cumene hydroperoxide.
Conclusions: Increased Ca2+ influx and currents in DRG neurons following spinal injury indicated TRPM2 and voltage-gated Ca2+ channel activation. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23841" xmlns="http://purl.org/rss/1.0/"><title>Correlating ultrasound findings of carpal tunnel syndrome with nerve conduction studies</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23841</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Correlating ultrasound findings of carpal tunnel syndrome with nerve conduction studies</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jae Min Kim, Min Wook Kim, Young Jin Ko</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:20:46.594404-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23841</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23841</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23841</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objective</b>: To determine correlations between ultrasonographic findings of thenar muscle and flexor retinaculum, and nerve conduction studies (NCS) in carpal tunnel syndrome (CTS).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: Ultrasound and NCS were performed on 92 wrists with CTS and on 40 wrists from healthy individuals. Ultrasound of thenar and hypothenar muscles, flexor retinaculum, and median nerve were assessed. The ultrasonographic findings were compared between the 2 groups, and correlation analysis between median latency and ultrasonographic findings was performed.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: Motor latency correlated positively with flexor retinaculum thickness (FRT) and correlated negatively with the ratio of thenar to hypothenar muscle. FRT and motor latency were found to be significantly increased in CTS. The ratio of thenar to hypothenar muscle was found to be significantly decreased in CTS when compared with controls.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions</b>: The ultrasonographic findings of FRT and thenar muscle reflect the severity of disease in patients with CTS and are valuable for the diagnosis of CTS. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Objective: To determine correlations between ultrasonographic findings of thenar muscle and flexor retinaculum, and nerve conduction studies (NCS) in carpal tunnel syndrome (CTS).
Methods: Ultrasound and NCS were performed on 92 wrists with CTS and on 40 wrists from healthy individuals. Ultrasound of thenar and hypothenar muscles, flexor retinaculum, and median nerve were assessed. The ultrasonographic findings were compared between the 2 groups, and correlation analysis between median latency and ultrasonographic findings was performed.
Results: Motor latency correlated positively with flexor retinaculum thickness (FRT) and correlated negatively with the ratio of thenar to hypothenar muscle. FRT and motor latency were found to be significantly increased in CTS. The ratio of thenar to hypothenar muscle was found to be significantly decreased in CTS when compared with controls.
Conclusions: The ultrasonographic findings of FRT and thenar muscle reflect the severity of disease in patients with CTS and are valuable for the diagnosis of CTS. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23842" xmlns="http://purl.org/rss/1.0/"><title>Electromyographic responses of the superficial quadriceps femoris muscles during incremental treadmill running</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23842</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Electromyographic responses of the superficial quadriceps femoris muscles during incremental treadmill running</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jorge M. Zuniga, Moh H. Malek</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:20:21.671152-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23842</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23842</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23842</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: We examined the individual patterns of responses for EMG amplitude and mean power frequency (MPF) during incremental treadmill running.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: Nine physically active men performed incremental treadmill running at a constant grade of 1%. The EMG signal was recorded from the 3 superficial quadriceps femoris muscles during the workbout.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: The results of the polynomial regression indicated that the linear model best fit the data for the composite data for all 3 muscles and the majority (7 of 9) of subjects. There were no consistent patterns of responses for the EMG MPF responses. Also, there were no significant (<em>P</em> &gt; 0.05) muscle × running velocity interactions for EMG amplitude and MPF.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion</b>: These results indicate consistent patterns of responses for EMG amplitude during incremental treadmill running regardless of which muscle was studied. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We examined the individual patterns of responses for EMG amplitude and mean power frequency (MPF) during incremental treadmill running.
Methods: Nine physically active men performed incremental treadmill running at a constant grade of 1%. The EMG signal was recorded from the 3 superficial quadriceps femoris muscles during the workbout.
Results: The results of the polynomial regression indicated that the linear model best fit the data for the composite data for all 3 muscles and the majority (7 of 9) of subjects. There were no consistent patterns of responses for the EMG MPF responses. Also, there were no significant (P &gt; 0.05) muscle × running velocity interactions for EMG amplitude and MPF.
Discussion: These results indicate consistent patterns of responses for EMG amplitude during incremental treadmill running regardless of which muscle was studied. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23840" xmlns="http://purl.org/rss/1.0/"><title>Surface distributed low-frequency asynchronous stimulation (sDLFAS) delays fatigue of stimulated muscles</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23840</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Surface distributed low-frequency asynchronous stimulation (sDLFAS) delays fatigue of stimulated muscles</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lana Z Popović Maneski, Nebojša M Malešević, Andrej M Savić, Thierry Keller, Dejan B Popović</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T04:19:42.680286-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23840</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23840</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23840</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>INTRODUCTION: One important reason why functional electrical stimulation (FES) has not gained widespread clinical use is the limitation imposed by rapid muscle fatigue due to the non-physiological activation of the stimulated muscles. We aimed to show that asynchronous low pulse rate (LPR) electrical stimulation applied by multi-pad surface electrodes greatly postpones the occurrence of muscle fatigue compared to conventional stimulation (high pulse rate, HPR). METHODS: We compared the produced force <em>vs</em>. time of the forearm muscles responsible for finger flexion in 2 stimulation protocols, LPR (f<sub>L</sub>= 10 Hz) and HPR (f<sub>H</sub>= 40 Hz). RESULTS: Surface distributed low-frequency asynchronous stimulation (sDLFAS) doubles the time interval before the onset of fatigue (104 ± 80%) compared to conventional synchronous stimulation. DISCUSSION: Combining the performance of multi-pad electrodes (increased selectivity and facilitated positioning) with sDLFAS (decreased fatigue) can improve many FES applications in both the lower and upper extremities. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

INTRODUCTION: One important reason why functional electrical stimulation (FES) has not gained widespread clinical use is the limitation imposed by rapid muscle fatigue due to the non-physiological activation of the stimulated muscles. We aimed to show that asynchronous low pulse rate (LPR) electrical stimulation applied by multi-pad surface electrodes greatly postpones the occurrence of muscle fatigue compared to conventional stimulation (high pulse rate, HPR). METHODS: We compared the produced force vs. time of the forearm muscles responsible for finger flexion in 2 stimulation protocols, LPR (fL= 10 Hz) and HPR (fH= 40 Hz). RESULTS: Surface distributed low-frequency asynchronous stimulation (sDLFAS) doubles the time interval before the onset of fatigue (104 ± 80%) compared to conventional synchronous stimulation. DISCUSSION: Combining the performance of multi-pad electrodes (increased selectivity and facilitated positioning) with sDLFAS (decreased fatigue) can improve many FES applications in both the lower and upper extremities. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23837" xmlns="http://purl.org/rss/1.0/"><title>Coenzyme Q10 deficiency in children: Frequent type 2C muscle fibers with normal morphology</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23837</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Coenzyme Q10 deficiency in children: Frequent type 2C muscle fibers with normal morphology</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. Brian Sommerville, Craig M. Zaidman, Alan Pestronk</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-14T04:19:00.97569-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23837</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23837</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23837</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: Neurological disorders with low tissue coenzyme Q<sub>10</sub> (CoQ<sub>10</sub>) levels are important to identify, as they may be treatable.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Methods</em>: We evaluated retrospectively clinical, laboratory, and muscle histochemistry and oxidative enzyme characteristics in 49 children with suspected mitochondrial disorders. We compared 18 with CoQ<sub>10</sub> deficiency in muscle to 31 with normal CoQ<sub>10</sub> values.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Results</em>: Muscle from CoQ<sub>10</sub>-deficient patients averaged 5.5-fold more frequent type 2C muscle fibers than controls (<em>P</em> &lt; 0.0001). A type 2C fiber frequency of ≥ 5% had 89% sensitivity and 84% specificity for CoQ<sub>10</sub> deficiency in this cohort. No biopsy showed active myopathy. There were no differences between groups in frequencies of mitochondrial myopathologic, clinical, or laboratory features. Multiple abnormalities in muscle oxidative enzyme activities were more frequent in CoQ<sub>10</sub>-deficient patients than in controls.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Conclusions</em>: When a childhood mitochondrial disorder is suspected, an increased frequency of type 2C fibers in morphologically normal muscle suggests CoQ<sub>10</sub> deficiency. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Neurological disorders with low tissue coenzyme Q10 (CoQ10) levels are important to identify, as they may be treatable.
Methods: We evaluated retrospectively clinical, laboratory, and muscle histochemistry and oxidative enzyme characteristics in 49 children with suspected mitochondrial disorders. We compared 18 with CoQ10 deficiency in muscle to 31 with normal CoQ10 values.
Results: Muscle from CoQ10-deficient patients averaged 5.5-fold more frequent type 2C muscle fibers than controls (P &lt; 0.0001). A type 2C fiber frequency of ≥ 5% had 89% sensitivity and 84% specificity for CoQ10 deficiency in this cohort. No biopsy showed active myopathy. There were no differences between groups in frequencies of mitochondrial myopathologic, clinical, or laboratory features. Multiple abnormalities in muscle oxidative enzyme activities were more frequent in CoQ10-deficient patients than in controls.
Conclusions: When a childhood mitochondrial disorder is suspected, an increased frequency of type 2C fibers in morphologically normal muscle suggests CoQ10 deficiency. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23838" xmlns="http://purl.org/rss/1.0/"><title>Expression of mitochondrial fission and fusion regulatory proteins in skeletal muscle during chronic use and disuse</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23838</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Expression of mitochondrial fission and fusion regulatory proteins in skeletal muscle during chronic use and disuse</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sobia Iqbal, Olga Ostojic, Kaustabh Singh, Anna-Maria Joseph, David A. Hood</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-14T04:18:58.637909-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23838</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23838</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23838</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>INTRODUCTION: The mitochondrial network within cells is mediated by fission and fusion processes. We investigated the expression of the proteins responsible for these events during conditions of altered oxidative capacity. RESULTS: With chronic contractile activity, the mitochondrial reticulum increased in size, along with concomitant increases in the fusion proteins Opa1 and Mfn2 (by 36% and 53%, p&lt;0.05). When we induced muscle disuse through denervation for 7-days, fragmented mitochondria were observed, along with significant decreases in the expression of Mfn2 and Opa1 (by 84% and 70%). To assess the effects of aging on mitochondrial morphology, young (5 month) and aged (35 month) Fisher344 Brown Norway rats were used. Aged animals also possessed smaller mitochondria and displayed increased levels of fission proteins. CONCLUSIONS: Chronic muscle use increases the ratio of fusion:fission proteins, leading to reticular mitochondria, whereas muscle disuse and aging result in a decrease in this ratio, culminating in fragmented organelles. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

INTRODUCTION: The mitochondrial network within cells is mediated by fission and fusion processes. We investigated the expression of the proteins responsible for these events during conditions of altered oxidative capacity. RESULTS: With chronic contractile activity, the mitochondrial reticulum increased in size, along with concomitant increases in the fusion proteins Opa1 and Mfn2 (by 36% and 53%, p&lt;0.05). When we induced muscle disuse through denervation for 7-days, fragmented mitochondria were observed, along with significant decreases in the expression of Mfn2 and Opa1 (by 84% and 70%). To assess the effects of aging on mitochondrial morphology, young (5 month) and aged (35 month) Fisher344 Brown Norway rats were used. Aged animals also possessed smaller mitochondria and displayed increased levels of fission proteins. CONCLUSIONS: Chronic muscle use increases the ratio of fusion:fission proteins, leading to reticular mitochondria, whereas muscle disuse and aging result in a decrease in this ratio, culminating in fragmented organelles. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23835" xmlns="http://purl.org/rss/1.0/"><title>Muscle volume as a predictor of maximum force generating ability in the plantar flexors post-stroke</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23835</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Muscle volume as a predictor of maximum force generating ability in the plantar flexors post-stroke</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Brian A. Knarr, John W. Ramsay, Thomas S. Buchanan, Jill S. Higginson, Stuart A. Binder-Macleod</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-14T04:18:54.452085-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23835</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23835</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23835</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Post-stroke muscle weakness is commonly thought to be the result of a combination of decreased voluntary activation and decreased maximum force generating ability (MFGA). We assessed the ability of muscle volumes obtained using magnetic resonance imaging (MRI) to estimate the MFGA of the plantar flexor muscle group in individuals post-stroke.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: MRI was used to measure muscle volume for the plantar flexor muscle group for 17 individuals with post-stroke hemiparesis. A modified burst superimposition test was used to measure MVC and predict the MFGA of the plantar flexors.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: While muscle volume obtained via MRI provided information on the overall size of muscle, it overestimated the force generating ability of the paretic plantar flexors.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion</b>: Results suggest that MRI-derived muscle volume underestimates the functional impairment in individuals post-stroke. Interestingly, the central activation ratio had a strong relationship with the maximum volitional force of contraction. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Post-stroke muscle weakness is commonly thought to be the result of a combination of decreased voluntary activation and decreased maximum force generating ability (MFGA). We assessed the ability of muscle volumes obtained using magnetic resonance imaging (MRI) to estimate the MFGA of the plantar flexor muscle group in individuals post-stroke.
Methods: MRI was used to measure muscle volume for the plantar flexor muscle group for 17 individuals with post-stroke hemiparesis. A modified burst superimposition test was used to measure MVC and predict the MFGA of the plantar flexors.
Results: While muscle volume obtained via MRI provided information on the overall size of muscle, it overestimated the force generating ability of the paretic plantar flexors.
Discussion: Results suggest that MRI-derived muscle volume underestimates the functional impairment in individuals post-stroke. Interestingly, the central activation ratio had a strong relationship with the maximum volitional force of contraction. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23836" xmlns="http://purl.org/rss/1.0/"><title>Fatigue and recovery from dynamic contractions in men and women differ for arm and leg muscles</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23836</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Fatigue and recovery from dynamic contractions in men and women differ for arm and leg muscles</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jonathon Senefeld, Tejin Yoon, Marie Hoeger Bement, Sandra K. Hunter</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-14T04:18:48.94761-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23836</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23836</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23836</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Whether there is gender difference in fatigue and recovery from maximal velocity fatiguing contractions and across muscles is not understood.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: 16 men and 19 women performed 90 isotonic contractions at maximal voluntary shortening velocity (maximal velocity concentric contractions: MVCC) with the elbow flexor and knee extensor muscles (separate days) at a load equivalent to 20% maximal voluntary isometric contraction (MVIC).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: Power (from MVCCs) decreased similarly for men and women for both muscles (<em>P</em>&gt;0.05). Men and women had similar declines in MVIC of elbow flexors, but men had greater reductions in knee extensor MVIC force and MVIC EMG activity than women (<em>P</em>&lt;0.05). The decline in MVIC and power was greater, and force recovery was slower for the elbow flexors compared to knee extensors.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion</b>: The gender difference in muscle fatigue often observed during isometric tasks was diminished during fast dynamic contractions for upper and lower limb muscles. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Whether there is gender difference in fatigue and recovery from maximal velocity fatiguing contractions and across muscles is not understood.
Methods: 16 men and 19 women performed 90 isotonic contractions at maximal voluntary shortening velocity (maximal velocity concentric contractions: MVCC) with the elbow flexor and knee extensor muscles (separate days) at a load equivalent to 20% maximal voluntary isometric contraction (MVIC).
Results: Power (from MVCCs) decreased similarly for men and women for both muscles (P&gt;0.05). Men and women had similar declines in MVIC of elbow flexors, but men had greater reductions in knee extensor MVIC force and MVIC EMG activity than women (P&lt;0.05). The decline in MVIC and power was greater, and force recovery was slower for the elbow flexors compared to knee extensors.
Discussion: The gender difference in muscle fatigue often observed during isometric tasks was diminished during fast dynamic contractions for upper and lower limb muscles. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23834" xmlns="http://purl.org/rss/1.0/"><title>Ethnic Differences in Epidermal Nerve Fiber Density</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23834</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Ethnic Differences in Epidermal Nerve Fiber Density</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cecilia M. Shikuma, Justin C. McArthur, Gigi J. Ebenezer, Jintanat Ananworanich, Nipat Teeratakulpisarn, Tanate Jadwattanakul, Victor G. Valcour, Kara Bennett, Nittaya Phanuphak, </dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-09T05:17:28.96027-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23834</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23834</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23834</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23833" xmlns="http://purl.org/rss/1.0/"><title>Electrical Impedance Myography in the Diagnosis of Radiculopathy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23833</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Electrical Impedance Myography in the Diagnosis of Radiculopathy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Andrew J. Spieker, Pushpa Narayanaswami, Laura Fleming, John C. Keel, Stefan C. Muzin, Seward B. Rutkove</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-09T05:17:24.830799-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23833</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23833</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23833</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction:</b> We sought to determine whether electrical impedance myography (EIM) could serve as a diagnostic procedure for evaluation of radiculopathy.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods:</b> Twenty-seven patients with clinically and radiologically diagnosed cervical or lumbosacral radiculopathy who met a gold-standard definition underwent EIM and standard needle electromyography (EMG) of multiple upper or lower extremity muscles.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> EIM reactance values revealed consistent reductions in the radiculopathy-affected myotomal muscles as compared to those on the unaffected side; the degree of asymmetry was associated strongly with the degree of EMG abnormality (<em>P</em> &lt; 0.001). EIM had a sensitivity of 64.5% and a specificity of 77.0%; in comparison, EMG had a sensitivity of 79.7% but a specificity of 69.7%.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion:</b> These findings support the potential for EIM to serve as a new noninvasive tool to assist in diagnosis of radiculopathy; however, further refinement of the technique for this specific application is needed. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We sought to determine whether electrical impedance myography (EIM) could serve as a diagnostic procedure for evaluation of radiculopathy.
Methods: Twenty-seven patients with clinically and radiologically diagnosed cervical or lumbosacral radiculopathy who met a gold-standard definition underwent EIM and standard needle electromyography (EMG) of multiple upper or lower extremity muscles.
Results: EIM reactance values revealed consistent reductions in the radiculopathy-affected myotomal muscles as compared to those on the unaffected side; the degree of asymmetry was associated strongly with the degree of EMG abnormality (P &lt; 0.001). EIM had a sensitivity of 64.5% and a specificity of 77.0%; in comparison, EMG had a sensitivity of 79.7% but a specificity of 69.7%.
Discussion: These findings support the potential for EIM to serve as a new noninvasive tool to assist in diagnosis of radiculopathy; however, further refinement of the technique for this specific application is needed. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23832" xmlns="http://purl.org/rss/1.0/"><title>The function of death-associated protein 1 in proliferation, differentiation, and apoptosis of chicken satellite cells</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23832</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The function of death-associated protein 1 in proliferation, differentiation, and apoptosis of chicken satellite cells</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jonghyun Shin, Douglas C. Mcfarland, Gale M. Strasburg, Sandra G. Velleman</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-09T05:17:21.912158-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23832</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23832</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23832</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Muscle growth and regeneration are processes closely associated with the proliferation, differentiation, and apoptosis of muscle cells. Death-associated protein 1 (DAP1) has been identified as a negative regulator of autophagy. Little is known about the function of DAP1 in the regulation of myogenesis and satellite cells. Methods: Chicken satellite cells were transfected with <em>DAP1</em> cloned into the pCMS-Enhanced Green Fluorescent Protein vector or pcDNA3.1 vector, or a small interference RNA against the endogenous <em>DAP1</em> gene. They were assayed for proliferation, differentiation, and apoptosis. Results: The over-expression of DAP1 increased proliferation, differentiation, and myotube diameter but it had no effect on satellite cell apoptosis. In contrast, knockdown of DAP1 significantly decreased proliferation, differentiation, and number of nuclei per myotube, and it increased apoptosis of the cells. Conclusion: DAP1 is required for regulating myogenesis and apoptosis of satellite cells, which may affect muscle mass accretion and regeneration, and ameliorate muscle sarcopenia. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Muscle growth and regeneration are processes closely associated with the proliferation, differentiation, and apoptosis of muscle cells. Death-associated protein 1 (DAP1) has been identified as a negative regulator of autophagy. Little is known about the function of DAP1 in the regulation of myogenesis and satellite cells. Methods: Chicken satellite cells were transfected with DAP1 cloned into the pCMS-Enhanced Green Fluorescent Protein vector or pcDNA3.1 vector, or a small interference RNA against the endogenous DAP1 gene. They were assayed for proliferation, differentiation, and apoptosis. Results: The over-expression of DAP1 increased proliferation, differentiation, and myotube diameter but it had no effect on satellite cell apoptosis. In contrast, knockdown of DAP1 significantly decreased proliferation, differentiation, and number of nuclei per myotube, and it increased apoptosis of the cells. Conclusion: DAP1 is required for regulating myogenesis and apoptosis of satellite cells, which may affect muscle mass accretion and regeneration, and ameliorate muscle sarcopenia. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23827" xmlns="http://purl.org/rss/1.0/"><title>Genetic and clinical characteristics of skeletal and cardiac muscle in patients with LMNA gene mutations</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23827</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Genetic and clinical characteristics of skeletal and cardiac muscle in patients with LMNA gene mutations</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nicola Carboni, Anna Mateddu, Giovanni Marrosu, Eleonora Cocco, Maria Giovanna Marrosu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-28T07:54:55.550736-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23827</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23827</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23827</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Invited Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Alterations of the lamin A/C (<em>LMNA</em>) gene are associated with different clinical entities, including disorders that affect skeletal and cardiac muscle, peripheral nerves, metabolism, bones, and disorders that cause premature aging. This article reviews the clinical and genetic characteristics of cardiac and skeletal muscle diseases related to alterations in the <em>LMNA</em> gene. There is not a univocal explanation of how <em>LMNA</em> gene alterations may cause these disorders; however, important goals have been achieved in understanding the pathogenic effects of <em>LMNA</em> gene mutations on cardiac and skeletal muscle. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Alterations of the lamin A/C (LMNA) gene are associated with different clinical entities, including disorders that affect skeletal and cardiac muscle, peripheral nerves, metabolism, bones, and disorders that cause premature aging. This article reviews the clinical and genetic characteristics of cardiac and skeletal muscle diseases related to alterations in the LMNA gene. There is not a univocal explanation of how LMNA gene alterations may cause these disorders; however, important goals have been achieved in understanding the pathogenic effects of LMNA gene mutations on cardiac and skeletal muscle. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23829" xmlns="http://purl.org/rss/1.0/"><title>The role of chemokines in Guillain-Barré syndrome</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23829</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The role of chemokines in Guillain-Barré syndrome</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sharon Chiang, Eroboghene E. Ubogu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-28T07:17:15.182158-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23829</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23829</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23829</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Invited Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Chemokines and their receptors are important mediators of inflammation. Guillain-Barré syndrome (GBS) is the most common cause of acute paralysis worldwide. Despite current treatments, outcomes are suboptimal. Specific chemokine receptor antagonists have the potential to be efficacious against pathogenic leukocyte trafficking in GBS.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Methods: A 36-year literature review was performed to summarize available data on chemokine expression in GBS and its representative animal model, experimental autoimmune neuritis (EAN).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results: Although there were a few observational human and animal studies demonstrating chemokine ligand/ receptor expression in GBS and EAN, <em>in vitro</em> and <em>in vivo</em> functional studies using gene knockouts, neutralizing antibodies, or small molecular antagonists were limited. CCL2-CCR2, CCL5-CCR5, and CXCL10-CXCR3 have been most strongly implicated in EAN and GBS pathogenesis, providing targets for molecular blockade.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Discussion: Preclinical human <em>in vitro</em> and <em>in vivo</em> EAN studies are needed to evaluate the potential efficacy of chemokine signaling inhibition in GBS. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Chemokines and their receptors are important mediators of inflammation. Guillain-Barré syndrome (GBS) is the most common cause of acute paralysis worldwide. Despite current treatments, outcomes are suboptimal. Specific chemokine receptor antagonists have the potential to be efficacious against pathogenic leukocyte trafficking in GBS.
Methods: A 36-year literature review was performed to summarize available data on chemokine expression in GBS and its representative animal model, experimental autoimmune neuritis (EAN).
Results: Although there were a few observational human and animal studies demonstrating chemokine ligand/ receptor expression in GBS and EAN, in vitro and in vivo functional studies using gene knockouts, neutralizing antibodies, or small molecular antagonists were limited. CCL2-CCR2, CCL5-CCR5, and CXCL10-CXCR3 have been most strongly implicated in EAN and GBS pathogenesis, providing targets for molecular blockade.
Discussion: Preclinical human in vitro and in vivo EAN studies are needed to evaluate the potential efficacy of chemokine signaling inhibition in GBS. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23830" xmlns="http://purl.org/rss/1.0/"><title>Multifocal radiculoneuropathy during ipilimumab treatment of melanoma</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23830</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Multifocal radiculoneuropathy during ipilimumab treatment of melanoma</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Georgios Manousakis, James Koch, R Brian Sommerville, Ahmed El-Dokla, Matthew B Harms, Muhammad T Al-Lozi, Robert E Schmidt, Alan Pestronk</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-28T07:15:28.467328-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23830</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23830</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23830</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Case of the Month</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Ipilimumab, a monoclonal anti-CTLA-4 antibody, is used to treat melanoma. Neuromuscular side effects, possibly autoimmune, may occur. <b>Methods</b>: Retrospective review of records. <b>Results</b>: After 3 doses of ipilimumab a 31-year old man developed asymmetric, severe weakness involving all limbs, respiration, and cranial nerves, which was progressive over 2 weeks. EMG/NCS showed an axonal polyradiculoneuropathy with multifocal motor conduction blocks. CSF protein was 749. Nerve pathology showed inflammation around endoneurial microvessels and subperineurial edema and inflammation. Spine MRI showed leptomeningeal and anterior and posterior root enhancement. Strength improved slowly over months after ipilimumab discontinuation and immunomodulating treatment. <b>Discussion</b>: Ipilimumab toxicity presented as a monophasic, multifocal, asymmetric polyradiculoneuropathy involving roots and peripheral and cranial nerves. Ipilimumab may produce a polyradiculoneuropathy with disruption of the blood-nerve barrier due to a microvasculopathy. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Ipilimumab, a monoclonal anti-CTLA-4 antibody, is used to treat melanoma. Neuromuscular side effects, possibly autoimmune, may occur. Methods: Retrospective review of records. Results: After 3 doses of ipilimumab a 31-year old man developed asymmetric, severe weakness involving all limbs, respiration, and cranial nerves, which was progressive over 2 weeks. EMG/NCS showed an axonal polyradiculoneuropathy with multifocal motor conduction blocks. CSF protein was 749. Nerve pathology showed inflammation around endoneurial microvessels and subperineurial edema and inflammation. Spine MRI showed leptomeningeal and anterior and posterior root enhancement. Strength improved slowly over months after ipilimumab discontinuation and immunomodulating treatment. Discussion: Ipilimumab toxicity presented as a monophasic, multifocal, asymmetric polyradiculoneuropathy involving roots and peripheral and cranial nerves. Ipilimumab may produce a polyradiculoneuropathy with disruption of the blood-nerve barrier due to a microvasculopathy. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23828" xmlns="http://purl.org/rss/1.0/"><title>Motor unit firing pattern of vastus lateralis muscle in type 2 diabetes mellitus patients</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23828</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Motor unit firing pattern of vastus lateralis muscle in type 2 diabetes mellitus patients</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kohei Watanabe, Marco Gazzoni, Ales Holobar, Toshiaki Miyamoto, Kazuhito Fukuda, Roberto Merletti, Toshio Moritani</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-28T07:15:24.369693-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23828</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23828</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23828</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b> We investigated the motor unit (MU) firing pattern in type 2 diabetes mellitus (T2DM) patients by means of multi-channel surface electromyography (SEMG). <b>Methods</b> Eight T2DM patients and 8 age-matched healthy men performed a ramp-up contraction up to 20% of maximal voluntary contraction (MVC). They also performed a sustained contraction at 10% of MVC during isometric knee extension. Multi-channel SEMG signals recorded from the vastus lateralis muscle were decomposed with the Convolution Kernel Compensation technique to extract individual MU firing patterns. <b>Results</b> During the ramp contraction, the extent of MU firing modulation was significantly attenuated in T2DM. Variability of MU firing rate was significantly higher in T2DM at later periods during the sustained contraction. <b>Discussion</b> Our findings suggest that T2DM patients manifest characteristic MU activity patterns due possibly to some degree of neuromuscular impairment affecting the integrity of MU firing modulation. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction We investigated the motor unit (MU) firing pattern in type 2 diabetes mellitus (T2DM) patients by means of multi-channel surface electromyography (SEMG). Methods Eight T2DM patients and 8 age-matched healthy men performed a ramp-up contraction up to 20% of maximal voluntary contraction (MVC). They also performed a sustained contraction at 10% of MVC during isometric knee extension. Multi-channel SEMG signals recorded from the vastus lateralis muscle were decomposed with the Convolution Kernel Compensation technique to extract individual MU firing patterns. Results During the ramp contraction, the extent of MU firing modulation was significantly attenuated in T2DM. Variability of MU firing rate was significantly higher in T2DM at later periods during the sustained contraction. Discussion Our findings suggest that T2DM patients manifest characteristic MU activity patterns due possibly to some degree of neuromuscular impairment affecting the integrity of MU firing modulation. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23825" xmlns="http://purl.org/rss/1.0/"><title>Reply to “Exertional hyperCKemia might be the first manifestation of a genetic disorder”</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23825</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Reply to “Exertional hyperCKemia might be the first manifestation of a genetic disorder”</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kimbra Kenney, Mark E Landau, William W Campbell</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-22T09:57:44.527374-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23825</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23825</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23825</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Reply to Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23824" xmlns="http://purl.org/rss/1.0/"><title>Grading severity of carpal tunnel syndrome in EDX Reports: Why grading is recommended</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23824</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Grading severity of carpal tunnel syndrome in EDX Reports: Why grading is recommended</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Benjamin M. Sucher</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-22T09:57:31.51563-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23824</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23824</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23824</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Issues &amp; Opinions</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Carpal tunnel syndrome (CTS) is not difficult to confirm by electrodiagnosis (EDX), but the challenge lies in whether to grade the severity and the method for doing so. The arguments about grading are discussed, with an emphasis in favor, using a method that relies on the EDX data, but qualifies that it is the median neuropathy being graded and not the syndrome of CTS. Although use of latencies can be arbitrary and misleading, it is possible to apply other criteria, such as low amplitudes or conduction block and denervation, to develop a grading scale that could be applied widely. Several previously published grading schemes are reviewed, and a new method is described that combines the prior ranking criteria into 3 basic categories. Application of a grading system identifies the degree of nerve injury and thus allows the referring physician to optimally utilize the EDX report to manage the patient. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Carpal tunnel syndrome (CTS) is not difficult to confirm by electrodiagnosis (EDX), but the challenge lies in whether to grade the severity and the method for doing so. The arguments about grading are discussed, with an emphasis in favor, using a method that relies on the EDX data, but qualifies that it is the median neuropathy being graded and not the syndrome of CTS. Although use of latencies can be arbitrary and misleading, it is possible to apply other criteria, such as low amplitudes or conduction block and denervation, to develop a grading scale that could be applied widely. Several previously published grading schemes are reviewed, and a new method is described that combines the prior ranking criteria into 3 basic categories. Application of a grading system identifies the degree of nerve injury and thus allows the referring physician to optimally utilize the EDX report to manage the patient. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23823" xmlns="http://purl.org/rss/1.0/"><title>We should not use a modifier to describe the severity of CTS</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23823</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">We should not use a modifier to describe the severity of CTS</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lawrence Robinson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-22T09:57:28.480883-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23823</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23823</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23823</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Issues &amp; Opinions</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23826" xmlns="http://purl.org/rss/1.0/"><title>Exertional hyperCKemia might be the first manifestation of a genetic disorder</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23826</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Exertional hyperCKemia might be the first manifestation of a genetic disorder</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nicol C. Voermans, Heinz Jungbluth, Esther Brusse, Baziel G. van Engelen, Pascal Lafôret</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-22T09:57:24.838942-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23826</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23826</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23826</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23822" xmlns="http://purl.org/rss/1.0/"><title>Loss of SPARC in mouse skeletal muscle causes myofiber atrophy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23822</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Loss of SPARC in mouse skeletal muscle causes myofiber atrophy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Katsuyuki Nakamura, Shin-ichi Nakano, Takahiro Miyoshi, Keitaro Yamanouchi, Masugi Nishihara</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-20T03:07:19.427684-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23822</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23822</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23822</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: The expression of secreted protein acidic and rich in cysteine (SPARC) in skeletal muscle decreases with age. Here, we examined the role of SPARC in skeletal muscle by reducing its expression.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: SPARC expression was suppressed by introducing short interfering RNA (siRNA) into mouse tibialis anterior muscle. Myofiber diameter, atrogin1 and muscle RING-finger protein 1 (MuRF1) expression, and tumor necrosis factor-α (TNFα) and tumor growth factor-β (TGFβ) signaling were then analyzed.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: Reduced SPARC expression caused decreases in the diameter of myofibers, especially fast-type ones, accompanied by upregulation of atrogin1, but not MuRF1, at 10 days after siRNA transfection. The expression of TNFα and TGFβ and the phosphorylation status of p38 were not affected by SPARC knockdown, whereas Smad3 phosphorylation was increased at 2 days after siRNA transfection.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion</b>: The loss of SPARC not only upregulates atrogin1 expression but also enhances TGFβ signaling, which may in turn cause muscle atrophy. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: The expression of secreted protein acidic and rich in cysteine (SPARC) in skeletal muscle decreases with age. Here, we examined the role of SPARC in skeletal muscle by reducing its expression.
Methods: SPARC expression was suppressed by introducing short interfering RNA (siRNA) into mouse tibialis anterior muscle. Myofiber diameter, atrogin1 and muscle RING-finger protein 1 (MuRF1) expression, and tumor necrosis factor-α (TNFα) and tumor growth factor-β (TGFβ) signaling were then analyzed.
Results: Reduced SPARC expression caused decreases in the diameter of myofibers, especially fast-type ones, accompanied by upregulation of atrogin1, but not MuRF1, at 10 days after siRNA transfection. The expression of TNFα and TGFβ and the phosphorylation status of p38 were not affected by SPARC knockdown, whereas Smad3 phosphorylation was increased at 2 days after siRNA transfection.
Discussion: The loss of SPARC not only upregulates atrogin1 expression but also enhances TGFβ signaling, which may in turn cause muscle atrophy. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23821" xmlns="http://purl.org/rss/1.0/"><title>Sensory chronic inflammatory demyelinating polyneuropathy: An under-recognized entity?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23821</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Sensory chronic inflammatory demyelinating polyneuropathy: An under-recognized entity?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Xavier Ayrignac, Karine Viala, Régine Morizot Koutlidis, Guillaume Taïeb, Tanya Stojkovic, Lucille Musset, Jean-Marc Léger, Emmanuel Fournier, Thierry Maisonobe, Pierre Bouche</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-20T03:07:01.317262-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23821</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23821</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23821</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Sensory chronic inflammatory demyelinating polyneuropathy (CIDP) can be difficult to diagnose.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Method: We report 22 patients with chronic sensory polyneuropathy with ≥1 clinical sign atypical for chronic idiopathic axonal polyneuropathy (CIAP) but no electrodiagnostic criteria for CIDP.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results: Clinical signs atypical for CIAP were: sensory ataxia (59%), generalized areflexia (36%), cranial nerve involvement (32%), rapid upper limb involvement (40%), and age at onset ≤55 years (50%). Additional features were: normal sensory nerve action potentials (36%), abnormal radial/normal sural pattern (23%), abnormal somatosensory evoked potentials (SSEPs) (100%), elevated CSF protein (73%), and demyelinating features in 5/7 nerve biopsies. Over 90% of patients responded to immunotherapy. We conclude that all patients had sensory CIDP.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Discussion: Sensory CIDP patients can be misdiagnosed as having CIAP. If atypical clinical/electrophysiologic features are present, we recommend performing SSEPs and CSF examination. Nerve biopsy should be restricted to disabled patients if other examinations are inconclusive. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Sensory chronic inflammatory demyelinating polyneuropathy (CIDP) can be difficult to diagnose.
Method: We report 22 patients with chronic sensory polyneuropathy with ≥1 clinical sign atypical for chronic idiopathic axonal polyneuropathy (CIAP) but no electrodiagnostic criteria for CIDP.
Results: Clinical signs atypical for CIAP were: sensory ataxia (59%), generalized areflexia (36%), cranial nerve involvement (32%), rapid upper limb involvement (40%), and age at onset ≤55 years (50%). Additional features were: normal sensory nerve action potentials (36%), abnormal radial/normal sural pattern (23%), abnormal somatosensory evoked potentials (SSEPs) (100%), elevated CSF protein (73%), and demyelinating features in 5/7 nerve biopsies. Over 90% of patients responded to immunotherapy. We conclude that all patients had sensory CIDP.
Discussion: Sensory CIDP patients can be misdiagnosed as having CIAP. If atypical clinical/electrophysiologic features are present, we recommend performing SSEPs and CSF examination. Nerve biopsy should be restricted to disabled patients if other examinations are inconclusive. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23820" xmlns="http://purl.org/rss/1.0/"><title>Lifestyle risk factors for ulnar neuropathy and ulnar neuropathy-like symptoms</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23820</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Lifestyle risk factors for ulnar neuropathy and ulnar neuropathy-like symptoms</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Poul Frost, Birger Johnsen, Anders Fuglsang-Frederiksen, Susanne W. Svendsen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-20T03:06:49.501877-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23820</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23820</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23820</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: We examined whether lifestyle factors differ between patients with ulnar neuropathy confirmed by electroneurography (ENG) and those with ulnar neuropathy-like symptoms with normal ulnar nerve ENG.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: Among patients examined by ENG for suspected ulnar neuropathy, we identified 546 patients with ulnar neuropathy and 633 patients with ulnar neuropathy-like symptoms. These groups were compared to 2 separate groups of matched community referents and to each other. Questionnaire information on lifestyle was obtained. The electrophysiological severity of neuropathy was also graded. We used conditional and unconditional logistic regression.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: The responses were obtained from 59%. Ulnar neuropathy was related to smoking, adjusted OR 4.31 (95% CI 2.43-7.64) for &gt;24 pack-years. Ulnar neuropathy-like symptoms were related to body mass index ≥30 kg/m<sup>2</sup>, OR 1.99 (95% CI 1.25-3.19). Smoking was associated with increased severity of ulnar neuropathy.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion</b>: Findings suggest that smoking specifically affects the ulnar nerve. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We examined whether lifestyle factors differ between patients with ulnar neuropathy confirmed by electroneurography (ENG) and those with ulnar neuropathy-like symptoms with normal ulnar nerve ENG.
Methods: Among patients examined by ENG for suspected ulnar neuropathy, we identified 546 patients with ulnar neuropathy and 633 patients with ulnar neuropathy-like symptoms. These groups were compared to 2 separate groups of matched community referents and to each other. Questionnaire information on lifestyle was obtained. The electrophysiological severity of neuropathy was also graded. We used conditional and unconditional logistic regression.
Results: The responses were obtained from 59%. Ulnar neuropathy was related to smoking, adjusted OR 4.31 (95% CI 2.43-7.64) for &gt;24 pack-years. Ulnar neuropathy-like symptoms were related to body mass index ≥30 kg/m2, OR 1.99 (95% CI 1.25-3.19). Smoking was associated with increased severity of ulnar neuropathy.
Discussion: Findings suggest that smoking specifically affects the ulnar nerve. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23819" xmlns="http://purl.org/rss/1.0/"><title>Reliability of spike triggered averaging of the surface electromyogram for motor unit action potential estimation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23819</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Reliability of spike triggered averaging of the surface electromyogram for motor unit action potential estimation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Xiaogang Hu, William Z. Rymer, Nina L. Suresh</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-20T03:06:42.581417-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23819</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23819</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23819</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: The reliability of estimated motor unit parameters using spike triggered averaging (STA) of the surface electromyogram (sEMG) has not been tested thoroughly. We investigated factors that may induce amplitude bias in estimated motor unit action potentials (MUAPs) and shape variations.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Methods</em>: An sEMG record was simulated. MUAPs were then estimated from the STA of the simulated EMG.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Results</em>: Variations in MUAP duration led to under-estimation of real MUAP amplitude, while synchronized firing led to over estimation of amplitude. Spurious firing resulted in over estimation of the amplitude of small motor units but under estimation of the amplitude of large ones. Variability in amplitude and high firing rates had minimal influence on amplitude estimation. High firing rates and variation in MUAP duration led to large variations in MUAP shape. Estimation errors also correlated with shape variations.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Conclusions</em>: Recommendations to enhance the accuracy of the STA estimates have been proposed. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: The reliability of estimated motor unit parameters using spike triggered averaging (STA) of the surface electromyogram (sEMG) has not been tested thoroughly. We investigated factors that may induce amplitude bias in estimated motor unit action potentials (MUAPs) and shape variations.
Methods: An sEMG record was simulated. MUAPs were then estimated from the STA of the simulated EMG.
Results: Variations in MUAP duration led to under-estimation of real MUAP amplitude, while synchronized firing led to over estimation of amplitude. Spurious firing resulted in over estimation of the amplitude of small motor units but under estimation of the amplitude of large ones. Variability in amplitude and high firing rates had minimal influence on amplitude estimation. High firing rates and variation in MUAP duration led to large variations in MUAP shape. Estimation errors also correlated with shape variations.
Conclusions: Recommendations to enhance the accuracy of the STA estimates have been proposed. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23818" xmlns="http://purl.org/rss/1.0/"><title>Cumulative effect of 5 daily sessions of theta burst stimulation on corticospinal excitability in amyotrophic lateral sclerosis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23818</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Cumulative effect of 5 daily sessions of theta burst stimulation on corticospinal excitability in amyotrophic lateral sclerosis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Moniek A.M. Munneke, Jan J. Rongen, Sebastiaan Overeem, H. Jurgen Schelhaas, Machiel J. Zwarts, Dick F. Stegeman</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-20T03:06:30.832392-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23818</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23818</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23818</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Excitotoxicity plays an important role in the pathogenesis of the preferential motor neuron death observed in ALS. Continuous Theta Burst Stimulation (cTBS) by transcranial magnetic stimulation has an inhibitory effect on corticospinal excitability (CSE). We characterized the neurophysiological changes induced by cTBS in ALS. Methods: The patients received 5 daily sessions of cTBS. CSE was assessed at baseline and after each session of cTBS. Results: The amplitude of a single pulse motor evoked potential was significantly decreased (34%) over the days. The amplitude returned to baseline a week after the last session. The resting motor threshold increased significantly, whereas intracortical inhibition and facilitation did not change over the sessions. Discussion: Daily cTBS has a cumulative depressing effect on CSE in patients with ALS. Our results suggest that modulation of CSE in ALS is possible, but repetitive sessions are needed to maintain the effect. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Excitotoxicity plays an important role in the pathogenesis of the preferential motor neuron death observed in ALS. Continuous Theta Burst Stimulation (cTBS) by transcranial magnetic stimulation has an inhibitory effect on corticospinal excitability (CSE). We characterized the neurophysiological changes induced by cTBS in ALS. Methods: The patients received 5 daily sessions of cTBS. CSE was assessed at baseline and after each session of cTBS. Results: The amplitude of a single pulse motor evoked potential was significantly decreased (34%) over the days. The amplitude returned to baseline a week after the last session. The resting motor threshold increased significantly, whereas intracortical inhibition and facilitation did not change over the sessions. Discussion: Daily cTBS has a cumulative depressing effect on CSE in patients with ALS. Our results suggest that modulation of CSE in ALS is possible, but repetitive sessions are needed to maintain the effect. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23817" xmlns="http://purl.org/rss/1.0/"><title>Neuromuscular disease and anesthesia</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23817</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Neuromuscular disease and anesthesia</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alan Romero, Girish P. Joshi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-20T03:06:20.68609-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23817</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23817</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23817</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">AANEM Minimonograph</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Patients with neuromuscular diseases pose many anesthetic challenges and are at a greater risk of perioperative complications, including respiratory or cardiovascular dysfunction and pulmonary aspiration. Therefore, these patients require special precautions, including interdisciplinary communication between primary care physician, neurologists, physiatrists, surgeons, and anesthesiologists. Preoperative evaluation and optimization of comorbid conditions is critical. These patients may have adverse response to neuromuscular blocking drugs and the reversal drugs (e.g., neostigmine). They should be used with caution and titrated based on objective neuromuscular monitoring. Drugs that potentiate neuromuscular blocking drugs should also be avoided or their doses limited if possible. The risk of malignant hyperthermia in certain neuromuscular diseases mandates avoidance of triggering agents such as succinylcholine and inhaled anesthetics. Patients with neuromuscular disease may also be sensitive to sedative-hypnotics and opioids, which should be used judiciously. Finally, the postoperative period requires close monitoring due to increased risk of postoperative cardiorespiratory dysfunction. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Patients with neuromuscular diseases pose many anesthetic challenges and are at a greater risk of perioperative complications, including respiratory or cardiovascular dysfunction and pulmonary aspiration. Therefore, these patients require special precautions, including interdisciplinary communication between primary care physician, neurologists, physiatrists, surgeons, and anesthesiologists. Preoperative evaluation and optimization of comorbid conditions is critical. These patients may have adverse response to neuromuscular blocking drugs and the reversal drugs (e.g., neostigmine). They should be used with caution and titrated based on objective neuromuscular monitoring. Drugs that potentiate neuromuscular blocking drugs should also be avoided or their doses limited if possible. The risk of malignant hyperthermia in certain neuromuscular diseases mandates avoidance of triggering agents such as succinylcholine and inhaled anesthetics. Patients with neuromuscular disease may also be sensitive to sedative-hypnotics and opioids, which should be used judiciously. Finally, the postoperative period requires close monitoring due to increased risk of postoperative cardiorespiratory dysfunction. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23816" xmlns="http://purl.org/rss/1.0/"><title>Lower motor neuron syndrome due to cauda equina hypertrophy with onion bulbs</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23816</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Lower motor neuron syndrome due to cauda equina hypertrophy with onion bulbs</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Erin K. O'Ferrall, Daniel Gendron, Marie-Christine Guiot, Jeffery Hall, Michael Sinnreich</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-20T03:06:08.929502-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23816</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23816</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23816</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Case of the Month</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Hypertrophy of the nerve roots of the cauda equina may occur with both acquired and inherited neuropathies. Although selective nerve root involvement of the sensory roots has been described and termed chronic inflammatory sensory polyradiculoneuropathy (CISP), selective involvement of the proximal motor roots has not been described.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: Clinical, electrophysiological, MRI and pathological findings are reported.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: Here we report a patient with cauda equina hypertrophy presenting with a pure lower motor neuron syndrome without clinical or electrophysiological evidence of sensory fiber involvement. Bowel and bladder functions were spared. Nerve root biopsy demonstrated abundant onion bulb formations. The patient experienced improvement in motor function with immunomodulatory treatment.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions</b>: We suggest the term chronic immune demyelinating motor polyradiculopathy (CIMP) to describe this particular form of CIDP, thereby expanding the clinical spectrum of CIDP. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Hypertrophy of the nerve roots of the cauda equina may occur with both acquired and inherited neuropathies. Although selective nerve root involvement of the sensory roots has been described and termed chronic inflammatory sensory polyradiculoneuropathy (CISP), selective involvement of the proximal motor roots has not been described.
Methods: Clinical, electrophysiological, MRI and pathological findings are reported.
Results: Here we report a patient with cauda equina hypertrophy presenting with a pure lower motor neuron syndrome without clinical or electrophysiological evidence of sensory fiber involvement. Bowel and bladder functions were spared. Nerve root biopsy demonstrated abundant onion bulb formations. The patient experienced improvement in motor function with immunomodulatory treatment.
Conclusions: We suggest the term chronic immune demyelinating motor polyradiculopathy (CIMP) to describe this particular form of CIDP, thereby expanding the clinical spectrum of CIDP. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23815" xmlns="http://purl.org/rss/1.0/"><title>Global prevention strategies against ulnar neuropathy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23815</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Global prevention strategies against ulnar neuropathy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alexis Descatha, Erika Sabbath</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-20T03:06:01.701949-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23815</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23815</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23815</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Editorial</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23811" xmlns="http://purl.org/rss/1.0/"><title>Spatial distribution of motor units recruited during electrical stimulation of the quadriceps muscle versus the femoral nerve</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23811</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Spatial distribution of motor units recruited during electrical stimulation of the quadriceps muscle versus the femoral nerve</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Javier Rodriguez-Falces, Nicola A. Maffiuletti, Nicolas Place</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-08T07:31:25.069477-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23811</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23811</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23811</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="mus23811-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>To investigate differences in the spatial recruitment of motor units (MUs) in the quadriceps when electrical stimulation is applied over the quadriceps belly versus the femoral nerve.</p></div></div>
<div class="section" id="mus23811-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>M-waves and mechanical twitches were evoked using over-the-quadriceps and femoral nerve stimulation of gradually increasing intensity from 22 young, healthy subjects. Spatial recruitment was investigated using recruitment curves of M-waves recorded from the vastus medialis (VM) and vastus lateralis (VL) and of twitches recorded from the quadriceps.</p></div></div>
<div class="section" id="mus23811-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>At maximal stimulation intensity (Imax), no differences were found between nerve and over-the-quadriceps stimulation. At submaximal intensities, VL M-wave amplitude was higher for over-the-quadriceps stimulation at 40 % Imax, and peak twitch force was greater for nerve stimulation at 60% and 80% Imax.</p></div></div>
<div class="section" id="mus23811-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>For the VM, MU spatial recruitment during nerve and over-the-quadriceps stimulation of increasing intensity occurred in a similar manner, whereas significant differences were observed for the VL. © 2013 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction
To investigate differences in the spatial recruitment of motor units (MUs) in the quadriceps when electrical stimulation is applied over the quadriceps belly versus the femoral nerve.


Methods
M-waves and mechanical twitches were evoked using over-the-quadriceps and femoral nerve stimulation of gradually increasing intensity from 22 young, healthy subjects. Spatial recruitment was investigated using recruitment curves of M-waves recorded from the vastus medialis (VM) and vastus lateralis (VL) and of twitches recorded from the quadriceps.


Results
At maximal stimulation intensity (Imax), no differences were found between nerve and over-the-quadriceps stimulation. At submaximal intensities, VL M-wave amplitude was higher for over-the-quadriceps stimulation at 40 % Imax, and peak twitch force was greater for nerve stimulation at 60% and 80% Imax.


Conclusions
For the VM, MU spatial recruitment during nerve and over-the-quadriceps stimulation of increasing intensity occurred in a similar manner, whereas significant differences were observed for the VL. © 2013 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23812" xmlns="http://purl.org/rss/1.0/"><title>Frequency and spectrum of myopathies in patients with psoriasis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23812</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Frequency and spectrum of myopathies in patients with psoriasis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Teerin Liewluck, Floranne C. Ernste, Jennifer A. Tracy</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-08T07:25:31.923553-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23812</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23812</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23812</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b><em>Introduction</em></b>: Psoriasis is a T-cell mediated skin disorder with uncommon extracutaneous manifestations. Rare patients with psoriasis and myopathy have been reported. <b><em>Methods</em></b>: We conducted a retrospective review of medical records of psoriasis patients seen at the Mayo Clinic January 1, 1996 - May 31, 2011. Patients who had pathologically-confirmed myopathy or lymphocytic infiltrates in muscle were included. <b><em>Results</em></b>: Among 11,370 psoriasis patients, 13 had pathologically-confirmed myopathies. Seventy percent were inflammatory myopathies, and 2 had focal inflammation in muscle. Psoriasis preceded myopathy onset in two-thirds (median, 14.7 years). Half had psoriatic arthritis; 60% had other autoimmune disorders. Patients who received anti-TNF-α therapy had a higher risk for developing myopathy or inflammation in muscle (odds ratio: 4.45). <b><em>Conclusions</em></b>: Myopathy or inflammation in muscle affects 1.32 in 1,000 psoriasis patients. Concomitant autoimmune disorders, psoriatic arthritis, and exposure to anti-TNF-α therapy may be associated with increased risk of developing myopathy in psoriasis patients. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Psoriasis is a T-cell mediated skin disorder with uncommon extracutaneous manifestations. Rare patients with psoriasis and myopathy have been reported. Methods: We conducted a retrospective review of medical records of psoriasis patients seen at the Mayo Clinic January 1, 1996 - May 31, 2011. Patients who had pathologically-confirmed myopathy or lymphocytic infiltrates in muscle were included. Results: Among 11,370 psoriasis patients, 13 had pathologically-confirmed myopathies. Seventy percent were inflammatory myopathies, and 2 had focal inflammation in muscle. Psoriasis preceded myopathy onset in two-thirds (median, 14.7 years). Half had psoriatic arthritis; 60% had other autoimmune disorders. Patients who received anti-TNF-α therapy had a higher risk for developing myopathy or inflammation in muscle (odds ratio: 4.45). Conclusions: Myopathy or inflammation in muscle affects 1.32 in 1,000 psoriasis patients. Concomitant autoimmune disorders, psoriatic arthritis, and exposure to anti-TNF-α therapy may be associated with increased risk of developing myopathy in psoriasis patients. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23809" xmlns="http://purl.org/rss/1.0/"><title>Nerve strain correlates with structural changes quantified by fourier analysis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23809</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Nerve strain correlates with structural changes quantified by fourier analysis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">James M. Love, Ting-Hsien Chuang, Richard L. Lieber, Sameer B. Shah</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-08T07:25:26.549873-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23809</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23809</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23809</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>BACKGROUND</b>: Nerve deformation affects physiological function. Bands of Fontana are an optical manifestation of axonal undulations and may provide a structural indicator of nerve strain.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>METHODS</b>: We developed an automated Fourier-based image processing method to quantify the periodicity of bands of Fontana both in bright field images and in axonal undulations in immuno-labeled longitudinal sections.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>RESULTS</b>: We found a strong linear relationship between applied strain and the frequency of bands of Fontana in rat sciatic nerves (-0.0056 μm<sup>-1</sup>.%<sup>-1</sup>, r<sup>2</sup> = 0.829; <em>P</em> &lt; 0.05). This relationship agreed with the observed trend between strain and axonal waviness, calculated from longitudinal sections of sciatic nerves immuno-labeled against myelin basic protein.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>CONCLUSIONS</b>: This accurate and objective approach has potential to increase our understanding of structure-function relationships in the nervous system and to guide preservation and enhancement of neural function. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

BACKGROUND: Nerve deformation affects physiological function. Bands of Fontana are an optical manifestation of axonal undulations and may provide a structural indicator of nerve strain.
METHODS: We developed an automated Fourier-based image processing method to quantify the periodicity of bands of Fontana both in bright field images and in axonal undulations in immuno-labeled longitudinal sections.
RESULTS: We found a strong linear relationship between applied strain and the frequency of bands of Fontana in rat sciatic nerves (-0.0056 μm-1.%-1, r2 = 0.829; P &lt; 0.05). This relationship agreed with the observed trend between strain and axonal waviness, calculated from longitudinal sections of sciatic nerves immuno-labeled against myelin basic protein.
CONCLUSIONS: This accurate and objective approach has potential to increase our understanding of structure-function relationships in the nervous system and to guide preservation and enhancement of neural function. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23810" xmlns="http://purl.org/rss/1.0/"><title>Report of MDA muscle disease symposium on newborn screening for duchenne muscular dystrophy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23810</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Report of MDA muscle disease symposium on newborn screening for duchenne muscular dystrophy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jerry R. Mendell, Michele Lloyd-Puryear</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-08T07:25:25.396958-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23810</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23810</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23810</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Issue &amp; Opinion</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This report summarizes the progress made in newborn screening for Duchenne muscular dystrophy (DMD). This subject was discussed fully at a symposium held on September 11-12, 2012, in Bethesda, MD, by a group of experts from multiple disciplines. The meeting was triggered by the simultaneous combination of improvements in methods for newborn screening for DMD and greater potential for treatment. On the screening side, a two-tier system of newborn screening was introduced that enabled creatine kinase levels and DMD gene analysis to be done on the same dried blood spots obtained at birth. Treatment improvements included promising results from exon skipping as well as multiple studies showing long-term benefits of glucocorticoids and data indicating that early intervention of both forms of therapy was the most beneficial. Conclusions from this symposium with supportive data could have a significant impact on propelling efforts for approval of newborn screening for DMD. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

This report summarizes the progress made in newborn screening for Duchenne muscular dystrophy (DMD). This subject was discussed fully at a symposium held on September 11-12, 2012, in Bethesda, MD, by a group of experts from multiple disciplines. The meeting was triggered by the simultaneous combination of improvements in methods for newborn screening for DMD and greater potential for treatment. On the screening side, a two-tier system of newborn screening was introduced that enabled creatine kinase levels and DMD gene analysis to be done on the same dried blood spots obtained at birth. Treatment improvements included promising results from exon skipping as well as multiple studies showing long-term benefits of glucocorticoids and data indicating that early intervention of both forms of therapy was the most beneficial. Conclusions from this symposium with supportive data could have a significant impact on propelling efforts for approval of newborn screening for DMD. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23805" xmlns="http://purl.org/rss/1.0/"><title>Reduced DHPRα1s and RyR1 expressions are associated with diaphragm contractile dysfunction during sepsis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23805</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Reduced DHPRα1s and RyR1 expressions are associated with diaphragm contractile dysfunction during sepsis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Guang-Yu Jiao, Li-Ying Hao, Chun-E Gao, Lie Chen, Xue-Fei Sun, Hua-Li Yang, Ying Li, Yi-Ning Dai</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-05T08:18:32.023515-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23805</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23805</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23805</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Sepsis often causes diaphragm contractile dysfunction. Dihydropyridine receptors (DHPRα1s and DHPRα1c) and ryanodine receptors (RyR1, RyR2, and RyR3) are essential for excitation-contraction coupling in striated muscles. However, their expressions in diaphragm during sepsis have not been explored. Methods: Eight rats received endotoxin while eight more rats received a placebo. After 24 hours, diaphragmatic isometric contractile force was measured. The mRNA and protein levels of DHPRs and RyRs in diaphragm muscles were determined. Results: Sepsis weakened the diaphragm contractile function. The expression levels of DHPRα1s and RyR1 were significantly lower in septic rats than in control rats. The expression levels of DHPRα1c and RyR3 were unaffected by sepsis. RyR2 was undetectable at both mRNA and protein levels in control and sepsis groups. Conclusions: Weakened diaphragm contraction observed in the septic rats was associated with the reduced mRNA and protein expressions of DHPRα1s and RyR1, the isoforms of skeletal muscles. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Sepsis often causes diaphragm contractile dysfunction. Dihydropyridine receptors (DHPRα1s and DHPRα1c) and ryanodine receptors (RyR1, RyR2, and RyR3) are essential for excitation-contraction coupling in striated muscles. However, their expressions in diaphragm during sepsis have not been explored. Methods: Eight rats received endotoxin while eight more rats received a placebo. After 24 hours, diaphragmatic isometric contractile force was measured. The mRNA and protein levels of DHPRs and RyRs in diaphragm muscles were determined. Results: Sepsis weakened the diaphragm contractile function. The expression levels of DHPRα1s and RyR1 were significantly lower in septic rats than in control rats. The expression levels of DHPRα1c and RyR3 were unaffected by sepsis. RyR2 was undetectable at both mRNA and protein levels in control and sepsis groups. Conclusions: Weakened diaphragm contraction observed in the septic rats was associated with the reduced mRNA and protein expressions of DHPRα1s and RyR1, the isoforms of skeletal muscles. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23804" xmlns="http://purl.org/rss/1.0/"><title>Responses of finger flexor and extensor muscles to TMS during isometric force production tasks</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23804</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Responses of finger flexor and extensor muscles to TMS during isometric force production tasks</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Woo-Hyung Park, Sheng Li</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-05T08:18:23.641455-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23804</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23804</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23804</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: We investigated neural mechanisms of finger force control. <em>Methods</em>: Ten right-handed subjects performed isometric finger flexion and extension force productions at 10 ~ 60% of maximum voluntary contraction (MVC) using 4 fingers of the dominant hand. Transcranial magnetic stimulation (TMS) was applied over the contralateral hand motor area. We measured fluctuation of the background force and TMS responses from finger flexor and extensor muscles. <em>Results</em>: Force fluctuation was greater during finger extension than during finger flexion. The motor evoked potentials (MEPs) increased with force levels in the flexor digitorum superfialis (FDS) during finger flexion and the extensor digitorum communis (EDC) during finger extension. The TMS-induced forces increased up to 40% MVC and then decreased during finger flexion, whereas they continuously decreased through the tested force levels during finger extension. <em>Conclusions</em>: These results suggest that FDS and EDC are controlled by different neural mechanisms, most likely attributable to their different functional roles in daily activities. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We investigated neural mechanisms of finger force control. Methods: Ten right-handed subjects performed isometric finger flexion and extension force productions at 10 ~ 60% of maximum voluntary contraction (MVC) using 4 fingers of the dominant hand. Transcranial magnetic stimulation (TMS) was applied over the contralateral hand motor area. We measured fluctuation of the background force and TMS responses from finger flexor and extensor muscles. Results: Force fluctuation was greater during finger extension than during finger flexion. The motor evoked potentials (MEPs) increased with force levels in the flexor digitorum superfialis (FDS) during finger flexion and the extensor digitorum communis (EDC) during finger extension. The TMS-induced forces increased up to 40% MVC and then decreased during finger flexion, whereas they continuously decreased through the tested force levels during finger extension. Conclusions: These results suggest that FDS and EDC are controlled by different neural mechanisms, most likely attributable to their different functional roles in daily activities. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23769" xmlns="http://purl.org/rss/1.0/"><title>Quantitative facial muscle ultrasound: Feasibility and reproducibility</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23769</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Quantitative facial muscle ultrasound: Feasibility and reproducibility</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nens van Alfen, H Jacobus Gilhuis, Jurre P Keijzers, Sigrid Pillen, Johannes P van Dijk</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:55:48.036237-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23769</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23769</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23769</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Regular Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: A protocol for quantitative ultrasound of facial muscles (procerus, zygomaticus major, levator labii superior, depressor anguli oris, mentalis, orbicularis oris pars labialis, orbicularis oris pars marginalis) was developed.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Methods: Muscle thickness (MT) and echo intensity (EI) were measured in 12 healthy subjects and a myotonic dystrophy type 1 patient.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Results: MT ranged between 0.15 - 0.30 mm, except for the procerus muscle (0.06 mm). EIs ranged from 1 to 34, except for the procerus muscle. Reproducibility for MT was fair for the orbicularis oris pars labialis, excellent for the procerus and levator labii, and good for the other muscles. The myotonic dystrophy type 1 patient showed high EIs, outside the range in healthy subjects in 6 of the 7 muscles. MT was lower than the range in healthy subjects in 4 muscles.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Discussion: Quantitative muscle ultrasound of the facial muscles is feasible and shows moderate to excellent reproducibility. © 2012 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: A protocol for quantitative ultrasound of facial muscles (procerus, zygomaticus major, levator labii superior, depressor anguli oris, mentalis, orbicularis oris pars labialis, orbicularis oris pars marginalis) was developed.
Methods: Muscle thickness (MT) and echo intensity (EI) were measured in 12 healthy subjects and a myotonic dystrophy type 1 patient.
Results: MT ranged between 0.15 - 0.30 mm, except for the procerus muscle (0.06 mm). EIs ranged from 1 to 34, except for the procerus muscle. Reproducibility for MT was fair for the orbicularis oris pars labialis, excellent for the procerus and levator labii, and good for the other muscles. The myotonic dystrophy type 1 patient showed high EIs, outside the range in healthy subjects in 6 of the 7 muscles. MT was lower than the range in healthy subjects in 4 muscles.
Discussion: Quantitative muscle ultrasound of the facial muscles is feasible and shows moderate to excellent reproducibility. © 2012 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23770" xmlns="http://purl.org/rss/1.0/"><title>Triple a syndrome in Japan</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23770</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Triple a syndrome in Japan</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Masanori Ikeda, Makito Hirano, Keiich Shinoda, Noriyuki Katsumata, Daisuke Furutama, Katsuya Nakamura, Shu-ichi Ikeda, Toshifumi Tanaka, Toshiaki Hanafusa, Hiroyuki Kitajima, Hitoshi Kohno, Mizuho Nakagawa, Yusaku Nakamura, Satoshi Ueno</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:55:27.436836-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23770</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23770</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23770</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Regular Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em><b>:</b> Triple A syndrome is an autosomal recessive disease, characterized by esophageal achalasia, alacrima, adrenal insufficiency, and involvement of central, peripheral, and autonomic nervous systems. This disease mimics amyotrophic lateral sclerosis in some patients. The causative gene encodes ALADIN, a nuclear pore complex (NPC) component. Only 5 patients have been reported in Japan.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Methods</em>: We conducted the first nationwide survey of Triple A syndrome. Identified mutants were expressed as GFP-fusion proteins in cultured cells.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Results</em>: Two new patients were identified, and 1 had a novel mutation (p.Ser182fsX19). All mutant proteins tested were mislocalized from NPC to cytoplasm.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Conclusions</em>: The most consistent neurologic manifestation of Triple A syndrome in Japanese patients was progressive bulbospinal muscular atrophy with both upper and lower motor neuron involvement, which mimicked motor neuron disease, similar to patients reported in Western countries. The identification of the new patients suggests that more cases are undiagnosed in Japan. © 2012 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Triple A syndrome is an autosomal recessive disease, characterized by esophageal achalasia, alacrima, adrenal insufficiency, and involvement of central, peripheral, and autonomic nervous systems. This disease mimics amyotrophic lateral sclerosis in some patients. The causative gene encodes ALADIN, a nuclear pore complex (NPC) component. Only 5 patients have been reported in Japan.
Methods: We conducted the first nationwide survey of Triple A syndrome. Identified mutants were expressed as GFP-fusion proteins in cultured cells.
Results: Two new patients were identified, and 1 had a novel mutation (p.Ser182fsX19). All mutant proteins tested were mislocalized from NPC to cytoplasm.
Conclusions: The most consistent neurologic manifestation of Triple A syndrome in Japanese patients was progressive bulbospinal muscular atrophy with both upper and lower motor neuron involvement, which mimicked motor neuron disease, similar to patients reported in Western countries. The identification of the new patients suggests that more cases are undiagnosed in Japan. © 2012 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23768" xmlns="http://purl.org/rss/1.0/"><title>Bone marrow stem cells in the facial nerve regeneration from isolated stumps</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23768</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Bone marrow stem cells in the facial nerve regeneration from isolated stumps</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Raquel Salomone, Ricardo F. Bento, Heloisa J. Z. R. Costa, Deborah Azzi-Nogueira, Patrícia C. Ovando, Ciro F. Da-Silva, Daniela B. Zanatta, Bryan E. Strauss, Luciana A. Haddad</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:55:12.259921-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23768</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23768</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23768</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Regular Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Severe lesions in the facial nerve may have extensive neural tissue loss and leave isolated stumps that impose technical difficulties for nerve grafting.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: We evaluated bone marrow stem cells (BMSC) in a silicone conduit for rat facial nerve regeneration from isolated stumps. Group A utilized empty silicone tubes; in groups B-D the tube was filled with acellular gel; and in groups C and D undifferentiated BMSC (uBMSC) or Schwann-like cells differentiated from BMSC (dBMSC) were added, respectively. Compound muscle action potentials (CMAP) were measured, and histology was evaluated.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> Groups C and D had the highest CMAP amplitudes. Group C had shorter CMAP durations than groups A, B, and D. Distal axonal number and density were increased in group C compared to groups A and B.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions</b>: Regeneration of the facial nerve was improved by both uBMSC and dBMSC in rats, yet uBMSC was associated with superior functional results. © 2012 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Severe lesions in the facial nerve may have extensive neural tissue loss and leave isolated stumps that impose technical difficulties for nerve grafting.
Methods: We evaluated bone marrow stem cells (BMSC) in a silicone conduit for rat facial nerve regeneration from isolated stumps. Group A utilized empty silicone tubes; in groups B-D the tube was filled with acellular gel; and in groups C and D undifferentiated BMSC (uBMSC) or Schwann-like cells differentiated from BMSC (dBMSC) were added, respectively. Compound muscle action potentials (CMAP) were measured, and histology was evaluated.
Results: Groups C and D had the highest CMAP amplitudes. Group C had shorter CMAP durations than groups A, B, and D. Distal axonal number and density were increased in group C compared to groups A and B.
Conclusions: Regeneration of the facial nerve was improved by both uBMSC and dBMSC in rats, yet uBMSC was associated with superior functional results. © 2012 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23775" xmlns="http://purl.org/rss/1.0/"><title>Inherited neuropathies: Clinical overview and update</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23775</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Inherited neuropathies: Clinical overview and update</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Christopher J. Klein, Xiaohui Duan, Michael E. Shy</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:53:38.891988-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23775</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23775</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23775</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Invited Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Inherited neuropathy is a group of common neurologic disorders with heterogeneous clinical presentations and genetic causes. Detailed neuromuscular evaluations, including nerve conduction studies, laboratory testing, and histopathologic examination can assist in identification of the inherited component beyond family history. Genetic testing increasingly enables definitive diagnosis of specific inherited neuropathies. Diagnosis, however, is often complex, and neurologic disability may have both genetic and acquired components in individual patients. The decision of which genetic test to order or whether to order genetic tests is often complicated and the strategies to maximize the value of testing are evolving. Apart from rare inherited metabolic neuropathies, treatment approaches still remain largely supportive. We provide a clinical update of the various types of inherited neuropathies, their differential diagnosis, and distinguishing clinical features (where available). A framework is provided for clinical evaluations, including the inheritance assessment, electrophysiologic examinations, and specific genetic tests. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Inherited neuropathy is a group of common neurologic disorders with heterogeneous clinical presentations and genetic causes. Detailed neuromuscular evaluations, including nerve conduction studies, laboratory testing, and histopathologic examination can assist in identification of the inherited component beyond family history. Genetic testing increasingly enables definitive diagnosis of specific inherited neuropathies. Diagnosis, however, is often complex, and neurologic disability may have both genetic and acquired components in individual patients. The decision of which genetic test to order or whether to order genetic tests is often complicated and the strategies to maximize the value of testing are evolving. Apart from rare inherited metabolic neuropathies, treatment approaches still remain largely supportive. We provide a clinical update of the various types of inherited neuropathies, their differential diagnosis, and distinguishing clinical features (where available). A framework is provided for clinical evaluations, including the inheritance assessment, electrophysiologic examinations, and specific genetic tests. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23766" xmlns="http://purl.org/rss/1.0/"><title>Ethambutol toxicity exacerbating the phenotype of CMT2A2</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23766</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Ethambutol toxicity exacerbating the phenotype of CMT2A2</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ekokobe Fonkem, Monica A. Skordilis, Elaine M. Binkley, David S. Raymer, Avrom Epstein, W. David Arnold, John T. Kissel, Victoria H. Lawson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:52:09.241703-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23766</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23766</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23766</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Case of the Month</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: CMT2A2 is associated with mutations in the <em>mitofusin 2</em> gene, which encodes a protein involved in mitochondrial fusion. Ethambutol is an antimycobacterial agent associated with toxic optic neuropathies. Ethambutol-induced optic neuropathy occurs in patients with mutations in a related fusion gene, <em>OPA1</em>, which is responsible for Autosomal Dominant Optic Atrophy.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Case</em>: We describe a patient with CMT2A2 (<em>MFN2</em> mutation: T669G, F223L) who developed accelerated weakness, vocal cord paralysis and optic atrophy after receiving ethambutol. Deterioration began within months of initiating ethambutol therapy. With discontinuation of ethambutol, neurologic deterioration stabilized with subsequent improvement in visual fields.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Discussion</em>: CMT2A2 is part of a group of genetic disorders which share an association with the process of mitochondrial fusion. This case shows that patients with CMT2A2, and possibly other mitochondrial fusion defects, may be uniquely susceptible to ethambutol-induced neurotoxicity. This has implications regarding the underlying pathophysiology of mitochondrial fusion defects. © 2012 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: CMT2A2 is associated with mutations in the mitofusin 2 gene, which encodes a protein involved in mitochondrial fusion. Ethambutol is an antimycobacterial agent associated with toxic optic neuropathies. Ethambutol-induced optic neuropathy occurs in patients with mutations in a related fusion gene, OPA1, which is responsible for Autosomal Dominant Optic Atrophy.
Case: We describe a patient with CMT2A2 (MFN2 mutation: T669G, F223L) who developed accelerated weakness, vocal cord paralysis and optic atrophy after receiving ethambutol. Deterioration began within months of initiating ethambutol therapy. With discontinuation of ethambutol, neurologic deterioration stabilized with subsequent improvement in visual fields.
Discussion: CMT2A2 is part of a group of genetic disorders which share an association with the process of mitochondrial fusion. This case shows that patients with CMT2A2, and possibly other mitochondrial fusion defects, may be uniquely susceptible to ethambutol-induced neurotoxicity. This has implications regarding the underlying pathophysiology of mitochondrial fusion defects. © 2012 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23772" xmlns="http://purl.org/rss/1.0/"><title>Asymmetric sensory ganglionopathy: A case series</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23772</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Asymmetric sensory ganglionopathy: A case series</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Celedonio Marquez-Infante, Sinéad M Murphy, Liberty Mathew, Ali Alsanousi, Michael P Lunn, Sebastian Brandner, Tarek A Yousry, Julian Blake, Mary M Reilly</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:50:17.317222-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23772</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23772</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23772</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Case of the Month</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="mus23772-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Sensory ganglionopathies are uncommon but potentially very disabling. They have heterogeneous etiologies including autoimmune, paraneoplastic, toxic, and inflammatory although many remain idiopathic despite intensive investigation. Asymmetric sensory loss is relatively common at the onset, but with time, symptoms usually spread to involve all limbs symmetrically.</p></div></div>
<div class="section" id="mus23772-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>We report 6 patients with a persistent strikingly asymmetrical sensory ganglionopathy with acute or subacute onset and slow progression.</p></div></div>
<div class="section" id="mus23772-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Peripheral nerve biopsies in 5 patients showed axonal loss without significant inflammation; a dorsal root ganglion biopsy in 1 patient showed neuronal loss and inflammatory infiltrate. Four patients received immunomodulatory treatment, but overall the response to treatment was poor.</p></div></div>
<div class="section" id="mus23772-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Discussion</h4><div class="para"><p>Asymmetrical sensory ganglionopathies may have an inflammatory basis. Immunomodulatory therapy may be considered early in the disease course, although in this series there was a limited response to treatment. © 2013 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction
Sensory ganglionopathies are uncommon but potentially very disabling. They have heterogeneous etiologies including autoimmune, paraneoplastic, toxic, and inflammatory although many remain idiopathic despite intensive investigation. Asymmetric sensory loss is relatively common at the onset, but with time, symptoms usually spread to involve all limbs symmetrically.


Methods
We report 6 patients with a persistent strikingly asymmetrical sensory ganglionopathy with acute or subacute onset and slow progression.


Results
Peripheral nerve biopsies in 5 patients showed axonal loss without significant inflammation; a dorsal root ganglion biopsy in 1 patient showed neuronal loss and inflammatory infiltrate. Four patients received immunomodulatory treatment, but overall the response to treatment was poor.


Discussion
Asymmetrical sensory ganglionopathies may have an inflammatory basis. Immunomodulatory therapy may be considered early in the disease course, although in this series there was a limited response to treatment. © 2013 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23795" xmlns="http://purl.org/rss/1.0/"><title>Screening for HIV-associated peripheral neuropathy in resource-limited settings</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23795</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Screening for HIV-associated peripheral neuropathy in resource-limited settings</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Deanna Cettomai, Judith K. Kwasa, Gretchen L. Birbeck, Richard W. Price, Craig R. Cohen, Elizabeth A. Bukusi, Caroline Kendi, Ana-Claire L. Meyer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:50:16.15133-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23795</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23795</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23795</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>INTRODUCTION</em></p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Peripheral neuropathy is the most common neurological complication of HIV but is widely under-diagnosed in resource-limited settings. We investigated the utility of screening tools administered by non-physician health care workers (HCW) and quantitative sensory testing (QST) administered by trained individuals for identification of moderate/severe neuropathy.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>METHODS</em></p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>We enrolled 240 HIV-infected outpatients using two-stage cluster randomized sampling. HCWs administered the several screening tools. Trained study staff performed QST. Tools were validated against a clinical diagnosis of neuropathy.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>RESULTS</em></p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Participants were 65% women, mean age 36.4 years, median CD4 324 cells/μL. 65% were taking antiretrovirals, and 18% had moderate/severe neuropathy. The screening tests were 76% sensitive in diagnosing moderate/severe neuropathy with negative predictive values of 84-92%. QST was less sensitive but more specific.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>DISCUSSION</em></p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Screening tests administered by HCW have excellent negative predictive values and are promising tools for scale-up in resource-limited settings. QST shows promise for research use. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

INTRODUCTION
Peripheral neuropathy is the most common neurological complication of HIV but is widely under-diagnosed in resource-limited settings. We investigated the utility of screening tools administered by non-physician health care workers (HCW) and quantitative sensory testing (QST) administered by trained individuals for identification of moderate/severe neuropathy.
METHODS
We enrolled 240 HIV-infected outpatients using two-stage cluster randomized sampling. HCWs administered the several screening tools. Trained study staff performed QST. Tools were validated against a clinical diagnosis of neuropathy.
RESULTS
Participants were 65% women, mean age 36.4 years, median CD4 324 cells/μL. 65% were taking antiretrovirals, and 18% had moderate/severe neuropathy. The screening tests were 76% sensitive in diagnosing moderate/severe neuropathy with negative predictive values of 84-92%. QST was less sensitive but more specific.
DISCUSSION
Screening tests administered by HCW have excellent negative predictive values and are promising tools for scale-up in resource-limited settings. QST shows promise for research use. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23793" xmlns="http://purl.org/rss/1.0/"><title>Why short stature is beneficial in Duchenne muscular dystrophy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23793</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Why short stature is beneficial in Duchenne muscular dystrophy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Marko Bodor, Craig M. McDonald</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:50:02.39345-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23793</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23793</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23793</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Issue &amp; Opinion</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Duchenne muscular dystrophy (DMD) is caused by a genetic defect resulting in absent dystrophin, yet children are able to walk when small and young but lose this ability as they grow. The <em>mdx</em> mouse has absent dystrophin yet does not exhibit significant disability.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: Allometric modeling of linearly increasing load per muscle fiber and stress on the sarcolemma with growth and exponential decline associated with loss of muscle fibers correlated with case studies and animal models of DMD.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: Smaller species or breeds are predictably less affected than large as follows: <em>mdx</em> mice &lt; small Golden Retriever muscular dystrophy (GRMD) dogs &lt; large GRMD dogs &lt; humans. Case reports of combined growth hormone and dystrophin deficiency show a relatively benign course of disease.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Conclusions</b>: Future therapeutic trials in DMD might include specific growth inhibitors in combination with standard of care treatments to the delay the clinical onset and reduce severity of disease and disability. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Duchenne muscular dystrophy (DMD) is caused by a genetic defect resulting in absent dystrophin, yet children are able to walk when small and young but lose this ability as they grow. The mdx mouse has absent dystrophin yet does not exhibit significant disability.
Methods: Allometric modeling of linearly increasing load per muscle fiber and stress on the sarcolemma with growth and exponential decline associated with loss of muscle fibers correlated with case studies and animal models of DMD.
Results: Smaller species or breeds are predictably less affected than large as follows: mdx mice &lt; small Golden Retriever muscular dystrophy (GRMD) dogs &lt; large GRMD dogs &lt; humans. Case reports of combined growth hormone and dystrophin deficiency show a relatively benign course of disease.
Conclusions: Future therapeutic trials in DMD might include specific growth inhibitors in combination with standard of care treatments to the delay the clinical onset and reduce severity of disease and disability. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23791" xmlns="http://purl.org/rss/1.0/"><title>The influence of maximum range of motion and stiffness on the viscoelastic stretch response</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23791</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The influence of maximum range of motion and stiffness on the viscoelastic stretch response</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Eric J. Sobolewski, Eric D. Ryan, Brennan J. Thompson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:45:35.874694-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23791</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23791</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23791</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Purpose</em>: We examined the influence of maximum range of motion (MROM) and passive stiffness on the viscoelastic stretch response. <em>Methods</em>: Four 30-s constant-angle passive stretches of the plantar flexors at a pre-determined torque were performed to determine the rate and relative change in stress relaxation (decline in torque during each 30-s stretch) and creep (increase in ankle joint angle across all 4 stretches). Stress relaxation and creep responses were examined between participants after they were ranked into high and low groups based on MROM and passive stiffness values. <em>Results</em>: Stress relaxation responses were unaffected by MROM and passive stiffness, however creep was influenced by differences in passive stiffness but not MROM. <em>Conclusion</em>: Passive stiffness but not MROM influences the acute viscoelastic responses to passive stretching. Participants with less stiff plantar flexors experience greater increases in range of motion when they are stretched at a constant torque. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Purpose: We examined the influence of maximum range of motion (MROM) and passive stiffness on the viscoelastic stretch response. Methods: Four 30-s constant-angle passive stretches of the plantar flexors at a pre-determined torque were performed to determine the rate and relative change in stress relaxation (decline in torque during each 30-s stretch) and creep (increase in ankle joint angle across all 4 stretches). Stress relaxation and creep responses were examined between participants after they were ranked into high and low groups based on MROM and passive stiffness values. Results: Stress relaxation responses were unaffected by MROM and passive stiffness, however creep was influenced by differences in passive stiffness but not MROM. Conclusion: Passive stiffness but not MROM influences the acute viscoelastic responses to passive stretching. Participants with less stiff plantar flexors experience greater increases in range of motion when they are stretched at a constant torque. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23789" xmlns="http://purl.org/rss/1.0/"><title>Dynamic sonographic measurements at the carpal tunnel inlet: Reliability and reference values in healthy wrists</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23789</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Dynamic sonographic measurements at the carpal tunnel inlet: Reliability and reference values in healthy wrists</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anika Filius, Jan-Wiebe H. Korstanje, Ruud W. Selles, Steven E.R. Hovius, Harm P. Slijper</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:45:33.671439-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23789</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23789</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23789</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Regular Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction:</em> Reliability and reference values are not well established for most dynamic sonographic measurements of the median nerve (MN) and flexor tendons that may be used for diagnosing carpal tunnel syndrome (CTS).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Methods:</em> Wrists of 20 healthy participants were imaged using ultrasound. Cines of the carpal tunnel inlet were acquired during hand motion. Based on shape and displacement measurements, intrarater and interrater reliability and reference values were calculated.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Results:</em> Intraclass correlation coefficients (ICC) for measurements of the MN and most flexor tendons were ≥0.51 for shape parameters and ≥0.71 for displacement parameters. During motion the MN flattened with ulnar movement, tendons became more circular, and flexor tendons of corresponding fingers moved towards each other.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Discussion:</em> Shape and displacement measurements of the MN and most flexor tendons had reliability results ranging from moderate to excellent. The reference values may be useful for the diagnosis of CTS. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Reliability and reference values are not well established for most dynamic sonographic measurements of the median nerve (MN) and flexor tendons that may be used for diagnosing carpal tunnel syndrome (CTS).
Methods: Wrists of 20 healthy participants were imaged using ultrasound. Cines of the carpal tunnel inlet were acquired during hand motion. Based on shape and displacement measurements, intrarater and interrater reliability and reference values were calculated.
Results: Intraclass correlation coefficients (ICC) for measurements of the MN and most flexor tendons were ≥0.51 for shape parameters and ≥0.71 for displacement parameters. During motion the MN flattened with ulnar movement, tendons became more circular, and flexor tendons of corresponding fingers moved towards each other.
Discussion: Shape and displacement measurements of the MN and most flexor tendons had reliability results ranging from moderate to excellent. The reference values may be useful for the diagnosis of CTS. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23788" xmlns="http://purl.org/rss/1.0/"><title>Assessment of transverse ultrasonographic parameters to optimize carpal tunnel syndrome diagnosis in a case-control study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23788</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Assessment of transverse ultrasonographic parameters to optimize carpal tunnel syndrome diagnosis in a case-control study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jan-Wiebe H. Korstanje, Richard van Balen, Marjan Scheltens-de Boer, Joleen H. Blok, Harm P. Slijper, Henk J. Stam, Steven E.R. Hovius, Ruud W. Selles</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:45:30.294618-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23788</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23788</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23788</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Regular Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="mus23788-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Transverse ultrasound findings of the median nerve (MN) for diagnosis of carpal tunnel syndrome (CTS) suffer from inconsistent findings within and between patients and healthy subjects. The objective of this study was to improve ultrasound assessment of CTS.</p></div></div>
<div class="section" id="mus23788-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>In a case-control study (51 cases, 25 controls) we evaluated the performance gained by: 1) correcting for ultrasound probe angulation, 2) including active parameters such as forceful gripping of the hand, and 3) including hand flexor tendon parameters.</p></div></div>
<div class="section" id="mus23788-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Correcting ultrasound probe angulation increased the correct classification rate by 4.5%; including forceful gripping resulted increase it 2.8%; and including the hand flexor tendon resulted in an increase of 1.3%.</p></div></div>
<div class="section" id="mus23788-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>The best predictive model combines correcting probe angulation with forceful gripping parameters and hand flexor tendon parameters. However, the clinically most practical model might only use probe angulation correction. © 2013 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction
Transverse ultrasound findings of the median nerve (MN) for diagnosis of carpal tunnel syndrome (CTS) suffer from inconsistent findings within and between patients and healthy subjects. The objective of this study was to improve ultrasound assessment of CTS.


Methods
In a case-control study (51 cases, 25 controls) we evaluated the performance gained by: 1) correcting for ultrasound probe angulation, 2) including active parameters such as forceful gripping of the hand, and 3) including hand flexor tendon parameters.


Results
Correcting ultrasound probe angulation increased the correct classification rate by 4.5%; including forceful gripping resulted increase it 2.8%; and including the hand flexor tendon resulted in an increase of 1.3%.


Conclusion
The best predictive model combines correcting probe angulation with forceful gripping parameters and hand flexor tendon parameters. However, the clinically most practical model might only use probe angulation correction. © 2013 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23787" xmlns="http://purl.org/rss/1.0/"><title>Motor unit potential change with contraction level: A concentric macro emg study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23787</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Motor unit potential change with contraction level: A concentric macro emg study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joe F. Jabre, Yuzhou Guan, Kenneth K.H. Chui</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:45:25.390252-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23787</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23787</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23787</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Regular Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Motor unit action potential (MUAP) reference values are usually given per muscle and age group.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Objectives</b>: To evaluate the change in MUAP size at different contraction levels using the Concentric Macro (ConMac) EMG technique.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: ConMac needles were used to record the electrode cannula MUAP and measure its amplitude and area during weak, moderate, and strong muscle contractions.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: MUAP area and amplitude gradually increased from weak to strong contraction levels in all muscles studied. MUAP amplitudes were larger in distal than proximal muscles, likely because of a higher fiber density distally.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion:</b> MUAP normal values in the literature per muscle do not take into account the contraction level at which they were recorded and can misrepresent the interpretation of normal. Concentric Macro EMG is a simple and useful compliment to routine EMG studies and yields additional information on MUAP neurophysiology. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Motor unit action potential (MUAP) reference values are usually given per muscle and age group.
Objectives: To evaluate the change in MUAP size at different contraction levels using the Concentric Macro (ConMac) EMG technique.
Methods: ConMac needles were used to record the electrode cannula MUAP and measure its amplitude and area during weak, moderate, and strong muscle contractions.
Results: MUAP area and amplitude gradually increased from weak to strong contraction levels in all muscles studied. MUAP amplitudes were larger in distal than proximal muscles, likely because of a higher fiber density distally.
Discussion: MUAP normal values in the literature per muscle do not take into account the contraction level at which they were recorded and can misrepresent the interpretation of normal. Concentric Macro EMG is a simple and useful compliment to routine EMG studies and yields additional information on MUAP neurophysiology. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23785" xmlns="http://purl.org/rss/1.0/"><title>Muscle architecture adaptations to knee extensor eccentric training: Rectus femoris vs. Vastus lateralis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23785</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Muscle architecture adaptations to knee extensor eccentric training: Rectus femoris vs. Vastus lateralis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bruno Manfredini Baroni, Jeam Marcel Geremia, Rodrigo Rodrigues, Rodrigo de Azevedo Franke, Kiros Karamanidis, Marco Aurélio Vaz</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:45:20.754369-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23785</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23785</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23785</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Regular Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction:</em> Changes in muscle architecture induced by eccentric knee extensor training remain unclear, as well as the adaptive responses of synergistic knee extensor muscles with different geometrical designs. <em>Methods:</em> Ultrasonographic images were taken from rectus femoris (RF) and vastus lateralis (VL) of 20 male volunteers before and after a non-training control period of 4 weeks, and additional evaluations were performed after 4, 8, and 12 weeks of isokinetic eccentric training. <em>Results:</em> RF and VL had significant changes in muscle architecture within the first 4 training weeks, and the adaptive response throughout the intervention was similar. Muscle thickness increased around 7-10%; fascicle length increased 17-19%; and pennation angle was unchanged. <em>Discussion:</em> Increased muscle thickness due to eccentric training was related to increased fascicle length and not to pennation angle changes. Even though RF and VL have different fascicular geometry, these muscles had similar morphological adaptations to eccentric training. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Changes in muscle architecture induced by eccentric knee extensor training remain unclear, as well as the adaptive responses of synergistic knee extensor muscles with different geometrical designs. Methods: Ultrasonographic images were taken from rectus femoris (RF) and vastus lateralis (VL) of 20 male volunteers before and after a non-training control period of 4 weeks, and additional evaluations were performed after 4, 8, and 12 weeks of isokinetic eccentric training. Results: RF and VL had significant changes in muscle architecture within the first 4 training weeks, and the adaptive response throughout the intervention was similar. Muscle thickness increased around 7-10%; fascicle length increased 17-19%; and pennation angle was unchanged. Discussion: Increased muscle thickness due to eccentric training was related to increased fascicle length and not to pennation angle changes. Even though RF and VL have different fascicular geometry, these muscles had similar morphological adaptations to eccentric training. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23784" xmlns="http://purl.org/rss/1.0/"><title>Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratified medicine?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23784</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratified medicine?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Samantha A Natanek, Harry R Gosker, Ilse GM Slot, Gemma S Marsh, Nicholas S Hopkinson, William D-C Man, Ruth Tal-Singer, John Moxham, Paul R Kemp, Nnemie MWJ Schols, Michael I Polkey</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:45:17.644389-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23784</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23784</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23784</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Regular Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction:</b> Quadriceps muscle dysfunction is common in COPD. Determining, and, if possible, predicting quadriceps phenotype in COPD is important for patient stratification for therapeutic trials.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods:</b> In biopsies from 114 COPD patients and 30 controls, we measured fiber size and proportion and assessed the relationship with quadriceps function (strength and endurance), clinical phenotype (lung function, physical activity, fat-free mass) and exercise performance. In a subset (n=40) we measured muscle mid-thigh cross-sectional area by computed tomography.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> Normal ranges for fiber proportions and fiber cross-sectional area were defined from controls; we found isolated fiber shift in 31% of patients, isolated fiber (predominantly type II) atrophy in 20%, both shift and atrophy in 25%, and a normal fiber appearance in 24%. Clinical parameters related poorly to muscle biopsy appearances.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion:</b> Quadriceps morphology is heterogeneous in COPD and cannot be predicted without biopsy, underlining the need for biomarkers. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Quadriceps muscle dysfunction is common in COPD. Determining, and, if possible, predicting quadriceps phenotype in COPD is important for patient stratification for therapeutic trials.
Methods: In biopsies from 114 COPD patients and 30 controls, we measured fiber size and proportion and assessed the relationship with quadriceps function (strength and endurance), clinical phenotype (lung function, physical activity, fat-free mass) and exercise performance. In a subset (n=40) we measured muscle mid-thigh cross-sectional area by computed tomography.
Results: Normal ranges for fiber proportions and fiber cross-sectional area were defined from controls; we found isolated fiber shift in 31% of patients, isolated fiber (predominantly type II) atrophy in 20%, both shift and atrophy in 25%, and a normal fiber appearance in 24%. Clinical parameters related poorly to muscle biopsy appearances.
Discussion: Quadriceps morphology is heterogeneous in COPD and cannot be predicted without biopsy, underlining the need for biomarkers. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23786" xmlns="http://purl.org/rss/1.0/"><title>Effect of different approaches to target force on transcranial magnetic stimulation responses</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23786</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effect of different approaches to target force on transcranial magnetic stimulation responses</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mathieu Gruet, John Temesi, Thomas Rupp, Guillaume Y Millet, Samuel Verges</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:40:38.863321-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23786</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23786</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23786</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction:</em> The aim of this study was to determine whether the manner in which a target force is approached can influence the EMG and mechanical parameters evoked by transcranial magnetic stimulation (TMS) during brief muscle contractions.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Methods:</em> The amplitude of motor-evoked potentials (MEP) and superimposed twitch and the duration of the silent period were recorded in 8 healthy participants in response to TMS delivered during brief isometric voluntary contractions of the quadriceps maintaining a target force (10 and 50% of maximal voluntary force) or gradually increasing or decreasing to it. <em>Results:</em> MEP and superimposed twitch, unlike the silent period, are influenced by the manner of reaching a low force.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Discussion:</em> This study demonstrates that clear instructions must be provided to research participants and patients. Rapidly increasing to a target force without exceeding it and maintaining the force before the delivery of TMS results in stable and representative MEP amplitudes. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: The aim of this study was to determine whether the manner in which a target force is approached can influence the EMG and mechanical parameters evoked by transcranial magnetic stimulation (TMS) during brief muscle contractions.
Methods: The amplitude of motor-evoked potentials (MEP) and superimposed twitch and the duration of the silent period were recorded in 8 healthy participants in response to TMS delivered during brief isometric voluntary contractions of the quadriceps maintaining a target force (10 and 50% of maximal voluntary force) or gradually increasing or decreasing to it. Results: MEP and superimposed twitch, unlike the silent period, are influenced by the manner of reaching a low force.
Discussion: This study demonstrates that clear instructions must be provided to research participants and patients. Rapidly increasing to a target force without exceeding it and maintaining the force before the delivery of TMS results in stable and representative MEP amplitudes. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23781" xmlns="http://purl.org/rss/1.0/"><title>Spontaneous electromyography activity of the tongue in amyotrophic lateral sclerosis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23781</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Spontaneous electromyography activity of the tongue in amyotrophic lateral sclerosis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hatice Tankisi, Marit Otto, Kirsten Pugdahl, Anders Fuglsang-Frederiksen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:40:32.026966-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23781</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23781</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23781</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: Detection of denervation in muscles in the craniobulbar area is important to assure widespread lower motor neuron involvement in the diagnosis of amyotrophic lateral sclerosis (ALS). The value of spontaneous activity analysis in needle electromyography (EMG) of the tongue has been questioned in the recent literature.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Methods</em>: Spontaneous activity in the tongue and sternocleidomastoid (SCM) muscles was reviewed retrospectively in 17 ALS patients.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Results</em>: Needle EMG showed spontaneous activity in the tongue in 14 out of 17 patients (82%) and in 6 patients of 17 (35%) in SCM. Spontaneous EMG activity in the tongue was found in patients with and without bulbar symptoms.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Conclusions</em>: Needle EMG is a valuable method for assessing clinical and subclinical involvement of the tongue in patients with bulbar and limb onset ALS. Adequate relaxation of the tongue is a prerequisite for proper spontaneous activity recording. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>
Introduction: Detection of denervation in muscles in the craniobulbar area is important to assure widespread lower motor neuron involvement in the diagnosis of amyotrophic lateral sclerosis (ALS). The value of spontaneous activity analysis in needle electromyography (EMG) of the tongue has been questioned in the recent literature.
Methods: Spontaneous activity in the tongue and sternocleidomastoid (SCM) muscles was reviewed retrospectively in 17 ALS patients.
Results: Needle EMG showed spontaneous activity in the tongue in 14 out of 17 patients (82%) and in 6 patients of 17 (35%) in SCM. Spontaneous EMG activity in the tongue was found in patients with and without bulbar symptoms.
Conclusions: Needle EMG is a valuable method for assessing clinical and subclinical involvement of the tongue in patients with bulbar and limb onset ALS. Adequate relaxation of the tongue is a prerequisite for proper spontaneous activity recording. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23780" xmlns="http://purl.org/rss/1.0/"><title>Generating color-coded anatomic muscle maps for correlation of quantitative mri analysis with clinical examination in neuromuscular disorders</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23780</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Generating color-coded anatomic muscle maps for correlation of quantitative mri analysis with clinical examination in neuromuscular disorders</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ramin Javan, Jeffrey J Horvath, Laura E. Case, Stephanie Austin, Jose Corderi, Alberto Dubrovsky, Priya S. Kishnani, Mustafa R. Bashir</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:40:27.972384-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23780</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23780</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23780</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Fatty infiltration of muscles may be seen in many neuromuscular disorders, including glycogen storage diseases (GSD), muscular dystrophies, and amyotrophic lateral sclerosis. Recording pathologic involvement of musculature in these patients is cumbersome, given marked disease heterogeneity within each individual. We describe a novel method for simplifying this process and present its application in a patient with GSD type IIIa. <b>Methods</b>: A color-coded visual mapping tool was developed based on a commonly used spreadsheet platform. <b>Results</b>: This tool depicts individual muscle groups as shapes linked to data cells corresponding to quantitative MRI-based measures of fatty infiltration and weakness assessed by physical examination. It allows for rapid evaluation and chronological comparison of all mapped muscle groups on a single graphical sheet, as well as assessment of response to therapy. <b>Discussion</b>: This can be applied in any neuromuscular disorder where muscle function is assessed by clinical or imaging scores. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Fatty infiltration of muscles may be seen in many neuromuscular disorders, including glycogen storage diseases (GSD), muscular dystrophies, and amyotrophic lateral sclerosis. Recording pathologic involvement of musculature in these patients is cumbersome, given marked disease heterogeneity within each individual. We describe a novel method for simplifying this process and present its application in a patient with GSD type IIIa. Methods: A color-coded visual mapping tool was developed based on a commonly used spreadsheet platform. Results: This tool depicts individual muscle groups as shapes linked to data cells corresponding to quantitative MRI-based measures of fatty infiltration and weakness assessed by physical examination. It allows for rapid evaluation and chronological comparison of all mapped muscle groups on a single graphical sheet, as well as assessment of response to therapy. Discussion: This can be applied in any neuromuscular disorder where muscle function is assessed by clinical or imaging scores. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23803" xmlns="http://purl.org/rss/1.0/"><title>A patient with mutation in the SCN4A p.M1592V presenting with fixed weakness, rhabdomyolysis and episodic worsening of weakness</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23803</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A patient with mutation in the SCN4A p.M1592V presenting with fixed weakness, rhabdomyolysis and episodic worsening of weakness</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Eric Lee, Nizar Chahin</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:40:25.121805-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23803</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23803</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23803</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23802" xmlns="http://purl.org/rss/1.0/"><title>The effect of generalized joint hypermobility on knee function and muscle activation in children and adults</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23802</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The effect of generalized joint hypermobility on knee function and muscle activation in children and adults</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bente R Jensen, Annesofie T Olesen, Mogens T Pedersen, Jens H Kristensen J, Lars Remvig, Erik B Simonsen, Birgit Juul-Kristensen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:40:17.690177-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23802</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23802</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23802</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: We investigated muscle activation strategy and performance of knee extensor and flexor muscles of children and adults with Generalized Joint Hypermobility (GJH) compared with controls. <em>Methods</em>: Muscle activation, torque steadiness, electromechanical delay, and muscle strength were evaluated in 39 children and 36 adults during isometric knee extension and flexion. Subjects performed isometric maximum contractions, submaximal contractions at 25%MVC, and explosive contractions. <em>Results</em>: Agonist activation was reduced, and co-activation ratio was greater in GJH during knee flexions compared to controls. Torque steadiness was impaired in adults with GJH during knee flexion. No effect of GJH was found on muscle strength or electromechanical delay. Correlation analysis revealed association between GJH severity and function in adults. <em>Conclusions</em>: The results indicate that muscle activation strategy and quality of force control were significantly affected in adults with GJH during knee flexion, while only muscle activation strategy was affected in children with GJH. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We investigated muscle activation strategy and performance of knee extensor and flexor muscles of children and adults with Generalized Joint Hypermobility (GJH) compared with controls. Methods: Muscle activation, torque steadiness, electromechanical delay, and muscle strength were evaluated in 39 children and 36 adults during isometric knee extension and flexion. Subjects performed isometric maximum contractions, submaximal contractions at 25%MVC, and explosive contractions. Results: Agonist activation was reduced, and co-activation ratio was greater in GJH during knee flexions compared to controls. Torque steadiness was impaired in adults with GJH during knee flexion. No effect of GJH was found on muscle strength or electromechanical delay. Correlation analysis revealed association between GJH severity and function in adults. Conclusions: The results indicate that muscle activation strategy and quality of force control were significantly affected in adults with GJH during knee flexion, while only muscle activation strategy was affected in children with GJH. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23801" xmlns="http://purl.org/rss/1.0/"><title>Muscle co-activation: A generalized or localized motor control strategy?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23801</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Muscle co-activation: A generalized or localized motor control strategy?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Laura A. Frey-Law, Keith G. Avin</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:35:32.506065-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23801</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23801</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23801</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction:</b> We examined generalized versus joint-specific influences on muscle co-activation.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods:</b> Muscle co-activation was assessed during maximal isometric and isokinetic knee and elbow joint extension moments in 48 healthy subjects (27 men). Local (joint-specific) and generalized (person-specific) contributions were examined using a combination of statistical tests: regression using generalized estimating equations (GEEs), exploratory factor analysis, and cluster analysis.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> GEEs produced similar significant coefficients for gender and joint; contraction type and test condition (angle or velocity) were not significant. Factor analysis indicated 2 joint-based factors, and cluster analysis indicated 2 groups of individuals, those with or without elevated co-activation at the knee and elbow. Women exhibited greater co-activation at both joints, however, no consistent influences of angle or velocity were observed at either joint.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion:</b> We conclude that muscle co-activation is a neuromuscular control response determined by local, joint-specific, and generalized, individual-specific influences. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: We examined generalized versus joint-specific influences on muscle co-activation.
Methods: Muscle co-activation was assessed during maximal isometric and isokinetic knee and elbow joint extension moments in 48 healthy subjects (27 men). Local (joint-specific) and generalized (person-specific) contributions were examined using a combination of statistical tests: regression using generalized estimating equations (GEEs), exploratory factor analysis, and cluster analysis.
Results: GEEs produced similar significant coefficients for gender and joint; contraction type and test condition (angle or velocity) were not significant. Factor analysis indicated 2 joint-based factors, and cluster analysis indicated 2 groups of individuals, those with or without elevated co-activation at the knee and elbow. Women exhibited greater co-activation at both joints, however, no consistent influences of angle or velocity were observed at either joint.
Discussion: We conclude that muscle co-activation is a neuromuscular control response determined by local, joint-specific, and generalized, individual-specific influences. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23800" xmlns="http://purl.org/rss/1.0/"><title>Microvascular decompression for hemifacial spasm in patients over 65 years of age: An analysis of outcomes and complications</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23800</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Microvascular decompression for hemifacial spasm in patients over 65 years of age: An analysis of outcomes and complications</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Raymond F. Sekula, Andrew M. Frederickson, Gregory D. Arnone, Matthew R. Quigley, Mark Hallett</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:35:27.254839-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23800</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23800</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23800</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Background:</b> Little data is available to quantify the risks and benefits of microvascular decompression (MVD) in elderly patients with hemifacial spasm.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: Twenty-seven patients above the age of 65 years and 104 younger patients who underwent MVD for HFS over a three-year period were analyzed retrospectively and compared.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results:</b> Twenty-six (96.3%) elderly patients and 93 of 104 (89.4%) young patients reported a spasm-free status at a mean follow-up of 26.5 months after MVD. No significant difference in spasm-free status was noted. Cranial nerve complications and other major complications were compared, and no significant differences were noted.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion:</b> Although this study does not offer definitive inclusion or exclusion criteria or clearly establish the safety of MVD for HFS in the elderly, our experience suggests that many elderly patients with HFS can undergo MVD safely, with outcomes and risk profiles similar to younger patients. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Background: Little data is available to quantify the risks and benefits of microvascular decompression (MVD) in elderly patients with hemifacial spasm.
Methods: Twenty-seven patients above the age of 65 years and 104 younger patients who underwent MVD for HFS over a three-year period were analyzed retrospectively and compared.
Results: Twenty-six (96.3%) elderly patients and 93 of 104 (89.4%) young patients reported a spasm-free status at a mean follow-up of 26.5 months after MVD. No significant difference in spasm-free status was noted. Cranial nerve complications and other major complications were compared, and no significant differences were noted.
Discussion: Although this study does not offer definitive inclusion or exclusion criteria or clearly establish the safety of MVD for HFS in the elderly, our experience suggests that many elderly patients with HFS can undergo MVD safely, with outcomes and risk profiles similar to younger patients. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23798" xmlns="http://purl.org/rss/1.0/"><title>Early changes of muscle IGF-1 and myostatin gene expression in gastric cancer patients</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23798</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Early changes of muscle IGF-1 and myostatin gene expression in gastric cancer patients</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Andrea Bonetto, Fabio Penna, Zaira Aversa, Paolo Mercantini, Francesco M. Baccino, Paola Costelli, Vincenzo Ziparo, Simone Lucia, Filippo Rossi Fanelli, Maurizio Muscaritoli</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:35:22.350433-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23798</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23798</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23798</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b>: Cachexia increases morbidity and mortality of cancer patients. The progressive loss of muscle mass negatively affects physical function and quality of life. We previously showed reduced muscle IGF-1 expression and enhanced myostatin signaling in tumor-bearing animals. This study was aimed at investigating whether similar perturbations occur in gastric cancer patients.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Methods</b>: Early perturbations of myostatin and IGF-1 signaling (including the expression of muscle-specific ubiquitin-ligases) were investigated in 16 gastric cancer patients and in 6 controls by analyzing muscle mRNA expression with semi-quantitative Reverse Transcriptase-PCR and real-time PCR.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Results</b>: In gastric cancer patients, muscle mRNA levels for IGF-1, myostatin, and atrogin-1 were reduced irrespective of weight loss (≤ 5% or &gt; 5%) while MuRF1 expression was unchanged.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Discussion:</b> IGF-1 and myostatin mRNA levels are down-regulated in gastric cancer patients who have minimal or no weight loss. These early alterations are particularly relevant in order to devise preventative and therapeutic strategies for cancer cachexia. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Cachexia increases morbidity and mortality of cancer patients. The progressive loss of muscle mass negatively affects physical function and quality of life. We previously showed reduced muscle IGF-1 expression and enhanced myostatin signaling in tumor-bearing animals. This study was aimed at investigating whether similar perturbations occur in gastric cancer patients.
Methods: Early perturbations of myostatin and IGF-1 signaling (including the expression of muscle-specific ubiquitin-ligases) were investigated in 16 gastric cancer patients and in 6 controls by analyzing muscle mRNA expression with semi-quantitative Reverse Transcriptase-PCR and real-time PCR.
Results: In gastric cancer patients, muscle mRNA levels for IGF-1, myostatin, and atrogin-1 were reduced irrespective of weight loss (≤ 5% or &gt; 5%) while MuRF1 expression was unchanged.
Discussion: IGF-1 and myostatin mRNA levels are down-regulated in gastric cancer patients who have minimal or no weight loss. These early alterations are particularly relevant in order to devise preventative and therapeutic strategies for cancer cachexia. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23797" xmlns="http://purl.org/rss/1.0/"><title>The prevalence of bifid median nerves and persistent median arteries and their association with carpal tunnel syndrome in a sample of latino poultry processing and other manual workers</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23797</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The prevalence of bifid median nerves and persistent median arteries and their association with carpal tunnel syndrome in a sample of latino poultry processing and other manual workers</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Francis O. Walker, Michael S. Cartwright, Jill N. Blocker, Thomas A. Arcury, Jung Im Suk, Haiying Chen, Mark R. Schultz, Joseph G. Grzywacz, Dana C. Mora, Sara A. Quandt</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-30T22:35:19.223437-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23797</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23797</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23797</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: The prevalence of bifid median nerves and persistent median arteries, their co-occurrence, and their relationship to carpal tunnel syndrome (CTS) are only partially understood.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Methods</em>: We screened 1026 wrists in 513 Latino manual laborers in North Carolina for bifid median nerves and persistent median arteries with electrodiagnosis and ultrasound.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Results</em>: 8.6% of wrists had a bifid median nerve, and 3.7% of wrists had a persistent median artery independent of sub-group ethnicity, age, gender, or type of work. An association with definite carpal tunnel syndrome was not found. The presence of either anatomic variant was associated with a high likelihood of co-occurrence of another variant in the same or the contralateral wrist.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Conclusions</em>: The occurrence of median anatomic variants can be determined in field studies using ultrasound. Persistent median arteries and bifid median nerves tend to co-occur but do not put manual laborers at additional risk of developing CTS. © 2013 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: The prevalence of bifid median nerves and persistent median arteries, their co-occurrence, and their relationship to carpal tunnel syndrome (CTS) are only partially understood.
Methods: We screened 1026 wrists in 513 Latino manual laborers in North Carolina for bifid median nerves and persistent median arteries with electrodiagnosis and ultrasound.
Results: 8.6% of wrists had a bifid median nerve, and 3.7% of wrists had a persistent median artery independent of sub-group ethnicity, age, gender, or type of work. An association with definite carpal tunnel syndrome was not found. The presence of either anatomic variant was associated with a high likelihood of co-occurrence of another variant in the same or the contralateral wrist.
Conclusions: The occurrence of median anatomic variants can be determined in field studies using ultrasound. Persistent median arteries and bifid median nerves tend to co-occur but do not put manual laborers at additional risk of developing CTS. © 2013 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23765" xmlns="http://purl.org/rss/1.0/"><title>A trial of proficiency of nerve conduction: Greater standardization needed</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23765</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A trial of proficiency of nerve conduction: Greater standardization needed</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Peter J. Dyck, James W. Albers, James Wolfe, Charles F. Bolton, Nancy Walsh, Christopher J. Klein, Andrew J. Zafft, James W. Russell, Karen Thomas, Jenny L. Davies, Rickey E. Carter, L. Joseph Melton, William J. Litchy</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-27T10:03:09.345052-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23765</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23765</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23765</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Specific Aim</b>: To test proficiency (accuracy among evaluators) of measured attributes of nerve conduction (NC). <b>Methods</b>: Expert clinical neurophysiologists, without instruction or consensus development, from 4 different medical centers independently assessed 8 attributes of NC of 24 patients with diabetes (DM) on consecutive days. <b>Results</b>: No significant intra-observer differencesbetween days 1 and 2 were found, but significant inter-observer differences were found. Use of standard reference values did not correctfor these observed differences. <b>Discussion</b>: The inter-observer variability was attributed to differences in performance of NC. It was of sufficient magnitude that it is of concern for the conduct of therapeutic trials. To deal with inter-rater variability in therapeutic trials, the same electromyographers might perform all NC assessments of individual patients, or preferably NC procedures should be more standardized. A further trial is needed to test whether such standardization will eliminate inter-observer variability. © 2012 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Specific Aim: To test proficiency (accuracy among evaluators) of measured attributes of nerve conduction (NC). Methods: Expert clinical neurophysiologists, without instruction or consensus development, from 4 different medical centers independently assessed 8 attributes of NC of 24 patients with diabetes (DM) on consecutive days. Results: No significant intra-observer differencesbetween days 1 and 2 were found, but significant inter-observer differences were found. Use of standard reference values did not correctfor these observed differences. Discussion: The inter-observer variability was attributed to differences in performance of NC. It was of sufficient magnitude that it is of concern for the conduct of therapeutic trials. To deal with inter-rater variability in therapeutic trials, the same electromyographers might perform all NC assessments of individual patients, or preferably NC procedures should be more standardized. A further trial is needed to test whether such standardization will eliminate inter-observer variability. © 2012 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23762" xmlns="http://purl.org/rss/1.0/"><title>Utility of multi-channel surface electromyography in assessment of focal hand dystonia</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23762</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Utility of multi-channel surface electromyography in assessment of focal hand dystonia</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ajith Sivadasan, M Sanjay, Mathew Alexander, Suresh R Devasahayam, Srinivasa Babu K</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-18T23:04:17.651795-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23762</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23762</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23762</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h4>INTRODUCTION:</h4><div class="para"><p>Surface electromyography (SEMG) allows objective assessment and guides selection of appropriate treatment in focal hand dystonia (FHD).</p></div></div>
<div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h4>METHODS:</h4><div class="para"><p>16-channel SEMG obtained during different phases of a writing task was used to study timing, activation patterns, and spread of muscle contractions in FHD compared with normal controls. Customized software was developed to acquire and analyze EMG signals.</p></div></div>
<div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h4>RESULTS:</h4><div class="para"><p>SEMG of FHD subjects (20) showed “early onset” during motor imagery, rapid proximal muscle recruitment, agonist-antagonist co-contraction involving proximal muscle groups, “delayed offset” after stopping writing, higher rectified mean amplitudes, and mirror activity in contralateral limb compared to controls (16). Muscle activation latencies were heterogenous in FHD.</p></div></div>
<div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h4>CONCLUSION:</h4><div class="para"><p>Anticipation, delayed relaxation, and mirror EMG activation were noted in FHD. A clear pattern of muscle activation cannot be ascertained. Multi-channel SEMG can aid in objective assessment of temporal-spatial distribution of activity and can refine targeted therapies like chemodenervation and biofeedback. © 2012 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


INTRODUCTION:
Surface electromyography (SEMG) allows objective assessment and guides selection of appropriate treatment in focal hand dystonia (FHD).


METHODS:
16-channel SEMG obtained during different phases of a writing task was used to study timing, activation patterns, and spread of muscle contractions in FHD compared with normal controls. Customized software was developed to acquire and analyze EMG signals.


RESULTS:
SEMG of FHD subjects (20) showed “early onset” during motor imagery, rapid proximal muscle recruitment, agonist-antagonist co-contraction involving proximal muscle groups, “delayed offset” after stopping writing, higher rectified mean amplitudes, and mirror activity in contralateral limb compared to controls (16). Muscle activation latencies were heterogenous in FHD.


CONCLUSION:
Anticipation, delayed relaxation, and mirror EMG activation were noted in FHD. A clear pattern of muscle activation cannot be ascertained. Multi-channel SEMG can aid in objective assessment of temporal-spatial distribution of activity and can refine targeted therapies like chemodenervation and biofeedback. © 2012 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23761" xmlns="http://purl.org/rss/1.0/"><title>A spatial analysis of amyotrophic lateral sclerosis in Northern New England, USA, 1997-2009</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23761</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A spatial analysis of amyotrophic lateral sclerosis in Northern New England, USA, 1997-2009</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tracie A. Caller, Jonathan W. Chipman, Nicholas C. Field, Elijah W. Stommel</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-14T02:45:24.696864-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23761</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23761</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23761</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h4>Background:</h4><div class="para"><p>An environmental trigger of sporadic ALS is supported by geographic disparities in ALS incidence and the development of the disease in conjugal couples. This study aims to investigate the incidence of ALS in the Northern New England states of New Hampshire (NH), Vermont (VT), and Maine (ME).</p></div></div>
<div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods:</h4><div class="para"><p>We reviewed medical records and community databases to identify dwelling addresses of 688 patients diagnosed with ALS in 1997-2009 in NH, VT, and ME. We used spatial analysis to identify clusters of census block groups with statistically significant high incidence.</p></div></div>
<div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h4>Results:</h4><div class="para"><p>We identified 11 clusters of statistically significant high incidence, each containing 6 or more cases of ALS. These 11 clusters are grouped in 4 distinct regions.</p></div></div>
<div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions:</h4><div class="para"><p>There appear to be areas of significant spatial clustering within Northern New England. Further analysis will be needed to confirm whether there is any correlation between these areas and potential environmental risk factors. © 2012 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Background:
An environmental trigger of sporadic ALS is supported by geographic disparities in ALS incidence and the development of the disease in conjugal couples. This study aims to investigate the incidence of ALS in the Northern New England states of New Hampshire (NH), Vermont (VT), and Maine (ME).


Methods:
We reviewed medical records and community databases to identify dwelling addresses of 688 patients diagnosed with ALS in 1997-2009 in NH, VT, and ME. We used spatial analysis to identify clusters of census block groups with statistically significant high incidence.


Results:
We identified 11 clusters of statistically significant high incidence, each containing 6 or more cases of ALS. These 11 clusters are grouped in 4 distinct regions.


Conclusions:
There appear to be areas of significant spatial clustering within Northern New England. Further analysis will be needed to confirm whether there is any correlation between these areas and potential environmental risk factors. © 2012 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23760" xmlns="http://purl.org/rss/1.0/"><title>Sarcomere lengths in human extensor carpi radialis brevis measured by microendoscopy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23760</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Sarcomere lengths in human extensor carpi radialis brevis measured by microendoscopy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Melinda J Cromie, Gabriel N Sanchez, Mark J Schnitzer, Scott L Delp</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-14T02:45:14.027835-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23760</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23760</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23760</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h4>INTRODUCTION:</h4><div class="para"><p>Second-harmonic generation microendoscopy is a minimally invasive technique to image sarcomeres and measure their lengths in humans, but low signal and motion artifact have limited the use of this novel technique.</p></div></div>
<div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h4>METHODS:</h4><div class="para"><p>We discovered that an excitation wavelength of 960nm maximized image signal; this enabled an image acquisition rate of 3 frames-per-second, which decreased motion artifact. We then used microendoscopy to measure sarcomere lengths in the human extensor carpi radialis brevis with the wrist at 45° extension and 45° flexion in 7 subjects. We also measured the variability in sarcomere lengths within single fibers.</p></div></div>
<div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h4>RESULTS:</h4><div class="para"><p>Average sarcomere lengths in 45° extension were 2.93±0.29μm (±SD) and increased to 3.58±0.19μm in 45° flexion. Within single fibers the standard deviation of sarcomere lengths in series was 0.20μm.</p></div></div>
<div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h4>CONCLUSIONS:</h4><div class="para"><p>Microendoscopy can be used to measure sarcomere lengths at different body postures. Lengths of sarcomeres in series within a fiber vary substantially. © 2012 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


INTRODUCTION:
Second-harmonic generation microendoscopy is a minimally invasive technique to image sarcomeres and measure their lengths in humans, but low signal and motion artifact have limited the use of this novel technique.


METHODS:
We discovered that an excitation wavelength of 960nm maximized image signal; this enabled an image acquisition rate of 3 frames-per-second, which decreased motion artifact. We then used microendoscopy to measure sarcomere lengths in the human extensor carpi radialis brevis with the wrist at 45° extension and 45° flexion in 7 subjects. We also measured the variability in sarcomere lengths within single fibers.


RESULTS:
Average sarcomere lengths in 45° extension were 2.93±0.29μm (±SD) and increased to 3.58±0.19μm in 45° flexion. Within single fibers the standard deviation of sarcomere lengths in series was 0.20μm.


CONCLUSIONS:
Microendoscopy can be used to measure sarcomere lengths at different body postures. Lengths of sarcomeres in series within a fiber vary substantially. © 2012 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23758" xmlns="http://purl.org/rss/1.0/"><title>Mast cells can regulate skeletal muscle cell proliferation by multiple mechanisms</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23758</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Mast cells can regulate skeletal muscle cell proliferation by multiple mechanisms</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Elise Duchesne, Patrice Bouchard, Marie-Pier Roussel, Claude H. Côté</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-14T02:44:36.868329-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23758</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23758</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23758</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction:</h4><div class="para"><p>Mast cells (MCs)can stimulate cell proliferation, but their specific contribution to skeletal muscle regeneration is not well defined.</p></div></div>
<div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods:</h4><div class="para"><p>L6myoblast proliferation was assessed in co-culture with MCs or when grown with MC-conditioned media. To addressthe <em>in vivo</em> implication of MCs in regeneration, rats were treated with cromolyn, and myoblast proliferation, immune cell accumulation, and myogenic factors were assessed in bupivacaine-injured muscles.</p></div></div>
<div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h4>Results:</h4><div class="para"><p><em>In vitro</em>, both procedures increased the L6 cell proliferation rate, and this was tryptase-dependent. <em>In vivo</em>, MC stabilization increased myoblast proliferation and accumulation of macrophages CD68 and CD163 following injury.This correlated with a sequential increase in MyoD and myogenin protein level expression.</p></div></div>
<div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h4>Discussion:</h4><div class="para"><p>MCs can directly stimulate muscle cell proliferation via tryptase. MCscan influence myoblast proliferation <em>in vivo,</em> but this effect seems to be predominantly related to their modulation of macrophage recruitment. MC is a potential actor in the early stages of muscle healing. © 2012 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction:
Mast cells (MCs)can stimulate cell proliferation, but their specific contribution to skeletal muscle regeneration is not well defined.


Methods:
L6myoblast proliferation was assessed in co-culture with MCs or when grown with MC-conditioned media. To addressthe in vivo implication of MCs in regeneration, rats were treated with cromolyn, and myoblast proliferation, immune cell accumulation, and myogenic factors were assessed in bupivacaine-injured muscles.


Results:
In vitro, both procedures increased the L6 cell proliferation rate, and this was tryptase-dependent. In vivo, MC stabilization increased myoblast proliferation and accumulation of macrophages CD68 and CD163 following injury.This correlated with a sequential increase in MyoD and myogenin protein level expression.


Discussion:
MCs can directly stimulate muscle cell proliferation via tryptase. MCscan influence myoblast proliferation in vivo, but this effect seems to be predominantly related to their modulation of macrophage recruitment. MC is a potential actor in the early stages of muscle healing. © 2012 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23757" xmlns="http://purl.org/rss/1.0/"><title>Cramps and small fiber neuropathy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23757</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Cramps and small fiber neuropathy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Glenn Lopate, Elizabeth Streif, Matthew Harms, Christopher Weihl, Alan Pestronk</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-14T02:44:17.293554-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23757</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23757</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23757</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction;</h4><div class="para"><p>Muscle cramps are a common complaint and are thought to arise from spontaneous discharges of the motor nerve terminal. Polyneuropathy is often causative, but small fiber neuropathy (SFN) has not been assessed.</p></div></div>
<div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods;</h4><div class="para"><p>Weperformed skin biopsies on consecutive patients with cramps but without neuropathic complaints. Twelve patients were biopsied, 8 with normal small fiber sensation.</p></div></div>
<div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h4>Results;</h4><div class="para"><p>Seven patients had decreased intraepidermal nerve fiber density (IENFD), 2 with non-length dependent loss. A cause for neuropathy was found in 1 patient with cramp-fasciculation syndrome. Creatine kinase was elevated in 8 patients, 4 with decreased IENFD. Muscle biopsy, performed in 8 patients, was diagnostic in only 1with McArdle disease.</p></div></div>
<div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions;</h4><div class="para"><p>Our data shows thatnearly 60% of patients withmuscle cramps who lack neuropathic complaints haveSFN as documented by decreased IENFD.Cramps may originate as local mediators of inflammation released by damaged small nerves diffuse to and excite intramuscular nerves. © 2012 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction;
Muscle cramps are a common complaint and are thought to arise from spontaneous discharges of the motor nerve terminal. Polyneuropathy is often causative, but small fiber neuropathy (SFN) has not been assessed.


Methods;
Weperformed skin biopsies on consecutive patients with cramps but without neuropathic complaints. Twelve patients were biopsied, 8 with normal small fiber sensation.


Results;
Seven patients had decreased intraepidermal nerve fiber density (IENFD), 2 with non-length dependent loss. A cause for neuropathy was found in 1 patient with cramp-fasciculation syndrome. Creatine kinase was elevated in 8 patients, 4 with decreased IENFD. Muscle biopsy, performed in 8 patients, was diagnostic in only 1with McArdle disease.


Conclusions;
Our data shows thatnearly 60% of patients withmuscle cramps who lack neuropathic complaints haveSFN as documented by decreased IENFD.Cramps may originate as local mediators of inflammation released by damaged small nerves diffuse to and excite intramuscular nerves. © 2012 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23756" xmlns="http://purl.org/rss/1.0/"><title>Effects of short-term resistance training and subsequent detraining on the electromechanical delay</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23756</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effects of short-term resistance training and subsequent detraining on the electromechanical delay</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Pablo B. Costa, Trent J. Herda, Ashley A. Walter, Andrea M. Valdez, Joel T. Cramer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-14T02:44:05.464638-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23756</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23756</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23756</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Purpose</b>: To examine and compare the effects of 3 days of dynamic constant external resistance (DCER) and isokinetic (ISOK) training and subsequent detraining on the electromechanical delay (EMD). <b>Methods</b>: Thirty-one men (mean ± SD age = 22.2 ± 4.2 yrs; body mass = 77.9 ± 12.9 kg; height = 173.9 ± 5.4 cm) were randomly assigned to a DCER training group, ISOK training group, or control (CONT) group. <b>Results</b>: No significant changes were found for EMD from pre- to post-training assessments 1, 2, and 3 (mean SE = 4.5 ± 0.2 ms, 4.7 ± 0.2, 4.5 ± 0.1, 4.5 ± 0.2, respectively) (<em>P</em>&gt; 0.05). <b>Discussion</b>: It can be hypothesized that increases in strength observed following a short-term resistance training program may not be attributed to stiffness changes in the series elastic component. © 2012 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Purpose: To examine and compare the effects of 3 days of dynamic constant external resistance (DCER) and isokinetic (ISOK) training and subsequent detraining on the electromechanical delay (EMD). Methods: Thirty-one men (mean ± SD age = 22.2 ± 4.2 yrs; body mass = 77.9 ± 12.9 kg; height = 173.9 ± 5.4 cm) were randomly assigned to a DCER training group, ISOK training group, or control (CONT) group. Results: No significant changes were found for EMD from pre- to post-training assessments 1, 2, and 3 (mean SE = 4.5 ± 0.2 ms, 4.7 ± 0.2, 4.5 ± 0.1, 4.5 ± 0.2, respectively) (P&gt; 0.05). Discussion: It can be hypothesized that increases in strength observed following a short-term resistance training program may not be attributed to stiffness changes in the series elastic component. © 2012 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23753" xmlns="http://purl.org/rss/1.0/"><title>Longitudinal characterization of functional, morphologic, and biochemical adaptations in mouse skeletal muscle with hindlimb suspension</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23753</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Longitudinal characterization of functional, morphologic, and biochemical adaptations in mouse skeletal muscle with hindlimb suspension</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Andrea M. Hanson, Brooke C. Harrison, Mary H. Young, Louis S. Stodieck, Virginia L. Ferguson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-14T02:43:19.574137-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23753</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23753</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23753</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Hindlimb unloading-induced muscle atrophy is often assessed after a homeostatic state is established, thus overlooking theearly adaptations that are critical to developing this pattern of atrophy. Methods: Muscle function and physiology werecharacterizedat 0, 1, 3, 7, and 14 days of hindlimb suspension (HS). Results: Reductions in muscle mass were maximal by Day 14 of HS. Functional strength and isolated muscle strength were reduced. MyHC-I and –IIa expressing fibers were reduced in sizeby Day 7 in the soleus and by Day 14 in the gastrocnemius (MyHC-I fibers only). Atrogin-1 and MuRF1expression was increased by Day 1 in both the calf and tibialis anteriorwhile IGF-1 expression was significantly reduced on Day 3. Phosphorylation of Akt was reduced on Day 14. Conclusions: Insight into these early changes in response to HS improves understanding of the molecular and functional changes that lead to muscle atrophy. © 2012 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction: Hindlimb unloading-induced muscle atrophy is often assessed after a homeostatic state is established, thus overlooking theearly adaptations that are critical to developing this pattern of atrophy. Methods: Muscle function and physiology werecharacterizedat 0, 1, 3, 7, and 14 days of hindlimb suspension (HS). Results: Reductions in muscle mass were maximal by Day 14 of HS. Functional strength and isolated muscle strength were reduced. MyHC-I and –IIa expressing fibers were reduced in sizeby Day 7 in the soleus and by Day 14 in the gastrocnemius (MyHC-I fibers only). Atrogin-1 and MuRF1expression was increased by Day 1 in both the calf and tibialis anteriorwhile IGF-1 expression was significantly reduced on Day 3. Phosphorylation of Akt was reduced on Day 14. Conclusions: Insight into these early changes in response to HS improves understanding of the molecular and functional changes that lead to muscle atrophy. © 2012 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23752" xmlns="http://purl.org/rss/1.0/"><title>Serial cerebrospinal fluid neurofilament heavy chain levels in severe Guillain–Barré syndrome</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23752</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Serial cerebrospinal fluid neurofilament heavy chain levels in severe Guillain–Barré syndrome</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Irena Dujmovic, Michael P. Lunn, Mary M. Reilly, Axel Petzold</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-14T02:43:06.79588-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23752</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23752</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23752</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction:</h4><div class="para"><p>Proximal axonotmesis results in the release of neurofilament (Nf) proteins into the cerebrospinal fluid (CSF) in patients with Guillain–Barré syndrome (GBS). High CSF levels of the phosphorylated form of Nf-heavy chains (NfH<sup>SMI35</sup>) at GBS onset have been reported to be a poor prognostic marker, but routine measurement of CSF NfH<sup>SMI35</sup> levels has not been done and the longitudinal profile of CSF NfH<sup>SMI35</sup> levels in GBS is not known.</p></div></div>
<div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods:</h4><div class="para"><p>This prospective case series describes the clinical, neurophysiological, and biomarker characteristics of 3 patients with severe GBS.</p></div></div>
<div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h4>Results:</h4><div class="para"><p>High and increasing levels of CSF NfH<sup>SMI35</sup> in serial CSF samples were associated with poor clinical and electrophysiological outcome.</p></div></div>
<div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h4>Discussion:</h4><div class="para"><p>These data further suggest that CSF NfH<sup>SMI35</sup> could be a prognostic biomarker which might indicate the development of retrograde axonal degeneration or additional proximal axonal damage during the course of GBS. © 2012 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction:
Proximal axonotmesis results in the release of neurofilament (Nf) proteins into the cerebrospinal fluid (CSF) in patients with Guillain–Barré syndrome (GBS). High CSF levels of the phosphorylated form of Nf-heavy chains (NfHSMI35) at GBS onset have been reported to be a poor prognostic marker, but routine measurement of CSF NfHSMI35 levels has not been done and the longitudinal profile of CSF NfHSMI35 levels in GBS is not known.


Methods:
This prospective case series describes the clinical, neurophysiological, and biomarker characteristics of 3 patients with severe GBS.


Results:
High and increasing levels of CSF NfHSMI35 in serial CSF samples were associated with poor clinical and electrophysiological outcome.


Discussion:
These data further suggest that CSF NfHSMI35 could be a prognostic biomarker which might indicate the development of retrograde axonal degeneration or additional proximal axonal damage during the course of GBS. © 2012 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23750" xmlns="http://purl.org/rss/1.0/"><title>Symmetry of paraspinal muscle denervation in clinical lumbar spinal stenosis: Support for a hypothesis of posterior primary ramus stretching?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23750</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Symmetry of paraspinal muscle denervation in clinical lumbar spinal stenosis: Support for a hypothesis of posterior primary ramus stretching?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Andrew J. Haig, Zachary London, Danielle E. Sandella</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-12T05:13:01.356855-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23750</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23750</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23750</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction:</h4><div class="para"><p>Denervation of the paraspinal muscles in spinal disorders is frequently attributed to radiculopathy. Therefore, persons with lumbar spinal stenosis causing asymmetrical symptoms should have asymmetrical paraspinal denervation.</p></div></div>
<div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods:</h4><div class="para"><p>73 persons with clinical lumbar spinal stenosis, aged 55 to 85, completed a pain drawing and underwent masked electrodiagnostic testing including bilateral paraspinal mapping and testing of 6 muscles on the most symptomatic (or randomly chosen) limb.</p></div></div>
<div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h4>Results:</h4><div class="para"><p>With the exception of 10 subjects with unilateral thigh pain (p=0.043), there was no relationship between side of pain and paraspinal mapping score for any subgroups (symmetrical pain, pain into one calf only). Among those with positive limb EMG (tested on one side), no relationship between side of pain and paraspinal EMG score was found.</p></div></div>
<div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h4>Discussion:</h4><div class="para"><p>The evidence suggests that paraspinal denervation in spinal stenosis may not be due to radiculopathy, but rather due to stretch or damage to the posterior primary ramus. © 2012 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction:
Denervation of the paraspinal muscles in spinal disorders is frequently attributed to radiculopathy. Therefore, persons with lumbar spinal stenosis causing asymmetrical symptoms should have asymmetrical paraspinal denervation.


Methods:
73 persons with clinical lumbar spinal stenosis, aged 55 to 85, completed a pain drawing and underwent masked electrodiagnostic testing including bilateral paraspinal mapping and testing of 6 muscles on the most symptomatic (or randomly chosen) limb.


Results:
With the exception of 10 subjects with unilateral thigh pain (p=0.043), there was no relationship between side of pain and paraspinal mapping score for any subgroups (symmetrical pain, pain into one calf only). Among those with positive limb EMG (tested on one side), no relationship between side of pain and paraspinal EMG score was found.


Discussion:
The evidence suggests that paraspinal denervation in spinal stenosis may not be due to radiculopathy, but rather due to stretch or damage to the posterior primary ramus. © 2012 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23749" xmlns="http://purl.org/rss/1.0/"><title>Guillain-Barré syndrome during childhood: Particular clinical and electrophysiological features</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23749</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Guillain-Barré syndrome during childhood: Particular clinical and electrophysiological features</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">David Devos, Armelle Magot, Julie Perrier-Boeswillwald, Guillemette Fayet, Laurène Leclair-Visonneau, Yolaine Ollivier, Sylvie Nguyen The Tich, Yann Péréon</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-12T05:12:48.008878-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23749</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23749</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23749</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Guillain-Barré syndrome (GBS) has some specific characteristics in children</p></div></div>
<div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Clinical, laboratory, electrophysiological and prognosis features of the 19 children diagnosed with GBS at Nantes University Hospital from 2000 to 2011 were reviewed.</p></div></div>
<div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Gait disturbance and leg pain were the most frequent presenting symptoms. Electrophysiological exams revealed significant abnormalities even when performed within the first week after onset. Decreased distal CMAP amplitude was noted in 89% of cases. The pattern indicated an acute inflammatory demyelinating polyneuropathy in 95% of cases and acute motor axonal neuropathy in the remaining 5%. About two-thirds of the children were treated by intravenous immunoglobulin. After more than a year of follow-up, 17 patients had complete recovery.</p></div></div>
<div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>Gait disorder, leg pain, a high rate of distal conduction block, and a good prognosis are among the main specific features of GSB in childhood. © 2012 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction
Guillain-Barré syndrome (GBS) has some specific characteristics in children


Methods
Clinical, laboratory, electrophysiological and prognosis features of the 19 children diagnosed with GBS at Nantes University Hospital from 2000 to 2011 were reviewed.


Results
Gait disturbance and leg pain were the most frequent presenting symptoms. Electrophysiological exams revealed significant abnormalities even when performed within the first week after onset. Decreased distal CMAP amplitude was noted in 89% of cases. The pattern indicated an acute inflammatory demyelinating polyneuropathy in 95% of cases and acute motor axonal neuropathy in the remaining 5%. About two-thirds of the children were treated by intravenous immunoglobulin. After more than a year of follow-up, 17 patients had complete recovery.


Conclusion
Gait disorder, leg pain, a high rate of distal conduction block, and a good prognosis are among the main specific features of GSB in childhood. © 2012 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23748" xmlns="http://purl.org/rss/1.0/"><title>Diaphragm muscle atrophy in mouse following long-term mechanical ventilation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23748</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Diaphragm muscle atrophy in mouse following long-term mechanical ventilation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Huibin Tang, Myung Lee, Amanda Khuong, Erika Wright, Joseph B. Shrager</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-12T05:12:33.799945-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23748</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23748</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23748</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction:</h4><div class="para"><p>Mechanical ventilation (MV) is a life-saving measure, but full ventilator support causes ventilator-induced diaphragm atrophy (VIDA). Previous studies of VIDA have relied on human biopsies or a rat model. If MV can induce diaphragm atrophy in mouse, then mechanistic study of VIDA could be explored via genetic manipulation.</p></div></div>
<div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h4>Results:</h4><div class="para"><p>We show that 18 hours of MV in mice results in a 15% loss of diaphragm weight and a 17% reduction in fiber cross-sectional area. Important catabolic cascades are activated in this mouse model: transcription of the ubiquitin ligases atrogin and MuRF1, and the apoptotic marker Bim, are increased; the marker of autophagy, LC3, is induced at the protein level and shows a punctate distribution in diaphragm muscle fibers.</p></div></div>
<div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions:</h4><div class="para"><p>This mouse model recapitulates the key pathophysiological findings of other models of VIDA, and it will enable the genetic manipulation required to fully explore the mechanisms underlying this important process. © 2012 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction:
Mechanical ventilation (MV) is a life-saving measure, but full ventilator support causes ventilator-induced diaphragm atrophy (VIDA). Previous studies of VIDA have relied on human biopsies or a rat model. If MV can induce diaphragm atrophy in mouse, then mechanistic study of VIDA could be explored via genetic manipulation.


Results:
We show that 18 hours of MV in mice results in a 15% loss of diaphragm weight and a 17% reduction in fiber cross-sectional area. Important catabolic cascades are activated in this mouse model: transcription of the ubiquitin ligases atrogin and MuRF1, and the apoptotic marker Bim, are increased; the marker of autophagy, LC3, is induced at the protein level and shows a punctate distribution in diaphragm muscle fibers.


Conclusions:
This mouse model recapitulates the key pathophysiological findings of other models of VIDA, and it will enable the genetic manipulation required to fully explore the mechanisms underlying this important process. © 2012 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23744" xmlns="http://purl.org/rss/1.0/"><title>Experimental model of alcohol related peripheral neuropathy (ALN)</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23744</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Experimental model of alcohol related peripheral neuropathy (ALN)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michelle L. Mellion, Van Anh Nguyen, Ming Tong, James Gilchrist, Suzanne de la Monte</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-12-02T01:56:12.64106-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23744</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23744</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23744</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective:</h4><div class="para"><p>Determine the effect of chronic alcohol exposure on peripheral nerves in a nutritionally balanced rat model of alcoholism.</p></div></div>
<div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods:</h4><div class="para"><p>Three different strains of adult male rats were pair-fed for 8 weeks with isocaloric liquid diets containing 0% or 37% ethanol. Nerve conduction studies (NCS) were performed. Peripheral nerve and muscle were examined histologically with morphometrics.</p></div></div>
<div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h4>Results:</h4><div class="para"><p>Ethanol exposure significantly slowed velocity in tibial and fibular nerves, but not in the plantar nerve in all 3 strains. Studies of the sciatic nerve revealed decreased fiber diameters and increased regenerative sprouts in peripheral nerves. There was muscle denervation of ethanol-exposed rats in all 3 strains.</p></div></div>
<div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions:</h4><div class="para"><p>Chronic ethanol exposure caused a polyneuropathy characterized by axonal degeneration despite adequate nutrition. These results suggest that ethanol exposure has direct neurotoxic effects on peripheral nerves. This model may be useful in understanding the underlying mechanism(s) of ALN. © 2012 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Objective:
Determine the effect of chronic alcohol exposure on peripheral nerves in a nutritionally balanced rat model of alcoholism.


Methods:
Three different strains of adult male rats were pair-fed for 8 weeks with isocaloric liquid diets containing 0% or 37% ethanol. Nerve conduction studies (NCS) were performed. Peripheral nerve and muscle were examined histologically with morphometrics.


Results:
Ethanol exposure significantly slowed velocity in tibial and fibular nerves, but not in the plantar nerve in all 3 strains. Studies of the sciatic nerve revealed decreased fiber diameters and increased regenerative sprouts in peripheral nerves. There was muscle denervation of ethanol-exposed rats in all 3 strains.


Conclusions:
Chronic ethanol exposure caused a polyneuropathy characterized by axonal degeneration despite adequate nutrition. These results suggest that ethanol exposure has direct neurotoxic effects on peripheral nerves. This model may be useful in understanding the underlying mechanism(s) of ALN. © 2012 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23739" xmlns="http://purl.org/rss/1.0/"><title>Region-specific myoelectric manifestations of fatigue in human rectus femoris muscle</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23739</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Region-specific myoelectric manifestations of fatigue in human rectus femoris muscle</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kohei Watanabe, Motoki Kouzaki, Toshio Moritani</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-11-29T23:18:57.219904-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23739</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23739</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23739</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><b>Introduction</b> Anatomical properties between proximal and other regions within the human rectus femoris (RF) muscle are non-uniform. We aimed to clarify the possible region-specific myoelectric manifestations of fatigue within the RF muscle by using an advanced surface electromyography (SEMG) technique. <b>Methods</b> Nine healthy men performed sustained contractions at 50% of maximal voluntary contraction until exhaustion during isometric knee extension and hip flexion. During these contractions, multi-channel SEMG was recorded from the RF muscle by using 46 electrode pairs which cover most of the superficial area of the muscle. <b>Results</b> Fatigue-induced SEMG, i.e. an increase in root mean square and a decrease in median frequency, was not uniform within the muscle during both tasks and was greater in proximal regions. <b>Discussion</b> Our findings suggest that myoelectric manifestations of fatigue within the human RF muscle are localized, and proximal regions are more fatigable than other regions within this muscle. © 2012 Wiley Periodicals, Inc.</p></div>
]]></content:encoded><description>

Introduction Anatomical properties between proximal and other regions within the human rectus femoris (RF) muscle are non-uniform. We aimed to clarify the possible region-specific myoelectric manifestations of fatigue within the RF muscle by using an advanced surface electromyography (SEMG) technique. Methods Nine healthy men performed sustained contractions at 50% of maximal voluntary contraction until exhaustion during isometric knee extension and hip flexion. During these contractions, multi-channel SEMG was recorded from the RF muscle by using 46 electrode pairs which cover most of the superficial area of the muscle. Results Fatigue-induced SEMG, i.e. an increase in root mean square and a decrease in median frequency, was not uniform within the muscle during both tasks and was greater in proximal regions. Discussion Our findings suggest that myoelectric manifestations of fatigue within the human RF muscle are localized, and proximal regions are more fatigable than other regions within this muscle. © 2012 Wiley Periodicals, Inc.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23740" xmlns="http://purl.org/rss/1.0/"><title>H63D HFEpolymorphisms are associated with increased disease duration and decreased muscle SOD1 expression in amyotrophic lateral sclerosis patients</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23740</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">H63D HFEpolymorphisms are associated with increased disease duration and decreased muscle SOD1 expression in amyotrophic lateral sclerosis patients</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Xiaowei W. Su, Sang Y. Lee, Ryan M. Mitchell, Helen E. Stephens, Zachary Simmons, James R. Connor</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-11-29T23:18:44.017874-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23740</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23740</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23740</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction:</h4><div class="para"><p>H63D <em>HFE</em> polymorphismsincreasethe risk of neurodegenerative disorders and,specifically, may increase ALS risk. Investigating the physiological alterations induced by H63D polymorphisms in ALS patients may elucidate mechanisms by which this genotype alters disease.</p></div></div>
<div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h4>Materials:</h4><div class="para"><p>Clinical measures and muscle biopsies were available from patients previously diagnosed with ALS who underwent<em>HFE</em> genotyping. Clinical outcomes and SOD1 protein expression were analyzed using standard statistical analyses.</p></div></div>
<div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h4>Results:</h4><div class="para"><p>ALS patients harboring H63D <em>HFE</em>(n=16) had 28.1 monthslonger average disease duration and 39.3%lower muscle SOD1 protein than ALS patients with wild type <em>HFE</em> (n=22).</p></div></div>
<div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h4>Discussion:</h4><div class="para"><p>Combined with previous reports suggesting the H63D polymorphism is associated with ALS,these results support a model whereinthe H63D polymorphism is involved inALS via pathways involving SOD1 but may limit cellular damage in individuals who develop disease. The association between <em>HFE</em> genotype and disease duration has important implications for clinical care and treatment trials. © 2012 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction:
H63D HFE polymorphismsincreasethe risk of neurodegenerative disorders and,specifically, may increase ALS risk. Investigating the physiological alterations induced by H63D polymorphisms in ALS patients may elucidate mechanisms by which this genotype alters disease.


Materials:
Clinical measures and muscle biopsies were available from patients previously diagnosed with ALS who underwentHFE genotyping. Clinical outcomes and SOD1 protein expression were analyzed using standard statistical analyses.


Results:
ALS patients harboring H63D HFE(n=16) had 28.1 monthslonger average disease duration and 39.3%lower muscle SOD1 protein than ALS patients with wild type HFE (n=22).


Discussion:
Combined with previous reports suggesting the H63D polymorphism is associated with ALS,these results support a model whereinthe H63D polymorphism is involved inALS via pathways involving SOD1 but may limit cellular damage in individuals who develop disease. The association between HFE genotype and disease duration has important implications for clinical care and treatment trials. © 2012 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23729" xmlns="http://purl.org/rss/1.0/"><title>The diagnostic value of high-resolution sonography in common fibular neuropathy at the fibular head</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23729</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The diagnostic value of high-resolution sonography in common fibular neuropathy at the fibular head</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">L. H Visser, V. Hens, M. Soethout, V. de Deugd-Maria, J. Pijnenburg, G.J.F. Brekelmans</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-11-18T23:41:46.423761-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23729</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23729</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23729</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>In 30% of patients with common fibular (CF) neuropathy at the fibular head, reliable localization of the site of the lesion by means of electrodiagnostic testing is challenging.</p></div></div>
<div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>We prospectively assessed proximal CF nerve cross sectional area (CSA) measurements and at the fibular head in 87 patients with CF neuropathy and 16 with a different condition. Reference values were obtained in 64 healthy volunteers.</p></div></div>
<div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Patients with CF neuropathy had a significantly larger CF nerve CSA than controls and patient controls (<em>P</em>&lt;0.0001). Sonography localized the lesion at the fibular head in 55% and just above it in 71%. Assessment of the most thickened part of the CF nerve resulted in a cutoff value of &gt; 8 mm<sup>2</sup> with a sensitivity of 90% (CI 81-95%) and a specificity of 69% (CI 58-78%).</p></div></div>
<div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>High-resolution sonography in addition to electrodiagnostic testing improves diagnostic reliability of CF neuropathy. © 2012 Wiley Periodicals, Inc.</p></div></div>
]]></content:encoded><description>


Introduction
In 30% of patients with common fibular (CF) neuropathy at the fibular head, reliable localization of the site of the lesion by means of electrodiagnostic testing is challenging.


Methods
We prospectively assessed proximal CF nerve cross sectional area (CSA) measurements and at the fibular head in 87 patients with CF neuropathy and 16 with a different condition. Reference values were obtained in 64 healthy volunteers.


Results
Patients with CF neuropathy had a significantly larger CF nerve CSA than controls and patient controls (P&lt;0.0001). Sonography localized the lesion at the fibular head in 55% and just above it in 71%. Assessment of the most thickened part of the CF nerve resulted in a cutoff value of &gt; 8 mm2 with a sensitivity of 90% (CI 81-95%) and a specificity of 69% (CI 58-78%).


Conclusion
High-resolution sonography in addition to electrodiagnostic testing improves diagnostic reliability of CF neuropathy. © 2012 Wiley Periodicals, Inc.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23767" xmlns="http://purl.org/rss/1.0/"><title>Single-fiber electromyography in amyotrophic lateral sclerosis and cervical spondylosis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23767</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Single-fiber electromyography in amyotrophic lateral sclerosis and cervical spondylosis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mingsheng Liu, Liying Cui, Yuzhou Guan, Benhong Li, Hua Du</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-21T23:35:28.820215-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23767</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23767</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23767</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Reports</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="section" id="mus23767-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Cervical spondylosis (CS) is a common disease in adults and may coexist with amyotrophic lateral sclerosis (ALS). It is important to detect ALS coexisting with CS (ALS-cs) at an early stage, especially when surgical treatment of CS is planned.</p></div></div>
<div class="section" id="mus23767-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Single-fiber electromyography was performed in 26 patients with ALS, 19 with ALS-cs, and 22 with CS.</p></div></div>
<div class="section" id="mus23767-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Mean jitter, percentage of jitter &gt;55 μs, and percentage of impulse blocking were not statistically different between ALS and ALS-cs cases, but they were significantly lower in CS. Mean fiber density was not statistically different among the 3 groups. The percentage of pairs with jitter &gt;55 μs exceeding 40% and mean jitter exceeding 55 μs had high sensitivity and specificity in the diagnosis of ALS.</p></div></div>
<div class="section" id="mus23767-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Single-fiber electromyography can supply valuable information in helping to differentiate ALS from CS. <em>Muscle Nerve</em>, 2013</p></div></div>
]]></content:encoded><description>

Introduction
Cervical spondylosis (CS) is a common disease in adults and may coexist with amyotrophic lateral sclerosis (ALS). It is important to detect ALS coexisting with CS (ALS-cs) at an early stage, especially when surgical treatment of CS is planned.


Methods
Single-fiber electromyography was performed in 26 patients with ALS, 19 with ALS-cs, and 22 with CS.


Results
Mean jitter, percentage of jitter &gt;55 μs, and percentage of impulse blocking were not statistically different between ALS and ALS-cs cases, but they were significantly lower in CS. Mean fiber density was not statistically different among the 3 groups. The percentage of pairs with jitter &gt;55 μs exceeding 40% and mean jitter exceeding 55 μs had high sensitivity and specificity in the diagnosis of ALS.


Conclusions
Single-fiber electromyography can supply valuable information in helping to differentiate ALS from CS. Muscle Nerve, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23771" xmlns="http://purl.org/rss/1.0/"><title>Exercise in neuromuscular disease</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23771</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Exercise in neuromuscular disease</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yaacov Anziska, Alex Sternberg</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-21T23:34:57.965147-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23771</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23771</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23771</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Invited Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>In this review, we present an overview of the role of exercise in neuromuscular disease (NMD). We demonstrate that despite the different pathologies in NMDs, exercise is beneficial, whether aerobic/endurance or strength/resistive training, and we explore whether this benefit has a similar mechanism to that of healthy subjects. We discuss further areas for study, incorporating imaginative and novel approaches to training and its assessment in NMD. We conclude by suggesting ways to improve future trials by avoiding previous methodological flaws and drawbacks in this field. <em>Muscle Nerve</em>, 2013</p></div>
]]></content:encoded><description>

In this review, we present an overview of the role of exercise in neuromuscular disease (NMD). We demonstrate that despite the different pathologies in NMDs, exercise is beneficial, whether aerobic/endurance or strength/resistive training, and we explore whether this benefit has a similar mechanism to that of healthy subjects. We discuss further areas for study, incorporating imaginative and novel approaches to training and its assessment in NMD. We conclude by suggesting ways to improve future trials by avoiding previous methodological flaws and drawbacks in this field. Muscle Nerve, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23745" xmlns="http://purl.org/rss/1.0/"><title>Electrophysiologic changes with incremental exercise in obstructive sleep apnea</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23745</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Electrophysiologic changes with incremental exercise in obstructive sleep apnea</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Meng-Yueh Chien, Ya-Ju Chang, Peilin Lee, Pan-Chyr Yang, Ying-Tai Wu</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-21T23:34:51.611218-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23745</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23745</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23745</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="section" id="mus23745-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>In patients with obstructive sleep apnea (OSA), intermittent apnea and hypopnea might cause different adaptations in inspiratory and peripheral muscles. In this study we aimed to determine the changes that occur in muscle activation characteristics during incremental exercise testing in patients with severe OSA. Surface electromyography of inspiratory muscles and knee extensors was performed.</p></div></div>
<div class="section" id="mus23745-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Eleven men with severe OSA and 11 matched controls were recruited. Changes in muscle activity were compared by determining root mean square (RMS) and median power frequency (MPF) values obtained at different exercise intensities.</p></div></div>
<div class="section" id="mus23745-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The ratios of RMS to oxygen consumption in inspiratory muscles and vastus lateralis increased significantly at peak workload in the control group (<em>P</em> &lt; 0.05), but not in the OSA group.</p></div></div>
<div class="section" id="mus23745-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Patients with severe OSA demonstrated an inability to increase motor unit recruitment of inspiratory muscles and knee extensors during incremental exercise. <em>Muscle Nerve</em>, 2013</p></div></div>
]]></content:encoded><description>

Introduction
In patients with obstructive sleep apnea (OSA), intermittent apnea and hypopnea might cause different adaptations in inspiratory and peripheral muscles. In this study we aimed to determine the changes that occur in muscle activation characteristics during incremental exercise testing in patients with severe OSA. Surface electromyography of inspiratory muscles and knee extensors was performed.


Methods
Eleven men with severe OSA and 11 matched controls were recruited. Changes in muscle activity were compared by determining root mean square (RMS) and median power frequency (MPF) values obtained at different exercise intensities.


Results
The ratios of RMS to oxygen consumption in inspiratory muscles and vastus lateralis increased significantly at peak workload in the control group (P &lt; 0.05), but not in the OSA group.


Conclusions
Patients with severe OSA demonstrated an inability to increase motor unit recruitment of inspiratory muscles and knee extensors during incremental exercise. Muscle Nerve, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23799" xmlns="http://purl.org/rss/1.0/"><title>Reply</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23799</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Reply</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Pieter J.A. Starre</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-21T23:32:22.200654-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23799</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23799</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23799</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Reply to Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23731" xmlns="http://purl.org/rss/1.0/"><title>Isolated median neuropathy as the first symptom of leprosy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23731</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Isolated median neuropathy as the first symptom of leprosy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Robson Teixeira Vital, Ximena Illarramendi, Sérgio Luiz Gomes Antunes, Márcio Nascimento, José Augusto Da Costa Nery, Osvaldo Nascimento, Euzenir Nunes Sarno, Márcia Rodrigues Jardim</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-17T02:12:48.943334-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23731</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23731</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23731</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23731-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Focal peripheral neuropathy of the median nerve is mainly caused by a traumatic event or pressure, but it may also be produced by systemic illnesses. Among the latter, leprosy is a rare cause.</p></div></div>
<div class="section" id="mus23731-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Six cases of isolated median neuropathy as the first sign of leprosy were selected from patients with an exclusively neurological complaint as the initial symptom. The patients, evaluated at the National Leprosy Reference Center in Rio de Janeiro, Brazil, followed routine and specialized procedures.</p></div></div>
<div class="section" id="mus23731-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Three of the patients had pure neural leprosy, and 3 had skin lesions. Clinical median nerve function impairment was confirmed by neurophysiological testing and histopathology. Both mononeuritis and mononeuritis multiplex were observed.</p></div></div>
<div class="section" id="mus23731-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>This case series demonstrates an additional form of presentation of leprosy, which, if not diagnosed and treated in time, may lead to permanent disability. <em>Muscle Nerve</em>, 2013</p></div></div>
]]></content:encoded><description>


Introduction
Focal peripheral neuropathy of the median nerve is mainly caused by a traumatic event or pressure, but it may also be produced by systemic illnesses. Among the latter, leprosy is a rare cause.


Methods
Six cases of isolated median neuropathy as the first sign of leprosy were selected from patients with an exclusively neurological complaint as the initial symptom. The patients, evaluated at the National Leprosy Reference Center in Rio de Janeiro, Brazil, followed routine and specialized procedures.


Results
Three of the patients had pure neural leprosy, and 3 had skin lesions. Clinical median nerve function impairment was confirmed by neurophysiological testing and histopathology. Both mononeuritis and mononeuritis multiplex were observed.


Conclusions
This case series demonstrates an additional form of presentation of leprosy, which, if not diagnosed and treated in time, may lead to permanent disability. Muscle Nerve, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23807" xmlns="http://purl.org/rss/1.0/"><title>The cooperative international neuromuscular research group duchenne natural history study—a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23807</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The cooperative international neuromuscular research group duchenne natural history study—a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Craig M. McDonald, Erik K. Henricson, R. Ted Abresch, Jay J. Han, Diana M. Escolar, Julaine M. Florence, Tina Duong, Adrienne Arrieta, Paula R. Clemens, Eric P. Hoffman, Avital Cnaan, </dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-15T23:57:12.253303-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23807</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23807</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23807</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23807-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p>Contemporary natural history data in Duchenne muscular dystrophy (DMD) is needed to assess care recommendations and aid in planning future trials.</p></div></div>
<div class="section" id="mus23807-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>The Cooperative International Neuromuscular Research Group (CINRG) DMD Natural History Study (DMD-NHS) enrolled 340 individuals, aged 2–28 years, with DMD in a longitudinal, observational study at 20 centers. Assessments obtained every 3 months for 1 year, at 18 months, and annually thereafter included: clinical history; anthropometrics; goniometry; manual muscle testing; quantitative muscle strength; timed function tests; pulmonary function; and patient-reported outcomes/health-related quality-of-life instruments.</p></div></div>
<div class="section" id="mus23807-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Glucocorticoid (GC) use at baseline was 62% present, 14% past, and 24% GC-naive. In those ≥6 years of age, 16% lost ambulation over the first 12 months (mean age 10.8 years).</p></div></div>
<div class="section" id="mus23807-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Detailed information on the study methodology of the CINRG DMD-NHS lays the groundwork for future analyses of prospective longitudinal natural history data. These data will assist investigators in designing clinical trials of novel therapeutics. <em>Muscle Nerve</em>, 2013</p></div></div>
]]></content:encoded><description>


Contemporary natural history data in Duchenne muscular dystrophy (DMD) is needed to assess care recommendations and aid in planning future trials.


Methods
The Cooperative International Neuromuscular Research Group (CINRG) DMD Natural History Study (DMD-NHS) enrolled 340 individuals, aged 2–28 years, with DMD in a longitudinal, observational study at 20 centers. Assessments obtained every 3 months for 1 year, at 18 months, and annually thereafter included: clinical history; anthropometrics; goniometry; manual muscle testing; quantitative muscle strength; timed function tests; pulmonary function; and patient-reported outcomes/health-related quality-of-life instruments.


Results
Glucocorticoid (GC) use at baseline was 62% present, 14% past, and 24% GC-naive. In those ≥6 years of age, 16% lost ambulation over the first 12 months (mean age 10.8 years).


Conclusions
Detailed information on the study methodology of the CINRG DMD-NHS lays the groundwork for future analyses of prospective longitudinal natural history data. These data will assist investigators in designing clinical trials of novel therapeutics. Muscle Nerve, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23724" xmlns="http://purl.org/rss/1.0/"><title>Congenital myasthenic syndrome and minicore-like myopathy with DOK7 mutation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23724</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Congenital myasthenic syndrome and minicore-like myopathy with DOK7 mutation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-08T23:41:30.77949-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23724</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23724</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23724</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23794" xmlns="http://purl.org/rss/1.0/"><title>Differential Effects of a 5% lidocaine medicated patch in peripheral nerve injury</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23794</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Differential Effects of a 5% lidocaine medicated patch in peripheral nerve injury</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Caspar S. Madsen, Birger Johnsen, Anders Fuglsang-Frederiksen, Troels S. Jensen, Nanna B. Finnerup</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:20:33.172732-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23794</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23794</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23794</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23794-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>We examined the effect of topical lidocaine on the function of small and large fibers in patients with peripheral neuropathic pain due to traumatic or postoperative nerve injury.</p></div></div>
<div class="section" id="mus23794-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>In an open-label study, 24 patients were treated with a 5% lidocaine patch for up to 12 weeks. We recorded contact heat evoked potentials (CHEPs) and performed quantitative sensory testing (QST) before and after treatment with the contralateral side as control.</p></div></div>
<div class="section" id="mus23794-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Twenty-one patients (mean age 47.6 ± 13.5 years) completed the study. Lidocaine increased cold pain threshold (<em>P</em> = 0.04) and reduced CHEP amplitude (<em>P</em> = 0.007) with no effect on other QST parameters. Patients responding to treatment had less cold detection deficit on the affected side and had a larger increase in cold pain detection threshold following treatment than nonresponders.</p></div></div>
<div class="section" id="mus23794-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Controlled trials are warranted to further understand the mechanisms mediating the effects of topical lidocaine. <em>Muscle Nerve</em>, 2013</p></div></div>
]]></content:encoded><description>


Introduction
We examined the effect of topical lidocaine on the function of small and large fibers in patients with peripheral neuropathic pain due to traumatic or postoperative nerve injury.


Methods
In an open-label study, 24 patients were treated with a 5% lidocaine patch for up to 12 weeks. We recorded contact heat evoked potentials (CHEPs) and performed quantitative sensory testing (QST) before and after treatment with the contralateral side as control.


Results
Twenty-one patients (mean age 47.6 ± 13.5 years) completed the study. Lidocaine increased cold pain threshold (P = 0.04) and reduced CHEP amplitude (P = 0.007) with no effect on other QST parameters. Patients responding to treatment had less cold detection deficit on the affected side and had a larger increase in cold pain detection threshold following treatment than nonresponders.


Conclusions
Controlled trials are warranted to further understand the mechanisms mediating the effects of topical lidocaine. Muscle Nerve, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23790" xmlns="http://purl.org/rss/1.0/"><title>Consider Danon disease in dilated cardiomyopathy with noncompaction</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23790</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Consider Danon disease in dilated cardiomyopathy with noncompaction</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Claudia Stöllberger, Josef Finsterer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:20:27.699484-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23790</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23790</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23790</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letters to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23871" xmlns="http://purl.org/rss/1.0/"><title>Acute motor axonal neuropathy and multifocal motor neuropathy: More in common than not</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23871</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Acute motor axonal neuropathy and multifocal motor neuropathy: More in common than not</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nobuhiro Yuki</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-07T23:20:19.73099-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23871</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23871</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23871</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Editorial</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23735" xmlns="http://purl.org/rss/1.0/"><title>Ultrasound for carpal tunnel syndrome screening in manual laborers</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23735</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Ultrasound for carpal tunnel syndrome screening in manual laborers</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michael S. Cartwright, Francis O. Walker, Jill N. Blocker, Mark R. Schulz, Thomas A. Arcury, Joseph G. Grzywacz, Dana Mora, Haiying Chen, Antonio J. Marín, Sara A. Quandt</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-06T01:57:24.496307-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23735</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23735</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23735</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23735-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Manual laborers are at increased risk for carpal tunnel syndrome (CTS), and a combination of history, physical examination, and nerve conduction studies is often used to screen for CTS in this population. Neuromuscular ultrasound may be a better screening tool, because it is painless. In this study we compare the accuracy of nerve conduction studies and ultrasound for CTS screening.</p></div></div>
<div class="section" id="mus23735-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Five hundred thirteen manual laborers were screened prospectively for CTS using nerve conduction studies and neuromuscular ultrasound, and the accuracy of the 2 techniques was compared using the Katz hand diagram as the diagnostic standard.</p></div></div>
<div class="section" id="mus23735-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The ROC curves for the 2 techniques were not significantly different (<em>P</em> = 0.542), indicating that the approaches had similar diagnostic accuracy.</p></div></div>
<div class="section" id="mus23735-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Neuromuscular ultrasound is a painless technique that has diagnostic accuracy similar to nerve conduction studies and can be used to screen large populations at risk for CTS. <em>Muscle Nerve</em>, 2013</p></div></div>
]]></content:encoded><description>


Introduction
Manual laborers are at increased risk for carpal tunnel syndrome (CTS), and a combination of history, physical examination, and nerve conduction studies is often used to screen for CTS in this population. Neuromuscular ultrasound may be a better screening tool, because it is painless. In this study we compare the accuracy of nerve conduction studies and ultrasound for CTS screening.


Methods
Five hundred thirteen manual laborers were screened prospectively for CTS using nerve conduction studies and neuromuscular ultrasound, and the accuracy of the 2 techniques was compared using the Katz hand diagram as the diagnostic standard.


Results
The ROC curves for the 2 techniques were not significantly different (P = 0.542), indicating that the approaches had similar diagnostic accuracy.


Conclusions
Neuromuscular ultrasound is a painless technique that has diagnostic accuracy similar to nerve conduction studies and can be used to screen large populations at risk for CTS. Muscle Nerve, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23808" xmlns="http://purl.org/rss/1.0/"><title>The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23808</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Erik K. Henricson, R. Ted Abresch, Avital Cnaan, Fengming Hu, Tina Duong, Adrienne Arrieta, Jay Han, Diana M. Escolar, Julaine M. Florence, Paula R. Clemens, Eric P. Hoffman, Craig M. McDonald, </dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-06T01:57:22.571319-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23808</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23808</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23808</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23808-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><em>Introduction</em>: Glucocorticoid (GC) therapy in Duchenne muscular dystrophy (DMD) has altered disease progression, necessitating contemporary natural history studies. <em>Methods</em>: The Cooperative Neuromuscular Research Group (CINRG) DMD Natural History Study (DMD-NHS) enrolled 340 DMD males, ages 2–28 years. A comprehensive battery of measures was obtained. <em>Results</em>: A novel composite functional “milestone” scale scale showed clinically meaningful mobility and upper limb abilities were significantly preserved in GC-treated adolescents/young adults. Manual muscle test (MMT)-based calculations of global strength showed that those patients &lt;10 years of age treated with steroids declined by 0.4±0.39 MMT unit/year, compared with −0.4±0.39 MMT unit/year in historical steroid-naive subjects. Pulmonary function tests (PFTs) were relatively preserved in steroid-treated adolescents. The linearity and magnitude of decline in measures were affected by maturational changes and functional status. <em>Conclusions</em>: In DMD, long-term use of GCs showed reduced strength loss and preserved functional capabilities and PFTs compared with previous natural history studies performed prior to the widespread use of GC therapy. <em>Muscle Nerve</em>, 2013</p></div></div>
]]></content:encoded><description>


Introduction: Glucocorticoid (GC) therapy in Duchenne muscular dystrophy (DMD) has altered disease progression, necessitating contemporary natural history studies. Methods: The Cooperative Neuromuscular Research Group (CINRG) DMD Natural History Study (DMD-NHS) enrolled 340 DMD males, ages 2–28 years. A comprehensive battery of measures was obtained. Results: A novel composite functional “milestone” scale scale showed clinically meaningful mobility and upper limb abilities were significantly preserved in GC-treated adolescents/young adults. Manual muscle test (MMT)-based calculations of global strength showed that those patients &lt;10 years of age treated with steroids declined by 0.4±0.39 MMT unit/year, compared with −0.4±0.39 MMT unit/year in historical steroid-naive subjects. Pulmonary function tests (PFTs) were relatively preserved in steroid-treated adolescents. The linearity and magnitude of decline in measures were affected by maturational changes and functional status. Conclusions: In DMD, long-term use of GCs showed reduced strength loss and preserved functional capabilities and PFTs compared with previous natural history studies performed prior to the widespread use of GC therapy. Muscle Nerve, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23725" xmlns="http://purl.org/rss/1.0/"><title>Effectiveness of second corticosteroid injections for carpal tunnel syndrome</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23725</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effectiveness of second corticosteroid injections for carpal tunnel syndrome</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nigel L. Ashworth, Jeremy D.P. Bland</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-03T02:55:44.339469-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23725</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23725</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23725</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23725-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>A single local corticosteroid injection is an effective treatment for carpal tunnel syndrome. No study has specifically examined the effectiveness of a second injection on relapse after primary injection.</p></div></div>
<div class="section" id="mus23725-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>We identified a cohort of patients who had received an initial corticosteroid injection into 1 wrist and then, at a later date, a second injection into the same wrist. We compared the change in the Boston Symptom Severity Scale (SSS) and Functional Status Scale (FSS) between first and second injections.</p></div></div>
<div class="section" id="mus23725-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>In 229 patients who received 2 injections the mean improvement on the SSS was 1.2 (SD = 0.8) for the first injection and 1.3 (SD = 0.9) for the second, which was not statistically significant. Improvement in FSS for the first injection was 0.4 (SD = 0.8) and 0.7 (SD = 0.8) for the second, which was statistically significant (<em>P</em> &lt; 0.001).</p></div></div>
<div class="section" id="mus23725-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>Second corticosteroid injections appear to be at least as effective as the first. <em>Muscle Nerve</em>, 2013</p></div></div>
]]></content:encoded><description>


Introduction
A single local corticosteroid injection is an effective treatment for carpal tunnel syndrome. No study has specifically examined the effectiveness of a second injection on relapse after primary injection.


Methods
We identified a cohort of patients who had received an initial corticosteroid injection into 1 wrist and then, at a later date, a second injection into the same wrist. We compared the change in the Boston Symptom Severity Scale (SSS) and Functional Status Scale (FSS) between first and second injections.


Results
In 229 patients who received 2 injections the mean improvement on the SSS was 1.2 (SD = 0.8) for the first injection and 1.3 (SD = 0.9) for the second, which was not statistically significant. Improvement in FSS for the first injection was 0.4 (SD = 0.8) and 0.7 (SD = 0.8) for the second, which was statistically significant (P &lt; 0.001).


Conclusion
Second corticosteroid injections appear to be at least as effective as the first. Muscle Nerve, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23806" xmlns="http://purl.org/rss/1.0/"><title>Selective stimulation of human tooth-pulp with a new stable method: Responses and validation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23806</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Selective stimulation of human tooth-pulp with a new stable method: Responses and validation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Samuel W. Cadden, Andrew G. Mason, Hilbert W. Glas</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-03T02:55:39.122873-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23806</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23806</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23806</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23806-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><div class="para"><p><em>Introduction</em>: The aims of this study were to establish a safe technique for selective stimulation of nerves in human tooth-pulp during long experiments and to validate its use even with stimuli of high intensities. <em>Methods</em>: A custom-made veneer containing 2 silver wire-conductive cream electrodes was attached with cement to the labial surface of an upper central incisor tooth. A variety of stimulus intensities were applied, and sensory and reflex responses from jaw-closing muscles were recorded. <em>Results</em>: In 15 participants, the stimuli evoked predominantly sharp or painful sensations and reflex inhibitions of activity in the jaw muscles. Stimulation of 3 non-vital teeth evoked no sensations or reflexes, even at intensities that evoked maximal reflexes in vital teeth. The electrodes had reasonably stable resistances throughout experiments lasting up to 90 min. <em>Conclusion</em>: The method described enables responses to low- or high-intensity stimulation of human pulpal nerves to be investigated in long experiments. <em>Muscle Nerve</em>, 2013</p></div></div>
]]></content:encoded><description>


Introduction: The aims of this study were to establish a safe technique for selective stimulation of nerves in human tooth-pulp during long experiments and to validate its use even with stimuli of high intensities. Methods: A custom-made veneer containing 2 silver wire-conductive cream electrodes was attached with cement to the labial surface of an upper central incisor tooth. A variety of stimulus intensities were applied, and sensory and reflex responses from jaw-closing muscles were recorded. Results: In 15 participants, the stimuli evoked predominantly sharp or painful sensations and reflex inhibitions of activity in the jaw muscles. Stimulation of 3 non-vital teeth evoked no sensations or reflexes, even at intensities that evoked maximal reflexes in vital teeth. The electrodes had reasonably stable resistances throughout experiments lasting up to 90 min. Conclusion: The method described enables responses to low- or high-intensity stimulation of human pulpal nerves to be investigated in long experiments. Muscle Nerve, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23726" xmlns="http://purl.org/rss/1.0/"><title>Electrical muscle stimulation after immediate nerve repair reduces muscle atrophy without affecting reinnervation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23726</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Electrical muscle stimulation after immediate nerve repair reduces muscle atrophy without affecting reinnervation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michael P. Willand, Michael Holmes, James R. Bain, Margaret Fahnestock, Hubert Bruin</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-01T23:25:22.861052-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23726</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23726</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23726</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23726-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Electrical stimulation of denervated muscle has been shown to minimize atrophy and fibrosis and increase force in animal and human models. However, electrical stimulation after nerve repair is controversial due to questions of efficacy.</p></div></div>
<div class="section" id="mus23726-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Using a rat model, we investigated the efficacy of short-term electrical muscle stimulation for increasing reinnervation and preventing muscle atrophy. After tibial nerve transection and immediate repair with the fibular nerve, 1 month of electrical stimulation was applied 5 days/week for 1 hour to the gastrocnemius muscle via implanted electrodes.</p></div></div>
<div class="section" id="mus23726-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>After 2 months of further recovery without stimulation, muscle weights, twitch forces, and type I fiber areas were significantly greater in stimulated animals than in repaired controls without stimulation. Motor unit size and numbers were not different between the 2 groups.</p></div></div>
<div class="section" id="mus23726-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Short-term electrical muscle stimulation after nerve repair significantly reduces muscle atrophy and does not affect motor reinnervation. <em>Muscle Nerve</em>, 2013</p></div></div>
]]></content:encoded><description>


Introduction
Electrical stimulation of denervated muscle has been shown to minimize atrophy and fibrosis and increase force in animal and human models. However, electrical stimulation after nerve repair is controversial due to questions of efficacy.


Methods
Using a rat model, we investigated the efficacy of short-term electrical muscle stimulation for increasing reinnervation and preventing muscle atrophy. After tibial nerve transection and immediate repair with the fibular nerve, 1 month of electrical stimulation was applied 5 days/week for 1 hour to the gastrocnemius muscle via implanted electrodes.


Results
After 2 months of further recovery without stimulation, muscle weights, twitch forces, and type I fiber areas were significantly greater in stimulated animals than in repaired controls without stimulation. Motor unit size and numbers were not different between the 2 groups.


Conclusions
Short-term electrical muscle stimulation after nerve repair significantly reduces muscle atrophy and does not affect motor reinnervation. Muscle Nerve, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23792" xmlns="http://purl.org/rss/1.0/"><title>Motor unit loss and weakness in association with diabetic neuropathy in humans</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23792</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Motor unit loss and weakness in association with diabetic neuropathy in humans</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Matti D. Allen, In Ho Choi, Kurt Kimpinski, Timothy J. Doherty, Charles L. Rice</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-30T01:32:00.15047-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23792</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23792</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23792</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23792-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Diabetes mellitus can be associated with peripheral neuropathy which may affect numbers of functioning motor units (MUs) of limb muscles. Direct quantitative assessment of MU numbers and muscle strength have not been performed in humans. We compared the estimated number of MUs of individuals with diabetic polyneuropathy (DPN) versus controls.</p></div></div>
<div class="section" id="mus23792-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Patients with signs/symptoms of DPN were studied using decomposition-enhanced quantitative electromyography of the tibialis anterior (TA). Motor unit number estimates were derived from this analysis.</p></div></div>
<div class="section" id="mus23792-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Dorsiflexion strength was ∼60% less in DPN than controls (<em>P</em> &lt; 0.05). Additionally, the estimated number of functioning TA MUs was ∼60% fewer in patients with DM (∼46) versus controls (∼111) (<em>P</em> &lt; 0.05).</p></div></div>
<div class="section" id="mus23792-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>These data directly measure MU loss associated with DPN in a proximal muscle in humans. It remains to be determined whether quantifying MU loss has clinical utility in monitoring the progression or management of DPN. <em>Muscle Nerve</em>, 2013</p></div></div>
]]></content:encoded><description>


Introduction
Diabetes mellitus can be associated with peripheral neuropathy which may affect numbers of functioning motor units (MUs) of limb muscles. Direct quantitative assessment of MU numbers and muscle strength have not been performed in humans. We compared the estimated number of MUs of individuals with diabetic polyneuropathy (DPN) versus controls.


Methods
Patients with signs/symptoms of DPN were studied using decomposition-enhanced quantitative electromyography of the tibialis anterior (TA). Motor unit number estimates were derived from this analysis.


Results
Dorsiflexion strength was ∼60% less in DPN than controls (P &lt; 0.05). Additionally, the estimated number of functioning TA MUs was ∼60% fewer in patients with DM (∼46) versus controls (∼111) (P &lt; 0.05).


Conclusions
These data directly measure MU loss associated with DPN in a proximal muscle in humans. It remains to be determined whether quantifying MU loss has clinical utility in monitoring the progression or management of DPN. Muscle Nerve, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23722" xmlns="http://purl.org/rss/1.0/"><title>Sensorimotor polyneuropathy in patients with SMA type-1: Electroneuromyographic findings</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23722</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Sensorimotor polyneuropathy in patients with SMA type-1: Electroneuromyographic findings</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ozgur Duman, Hilmi Uysal, Karen L. Skjei, Ferah Kizilay, Sibel Karauzum, Senay Haspolat</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-30T01:31:52.39426-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23722</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23722</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23722</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: Generally, spinal muscular atrophy (SMA) is believed to be a pure motor neuron disease. We retrospectively evaluated our electrodiagnostic findings in SMA type 1 patients to demonstrate co-existence of sensorimotor neuropathies. <em>Methods</em>: Electroneuromyographic (ENMG) studies in 15 patients (11 boys, 4 girls) were reviewed independently by 2 neurophysiologists. Upper extremity findings were compared with normal right arm controls. <em>Results</em>: Patient ages ranged from 1.5 to 26 months. Four SMA patients (26.7%) had decreased sensory nerve action potentials (SNAPs) or sensory nerve conduction velocities. Of them, median SNAPs could not be elicited in 3, and sural SNAPs could not be elicited in 2. Compound muscle action potential amplitudes were severely decreased in 14 (93.3%) and normal in 1. <em>Conclusions</em>: Survival motor neuron 1 (<em>SMN1</em>) gene analysis should be considered if clinical features are consistent with SMA, even if pathological or electrophysiological findings demonstrate peripheral sensorimotor polyneuropathies. Muscle Nerve, 2013</p></div>
]]></content:encoded><description>
Introduction: Generally, spinal muscular atrophy (SMA) is believed to be a pure motor neuron disease. We retrospectively evaluated our electrodiagnostic findings in SMA type 1 patients to demonstrate co-existence of sensorimotor neuropathies. Methods: Electroneuromyographic (ENMG) studies in 15 patients (11 boys, 4 girls) were reviewed independently by 2 neurophysiologists. Upper extremity findings were compared with normal right arm controls. Results: Patient ages ranged from 1.5 to 26 months. Four SMA patients (26.7%) had decreased sensory nerve action potentials (SNAPs) or sensory nerve conduction velocities. Of them, median SNAPs could not be elicited in 3, and sural SNAPs could not be elicited in 2. Compound muscle action potential amplitudes were severely decreased in 14 (93.3%) and normal in 1. Conclusions: Survival motor neuron 1 (SMN1) gene analysis should be considered if clinical features are consistent with SMA, even if pathological or electrophysiological findings demonstrate peripheral sensorimotor polyneuropathies. Muscle Nerve, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23839" xmlns="http://purl.org/rss/1.0/"><title>A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23839</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">James F. Howard, Richard J. Barohn, Gary R. Cutter, Miriam Freimer, Vern C. Juel, Tahseen Mozaffar, Michelle L. Mellion, Michael G. Benatar, Maria Elena Farrugia, Jing Jing Wang, Suneil S. Malhotra, John T. Kissel, </dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-30T01:13:29.691273-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23839</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23839</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23839</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction:</em> Complement activation at the neuromuscular junction is a primary cause of acetylcholine receptor loss and failure of neuromuscular transmission in myasthenia gravis (MG). Eculizumab, a humanized monoclonal antibody, blocks the formation of terminal complement complex by specifically preventing the enzymatic cleavage of complement 5 (C5). <em>Methods:</em> This study was a randomized, double-blind, placebo-controlled, crossover trial involving 14 patients with severe, refractory generalized MG (gMG). <em>Results:</em> Six of 7 patients treated with eculizumab for 16 weeks (86%) achieved the primary endpoint of a 3-point reduction in the quantitative myasthenia gravis (QMG) score. Examining both treatment periods, the overall change in mean QMG total score was significantly different between eculizumab and placebo (<em>P</em> = 0.0144). After assessing data obtained from all visits, the overall change in mean QMG total score from baseline was found to be significantly different between eculizumab and placebo (<em>P</em> &lt; 0.0001). Eculizumab was well tolerated. <em>Conclusion:</em> The data suggest that eculizumab may have a role in treating severe, refractory MG. <em>Muscle Nerve</em> <b>000</b>:000–000, 2013</p></div>
]]></content:encoded><description>

Introduction: Complement activation at the neuromuscular junction is a primary cause of acetylcholine receptor loss and failure of neuromuscular transmission in myasthenia gravis (MG). Eculizumab, a humanized monoclonal antibody, blocks the formation of terminal complement complex by specifically preventing the enzymatic cleavage of complement 5 (C5). Methods: This study was a randomized, double-blind, placebo-controlled, crossover trial involving 14 patients with severe, refractory generalized MG (gMG). Results: Six of 7 patients treated with eculizumab for 16 weeks (86%) achieved the primary endpoint of a 3-point reduction in the quantitative myasthenia gravis (QMG) score. Examining both treatment periods, the overall change in mean QMG total score was significantly different between eculizumab and placebo (P = 0.0144). After assessing data obtained from all visits, the overall change in mean QMG total score from baseline was found to be significantly different between eculizumab and placebo (P &lt; 0.0001). Eculizumab was well tolerated. Conclusion: The data suggest that eculizumab may have a role in treating severe, refractory MG. Muscle Nerve 000:000–000, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23717" xmlns="http://purl.org/rss/1.0/"><title>Somatic instability of CTG repeats in the cerebellum of myotonic dystrophy type 1</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23717</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Somatic instability of CTG repeats in the cerebellum of myotonic dystrophy type 1</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kenji Jinnai, Maki Mitani, Naonobu Futamura, Kunihiko Kawamoto, Itaru Funakawa, Kyoko Itoh</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-29T07:12:15.330225-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23717</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23717</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23717</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: We statistically analyzed somatic instability of the CTG expansion in the central nervous system and visceral organs in 7 patients with myotonic dystrophy type 1 and also report intracerebellar instability in 2 patients. <em>Methods</em>: CTG repeat expansion was estimated in the samples from autopsied brains and visceral organs by Southern blot analysis. Pathological study was performed. Samples were taken from several sites in the cerebellum to examine intracerebellar instability. <em>Results</em>: The CTG repeat expansion was shortest in the cerebellar cortex among all tissues examined. With regard to the intracerebellar difference, the shortest expansion was seen in the cortices of the hemisphere and vermis, whereas it was moderate in the dentate nucleus and longest in the white matter of the hemisphere and middle cerebellar peduncle. <em>Conclusions</em>: The shortest expansion might be attributable to packed granule cells in the cerebellar cortex. Further analysis of cell-specific methylation states might elucidate the enigma of somatic instability. Muscle Nerve, 2013</p></div>
]]></content:encoded><description>
Introduction: We statistically analyzed somatic instability of the CTG expansion in the central nervous system and visceral organs in 7 patients with myotonic dystrophy type 1 and also report intracerebellar instability in 2 patients. Methods: CTG repeat expansion was estimated in the samples from autopsied brains and visceral organs by Southern blot analysis. Pathological study was performed. Samples were taken from several sites in the cerebellum to examine intracerebellar instability. Results: The CTG repeat expansion was shortest in the cerebellar cortex among all tissues examined. With regard to the intracerebellar difference, the shortest expansion was seen in the cortices of the hemisphere and vermis, whereas it was moderate in the dentate nucleus and longest in the white matter of the hemisphere and middle cerebellar peduncle. Conclusions: The shortest expansion might be attributable to packed granule cells in the cerebellar cortex. Further analysis of cell-specific methylation states might elucidate the enigma of somatic instability. Muscle Nerve, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23719" xmlns="http://purl.org/rss/1.0/"><title>Botulinum toxin modulates cortical maladaptation in post-stroke spasticity</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23719</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Botulinum toxin modulates cortical maladaptation in post-stroke spasticity</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">William Huynh, Arun V. Krishnan, Cindy S.-Y. Lin, Steve Vucic, Pesi Katrak, Michael Hornberger, Matthew C. Kiernan</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-28T23:11:16.812289-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23719</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23719</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23719</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: Maladaptive plasticity involving the unaffected hemisphere (UH) in stroke patients may contribute to post-stroke deficits, including spasticity. We investigated the central and peripheral effects of botulinum toxin in post-stroke spasticity to determine whether there is modulation of cortical processes in the UH. <em>Methods</em>: Transcranial magnetic stimulation and peripheral nerve excitability studies were undertaken in 5 stroke patients with upper limb spasticity before (T1) and 6 weeks after (T2) botulinum injection. <em>Results</em>: Transcranial magnetic stimulation demonstrated inexcitable motor cortices of the affected hemisphere at T1 and T2, and short-interval intracortical inhibition (SICI) in the UH was significantly reduced at T1. At T2, SICI in the UH increased significantly compared with T1, normalizing to controls, and was found to be associated with clinical improvements in spasticity. Peripheral excitability parameters were unchanged after injection. <em>Conclusion</em>: Cortical excitability changes were demonstrated in UH, suggesting that the clinical benefits of botulinum toxin relate to modulation of abnormal central reorganization (maladaptive plasticity) in post-stroke spasticity. Muscle Nerve, 2013</p></div>
]]></content:encoded><description>
Introduction: Maladaptive plasticity involving the unaffected hemisphere (UH) in stroke patients may contribute to post-stroke deficits, including spasticity. We investigated the central and peripheral effects of botulinum toxin in post-stroke spasticity to determine whether there is modulation of cortical processes in the UH. Methods: Transcranial magnetic stimulation and peripheral nerve excitability studies were undertaken in 5 stroke patients with upper limb spasticity before (T1) and 6 weeks after (T2) botulinum injection. Results: Transcranial magnetic stimulation demonstrated inexcitable motor cortices of the affected hemisphere at T1 and T2, and short-interval intracortical inhibition (SICI) in the UH was significantly reduced at T1. At T2, SICI in the UH increased significantly compared with T1, normalizing to controls, and was found to be associated with clinical improvements in spasticity. Peripheral excitability parameters were unchanged after injection. Conclusion: Cortical excitability changes were demonstrated in UH, suggesting that the clinical benefits of botulinum toxin relate to modulation of abnormal central reorganization (maladaptive plasticity) in post-stroke spasticity. Muscle Nerve, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23700" xmlns="http://purl.org/rss/1.0/"><title>Protective effect of female gender–related factors on muscle force-generating capacity and fragility in the dystrophic mdx mouse</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23700</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Protective effect of female gender–related factors on muscle force-generating capacity and fragility in the dystrophic mdx mouse</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Christophe Hourdé, Pierre Joanne, Phillippe Noirez, Onnik Agbulut, Gillian Butler-Browne, Arnaud Ferry</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-28T23:10:31.700554-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23700</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23700</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23700</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: The dystrophic features in hindlimb skeletal muscles of female <em>mdx</em> mice are unclear. <em>Methods</em>: We analyzed force-generating capacity and force decline after lengthening contraction-induced damage (fragility). <em>Results</em>: Young (6-month-old) female <em>mdx</em> mice displayed reduced force-generating capacity (−18%) and higher fragility (23% force decline) compared with female age-matched wild-type mice. These 2 dystrophic features were less accentuated in young female than in young male <em>mdx</em> mice (−32% and 42% force drop). With advancing age, force-generating capacity decreased and fragility increased in old (20 month) female <em>mdx</em> mice (−21% and 57% force decline), but they were unchanged in old male <em>mdx</em> mice. Moreover, estradiol treatment had no effect in old female <em>mdx</em> mice. <em>Conclusions</em>: Female gender–related factors mitigate dystrophic features in young but not old <em>mdx</em> mice. Further studies are warranted to identify the beneficial gender-related factor in dystrophic muscle. Muscle Nerve, 2013</p></div>
]]></content:encoded><description>
Introduction: The dystrophic features in hindlimb skeletal muscles of female mdx mice are unclear. Methods: We analyzed force-generating capacity and force decline after lengthening contraction-induced damage (fragility). Results: Young (6-month-old) female mdx mice displayed reduced force-generating capacity (−18%) and higher fragility (23% force decline) compared with female age-matched wild-type mice. These 2 dystrophic features were less accentuated in young female than in young male mdx mice (−32% and 42% force drop). With advancing age, force-generating capacity decreased and fragility increased in old (20 month) female mdx mice (−21% and 57% force decline), but they were unchanged in old male mdx mice. Moreover, estradiol treatment had no effect in old female mdx mice. Conclusions: Female gender–related factors mitigate dystrophic features in young but not old mdx mice. Further studies are warranted to identify the beneficial gender-related factor in dystrophic muscle. Muscle Nerve, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23831" xmlns="http://purl.org/rss/1.0/"><title>Corticosteroids in Duchenne muscular dystrophy: Major variations in practice</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23831</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Corticosteroids in Duchenne muscular dystrophy: Major variations in practice</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Robert C. Griggs, Barbara E. Herr, Allen Reha, Gary Elfring, Leone Atkinson, Valerie Cwik, Elaine Mccoll, Rabi Tawil, Shree Pandya, Michael P. McDermott, Kate Bushby</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-24T23:52:53.268312-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23831</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23831</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23831</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Issues &amp; Opinions</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: In 2004, a Cochrane Review and AAN practice parameter concluded that prednisone 0.75 mg/kg/day is of short-term efficacy in Duchenne muscular dystrophy (DMD). Subsequent efforts to standardize care for DMD indicated wide variation in corticosteroid use. Methods: We surveyed physicians who follow patients with DMD, including: (1) clinics in the TREAT-NMD (Translational Research in Europe—Assessment and Treatment of Neuromuscular Diseases) network (predominantly Europe) and (2) U.S. MDA clinic directors. We also documented the co-administered corticosteroids in a trial of a putative treatment (ataluren) for DMD. Results: Of 105 Treat-NMD clinicians, corticosteroids were not used in 10 clinics, and 29 different regimens were used—the most frequent 0.75 mg/kg/day prednisone (61 centers); 10 days on/10 days off (36 centers); 0.9 mg/kg/day deflazacort (32 centers); and 5 mg/kg/day on weekends (10 centers). Similar diversity was identified in MDA clinics and in the ataluren trial. Conclusions: Variability in corticosteroid use suggests uncertainty about risks/benefits of corticosteroid regimens for DMD. <em>Muscle Nerve</em> <b>000</b>:000–000, 2013</p></div>
]]></content:encoded><description>

Introduction: In 2004, a Cochrane Review and AAN practice parameter concluded that prednisone 0.75 mg/kg/day is of short-term efficacy in Duchenne muscular dystrophy (DMD). Subsequent efforts to standardize care for DMD indicated wide variation in corticosteroid use. Methods: We surveyed physicians who follow patients with DMD, including: (1) clinics in the TREAT-NMD (Translational Research in Europe—Assessment and Treatment of Neuromuscular Diseases) network (predominantly Europe) and (2) U.S. MDA clinic directors. We also documented the co-administered corticosteroids in a trial of a putative treatment (ataluren) for DMD. Results: Of 105 Treat-NMD clinicians, corticosteroids were not used in 10 clinics, and 29 different regimens were used—the most frequent 0.75 mg/kg/day prednisone (61 centers); 10 days on/10 days off (36 centers); 0.9 mg/kg/day deflazacort (32 centers); and 5 mg/kg/day on weekends (10 centers). Similar diversity was identified in MDA clinics and in the ataluren trial. Conclusions: Variability in corticosteroid use suggests uncertainty about risks/benefits of corticosteroid regimens for DMD. Muscle Nerve 000:000–000, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23699" xmlns="http://purl.org/rss/1.0/"><title>Spasticity, weakness, force variability, and sustained spontaneous motor unit discharges of resting spastic–paretic biceps brachii muscles in chronic stroke</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23699</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Spasticity, weakness, force variability, and sustained spontaneous motor unit discharges of resting spastic–paretic biceps brachii muscles in chronic stroke</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Shuo-Hsiu Chang, Gerard e. Francisco, Ping Zhou, W. Zev Rymer, Sheng Li</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-21T22:50:24.012114-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23699</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23699</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23699</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: The purpose of our study was to examine relations among spasticity, weakness, force variability, and sustained spontaneous motor unit discharges in spastic–paretic biceps brachii muscles in chronic stroke. <em>Methods</em>: Ten chronic stroke subjects produced submaximal isometric elbow flexion force on impaired and non-impaired sides. Intramuscular EMG (iEMG) was recorded from biceps and triceps brachii muscles. <em>Results</em>: We observed sustained spontaneous motor unit discharges in resting biceps on iEMG. Spontaneous discharges increased after voluntary activation only on the impaired side. The impaired side had greater matching errors and greater fluctuations in isometric force. Spontaneous discharges were not related functionally to spasticity, force variability, or weakness. However, greater strength on the impaired side correlated with less force variability. <em>Conclusion</em>: Weakness rather than spasticity is a main factor interfering with voluntary force control in paretic–spastic biceps brachii muscles in chronic stroke. Muscle Nerve, 2013</p></div>
]]></content:encoded><description>
Introduction: The purpose of our study was to examine relations among spasticity, weakness, force variability, and sustained spontaneous motor unit discharges in spastic–paretic biceps brachii muscles in chronic stroke. Methods: Ten chronic stroke subjects produced submaximal isometric elbow flexion force on impaired and non-impaired sides. Intramuscular EMG (iEMG) was recorded from biceps and triceps brachii muscles. Results: We observed sustained spontaneous motor unit discharges in resting biceps on iEMG. Spontaneous discharges increased after voluntary activation only on the impaired side. The impaired side had greater matching errors and greater fluctuations in isometric force. Spontaneous discharges were not related functionally to spasticity, force variability, or weakness. However, greater strength on the impaired side correlated with less force variability. Conclusion: Weakness rather than spasticity is a main factor interfering with voluntary force control in paretic–spastic biceps brachii muscles in chronic stroke. Muscle Nerve, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23721" xmlns="http://purl.org/rss/1.0/"><title>Satellite cell pool expansion is affected by skeletal muscle characteristics</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23721</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Satellite cell pool expansion is affected by skeletal muscle characteristics</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Filippo Macaluso, Naomi E. Brooks, Carola U. Niesler, Kathryn H. Myburgh</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-21T22:50:21.039399-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23721</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23721</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23721</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: We investigated changes in satellite cell (SC) pool size after an acute bout of strenuous exercise and evaluated the influence of baseline SC count and fiber type. <em>Methods</em>: Participants completed a downhill running (DHR) intervention (5 × 8 min, 2-min rest; 80% V<span class="smallCaps">O</span><sub>2max</sub>; −10% gradient). Muscle biopsies were taken 7 days before V<span class="smallCaps">O</span><sub>2max</sub> and 7–9 days after the DHR intervention. Delayed-onset muscle soreness (DOMS) and creatine kinase activity (CK) were measured on days 1, 2, 7, and 9 post-DHR. SCs were identified by Pax7 and laminin staining. Relative distribution of MHC isoforms was determined by electrophoresis. <em>Results</em>: DOMS and CK peaked on day 1 post-DHR (<em>P</em> &lt; 0.01). The SC pool increased (26%) after DHR (<em>P</em> = 0.005). SCs/total myonuclei after recovery correlated with baseline SCs (<em>r</em> = 0.979, <em>P</em> = 0.003) and V<span class="smallCaps">O</span><sub>2max</sub> (<em>r</em> = 0.956, <em>P</em> = 0.011), whereas change in SC pool (Pax7<sup>+</sup> cells/total myonuclei: recovery minus baseline) tended to correlate with percent MHC II (<em>r</em> = 0.848; <em>P</em> = 0.06). <em>Conclusion</em>: Interindividual physiological characteristics affect SC pool expansion after a single bout of DHR and are influenced by V<span class="smallCaps">O</span><sub>2max</sub>. Muscle Nerve, 2013</p></div>
]]></content:encoded><description>
Introduction: We investigated changes in satellite cell (SC) pool size after an acute bout of strenuous exercise and evaluated the influence of baseline SC count and fiber type. Methods: Participants completed a downhill running (DHR) intervention (5 × 8 min, 2-min rest; 80% VO2max; −10% gradient). Muscle biopsies were taken 7 days before VO2max and 7–9 days after the DHR intervention. Delayed-onset muscle soreness (DOMS) and creatine kinase activity (CK) were measured on days 1, 2, 7, and 9 post-DHR. SCs were identified by Pax7 and laminin staining. Relative distribution of MHC isoforms was determined by electrophoresis. Results: DOMS and CK peaked on day 1 post-DHR (P &lt; 0.01). The SC pool increased (26%) after DHR (P = 0.005). SCs/total myonuclei after recovery correlated with baseline SCs (r = 0.979, P = 0.003) and VO2max (r = 0.956, P = 0.011), whereas change in SC pool (Pax7+ cells/total myonuclei: recovery minus baseline) tended to correlate with percent MHC II (r = 0.848; P = 0.06). Conclusion: Interindividual physiological characteristics affect SC pool expansion after a single bout of DHR and are influenced by VO2max. Muscle Nerve, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23846" xmlns="http://purl.org/rss/1.0/"><title>Creatine kinase response to high-intensity aerobic exercise in adult-onset muscular dystrophy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23846</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Creatine kinase response to high-intensity aerobic exercise in adult-onset muscular dystrophy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Søren P. Andersen, Marie-Louise Sveen, Regitze S. Hansen, Karen L. Madsen, Jonas B. Hansen, Mads Madsen, John Vissing</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-21T22:46:38.62887-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23846</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23846</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23846</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23846-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>We investigated the effect of high-intensity exercise on plasma creatine kinase (CK) in patients with muscular dystrophies.</p></div></div>
<div class="section" id="mus23846-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Fourteen patients with Becker (BMD), facioscapulohumeral (FSHD), or limb-girdle type 2 (LGMD2) muscular dystrophy, and 8 healthy subjects performed 5 cycling tests: an incremental max test, and tests at 65%, 75%, 85%, and 95% of maximal oxygen uptake (VO<sub>2max</sub>). Heart rate and oxygen consumption were measured during the tests, and plasma CK was measured before, immediately after, and 24 hours after exercise.</p></div></div>
<div class="section" id="mus23846-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>All subjects were able to perform high-intensity exercise at the different levels. In patients with LGMD2 and FSHD, CK normalized 24 hours after exercise compared with the pre-exercise value, whereas those with BMD and healthy controls had elevated CK values 24 hours after exercise.</p></div></div>
<div class="section" id="mus23846-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>The findings suggest that high-intensity exercise is generally well tolerated in patients with LGMD2 and FSHD, whereas those with BMD may be more prone to exercise-induced damage. <em>Muscle Nerve</em>, 2013</p></div></div>
]]></content:encoded><description>


Introduction
We investigated the effect of high-intensity exercise on plasma creatine kinase (CK) in patients with muscular dystrophies.


Methods
Fourteen patients with Becker (BMD), facioscapulohumeral (FSHD), or limb-girdle type 2 (LGMD2) muscular dystrophy, and 8 healthy subjects performed 5 cycling tests: an incremental max test, and tests at 65%, 75%, 85%, and 95% of maximal oxygen uptake (VO2max). Heart rate and oxygen consumption were measured during the tests, and plasma CK was measured before, immediately after, and 24 hours after exercise.


Results
All subjects were able to perform high-intensity exercise at the different levels. In patients with LGMD2 and FSHD, CK normalized 24 hours after exercise compared with the pre-exercise value, whereas those with BMD and healthy controls had elevated CK values 24 hours after exercise.


Conclusions
The findings suggest that high-intensity exercise is generally well tolerated in patients with LGMD2 and FSHD, whereas those with BMD may be more prone to exercise-induced damage. Muscle Nerve, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23712" xmlns="http://purl.org/rss/1.0/"><title>Sternocleidomastoid ultrasonography data for muscular torticollis in infants</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23712</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Sternocleidomastoid ultrasonography data for muscular torticollis in infants</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bo Young Hong, Young Jin Ko, Joon Sung Kim, Eun Jae Ok, Youngdeok Hwang, Hye Won Kim</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-21T22:45:58.503829-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23712</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23712</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23712</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: This study was performed to obtain normative ultrasonographic data of the sternocleidomastoid (SCM) muscle in infants and to describe an ultrasound method for evaluating muscular torticollis. <em>Methods</em>: The thickness and cross-sectional area (CSA) of the sternal and clavicular heads of the SCM in 84 subjects were analyzed retrospectively. The diagnostic performance of ultrasonography (US) was estimated using receiver-operating characteristic analysis. <em>Results</em>: Muscle thickness increased with age until 10 months. There were no significant differences in thickness or CSA between the right and left sides (<em>P</em> &gt; 0.05) in normal subjects. A ratio of the thickness of the affected side to the unaffected side for the sternal head of the SCM muscle of &gt;1.19 showed a diagnostic sensitivity of 97.9% and specificity of 96.4%. <em>Conclusions</em>: Distinguishing the heads of the SCM muscle and comparing the thickness of the same head on both sides using US may be helpful for evaluating torticollis in infants. Muscle Nerve 000: 000–000, 2013</p></div>
]]></content:encoded><description>
Introduction: This study was performed to obtain normative ultrasonographic data of the sternocleidomastoid (SCM) muscle in infants and to describe an ultrasound method for evaluating muscular torticollis. Methods: The thickness and cross-sectional area (CSA) of the sternal and clavicular heads of the SCM in 84 subjects were analyzed retrospectively. The diagnostic performance of ultrasonography (US) was estimated using receiver-operating characteristic analysis. Results: Muscle thickness increased with age until 10 months. There were no significant differences in thickness or CSA between the right and left sides (P &gt; 0.05) in normal subjects. A ratio of the thickness of the affected side to the unaffected side for the sternal head of the SCM muscle of &gt;1.19 showed a diagnostic sensitivity of 97.9% and specificity of 96.4%. Conclusions: Distinguishing the heads of the SCM muscle and comparing the thickness of the same head on both sides using US may be helpful for evaluating torticollis in infants. Muscle Nerve 000: 000–000, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23746" xmlns="http://purl.org/rss/1.0/"><title>Origin of Surface Motor Unit Potentials in Hypothenar Motor Unit Number Estimation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23746</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Origin of Surface Motor Unit Potentials in Hypothenar Motor Unit Number Estimation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yasuomi Kawamura, Masahiro Sonoo, Mana Higashihara, Takashi Chiba, Yuki Hatanaka</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-05T05:20:35.66476-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23746</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23746</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23746</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: Far-field potentials (FFPs) from muscles other than the abductor digiti minimi (ADM) may interfere with motor unit number estimation (MUNE) from that muscle. <em>Methods</em>: We identified the origin of each surface motor unit potential (SMUP) during hypothenar MUNE using the multiple point stimulation method in 20 control subjects by recording from individual ulnar-innervated muscles with a common proximal reference (pref). <em>Results</em>: ADM SMUPs comprised 39.0% of the accepted SMUPs, followed by those from the fourth dorsal interosseous muscle (14.0%), the fourth lumbrical muscle (9.2%), and the second and third palmar interosseous muscles (8.8% each). The percentage of ADM SMUPs varied from 18% to 73% of accepted SMUPs among individual subjects. Accepted non-ADM SMUPs were usually much smaller than ADM SMUPs, and many more non-ADM SMUPs were excluded due to their small size. <em>Conclusions</em>: A large contribution from non-ADM or non-hypothenar SMUPs obscures the meaning of the MUNE value. <em>Muscle Nerve</em>, 2013</p></div>
]]></content:encoded><description>

Introduction: Far-field potentials (FFPs) from muscles other than the abductor digiti minimi (ADM) may interfere with motor unit number estimation (MUNE) from that muscle. Methods: We identified the origin of each surface motor unit potential (SMUP) during hypothenar MUNE using the multiple point stimulation method in 20 control subjects by recording from individual ulnar-innervated muscles with a common proximal reference (pref). Results: ADM SMUPs comprised 39.0% of the accepted SMUPs, followed by those from the fourth dorsal interosseous muscle (14.0%), the fourth lumbrical muscle (9.2%), and the second and third palmar interosseous muscles (8.8% each). The percentage of ADM SMUPs varied from 18% to 73% of accepted SMUPs among individual subjects. Accepted non-ADM SMUPs were usually much smaller than ADM SMUPs, and many more non-ADM SMUPs were excluded due to their small size. Conclusions: A large contribution from non-ADM or non-hypothenar SMUPs obscures the meaning of the MUNE value. Muscle Nerve, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23734" xmlns="http://purl.org/rss/1.0/"><title>Far-Field Potentials in Hypothenar Motor Unit Number Estimation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23734</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Far-Field Potentials in Hypothenar Motor Unit Number Estimation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mana Higashihara, Masahiro Sonoo, Tomotaka Yamamoto, Yasuomi Kawamura, Yu Nagashima, Yasuo Terao, Kenichi Kaida, Fumihiko Kimura, Yoshikazu Ugawa, Shoji Tsuji</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-04T22:45:23.705009-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23734</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23734</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23734</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: Contamination by far-field potentials (FFPs) may interfere with motor unit number estimation (MUNE) in the ulnar nerve. <em>Methods</em>: Surface motor unit potentials (SMUPs) from 29 spinal and bulbar muscular atrophy (SBMA) patients and 27 control subjects were classified into SMUPs from the abductor digiti minimi muscle (ADM SMUPs) or non-ADM SMUPs, based on the waveform patterns from 3-channel recordings. <em>Results</em>: The mean areas of the ADM SMUPs and non-ADM SMUPs in control subjects were 219.0 ± 131.3 and 63.7 ± 48.5 μVms, respectively. In SBMA patients they were 1988.9 ± 999.4 and 222.7 ± 125.7 μVms, respectively. The percentages of non-ADM SMUPs were 68 ± 22% in controls and 84 ± 15% in SBMA patients. <em>Conclusions</em>: Non-ADM SMUPs generated mainly by FFPs often had a negative onset in the routine lead and were indistinguishable from ADM SMUPs. More frequent exclusion of smaller non-ADM SMUPs in controls by size criteria would reduce the diagnostic yield of MUNE. <em>Muscle Nerve</em>, 2013</p></div>
]]></content:encoded><description>

Introduction: Contamination by far-field potentials (FFPs) may interfere with motor unit number estimation (MUNE) in the ulnar nerve. Methods: Surface motor unit potentials (SMUPs) from 29 spinal and bulbar muscular atrophy (SBMA) patients and 27 control subjects were classified into SMUPs from the abductor digiti minimi muscle (ADM SMUPs) or non-ADM SMUPs, based on the waveform patterns from 3-channel recordings. Results: The mean areas of the ADM SMUPs and non-ADM SMUPs in control subjects were 219.0 ± 131.3 and 63.7 ± 48.5 μVms, respectively. In SBMA patients they were 1988.9 ± 999.4 and 222.7 ± 125.7 μVms, respectively. The percentages of non-ADM SMUPs were 68 ± 22% in controls and 84 ± 15% in SBMA patients. Conclusions: Non-ADM SMUPs generated mainly by FFPs often had a negative onset in the routine lead and were indistinguishable from ADM SMUPs. More frequent exclusion of smaller non-ADM SMUPs in controls by size criteria would reduce the diagnostic yield of MUNE. Muscle Nerve, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23351" xmlns="http://purl.org/rss/1.0/"><title>Reply</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23351</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Reply</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Casanova-Molla, J. Valls-Solé</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-09-19T22:35:18.994827-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23351</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23351</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23351</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.21394" xmlns="http://purl.org/rss/1.0/"><title>RETRACTED: Effects of recombinant type I interferon therapy on human muscle diseases</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.21394</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">RETRACTED: Effects of recombinant type I interferon therapy on human muscle diseases</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joerg-Patrick Stübgen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2009-08-07T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.21394</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.21394</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.21394</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Invited Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Interferons (IFNs) are potent extracellular protein mediators of host defense and homeostasis. Type I IFNs have well-established direct antiviral, antiproliferative, and immunomodulatory properties. The worldwide, increasing and long-term use of INFα, particularly for the treatment of chronic hepatitis C virus infection, has drawn attention to the development or exacerbation of numerous autoimmune phenomena, including a spectrum of myopathies. Management entailed withdrawal of INFα with supportive, immunomodulatory, and symptomatic treatment as deemed clinically indicated. However, IFNβ therapy for relapsing-remitting multiple sclerosis rarely triggered clinically manifest autoimmunity. The mechanisms through which type I IFNs induce autoimmunity are incompletely understood, and they likely vary depending on the inherent differences in the pathogenesis of the immune disorder on a background of patient genetic susceptibility. INFα therapy had unpredictable effects on hepatitis C-associated myopathies. The immunomodulating effects of IFNβ therapy showed no clinically significant benefit during prospective controlled treatment trials of inclusion body myositis. Type I IFNs have the theoretical potential to either cause or treat autoimmune muscular disorders by altering the complicated and delicate balances within immune system networks. Muscle Nerve, 2009</p></div>]]></content:encoded><description>Interferons (IFNs) are potent extracellular protein mediators of host defense and homeostasis. Type I IFNs have well-established direct antiviral, antiproliferative, and immunomodulatory properties. The worldwide, increasing and long-term use of INFα, particularly for the treatment of chronic hepatitis C virus infection, has drawn attention to the development or exacerbation of numerous autoimmune phenomena, including a spectrum of myopathies. Management entailed withdrawal of INFα with supportive, immunomodulatory, and symptomatic treatment as deemed clinically indicated. However, IFNβ therapy for relapsing-remitting multiple sclerosis rarely triggered clinically manifest autoimmunity. The mechanisms through which type I IFNs induce autoimmunity are incompletely understood, and they likely vary depending on the inherent differences in the pathogenesis of the immune disorder on a background of patient genetic susceptibility. INFα therapy had unpredictable effects on hepatitis C-associated myopathies. The immunomodulating effects of IFNβ therapy showed no clinically significant benefit during prospective controlled treatment trials of inclusion body myositis. Type I IFNs have the theoretical potential to either cause or treat autoimmune muscular disorders by altering the complicated and delicate balances within immune system networks. Muscle Nerve, 2009</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.20945" xmlns="http://purl.org/rss/1.0/"><title>Unilateral lower cranial nerve palsies as the sole manifestation of internal carotid artery dissection: Case report</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.20945</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Unilateral lower cranial nerve palsies as the sole manifestation of internal carotid artery dissection: Case report</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Giovanni Caranci, Elena Giacomelli, Maurizio Inghilleri</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2008-07-18T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.20945</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.20945</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.20945</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23571" xmlns="http://purl.org/rss/1.0/"><title>Table of Contents</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23571</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Table of Contents</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-23T23:26:58.197863-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23571</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23571</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23571</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Table of Contents</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">iii</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">iv</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23575" xmlns="http://purl.org/rss/1.0/"><title>Between the covers june, 2013 issue</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23575</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Between the covers june, 2013 issue</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lawrence H. Phillips</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-23T23:26:58.197863-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23575</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23575</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23575</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Between the Covers</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">v</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">vii</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23814" xmlns="http://purl.org/rss/1.0/"><title>A role for androgen reduction treatment in kennedy disease?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23814</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A role for androgen reduction treatment in kennedy disease?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kenneth H. Fischbeck</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-21T00:02:51.878793-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23814</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23814</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23814</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Editorial</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">789</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">789</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23737" xmlns="http://purl.org/rss/1.0/"><title>Neuromuscular ultrasound in polyneuropathies and motor neuron disease</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23737</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Neuromuscular ultrasound in polyneuropathies and motor neuron disease</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lisa D. Hobson-Webb</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-29T07:12:22.416215-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23737</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23737</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23737</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Invited Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">790</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">804</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Current standards for diagnosing polyneuropathies (PN) and motor neuron disease (MND) sometimes lack early sensitivity and result in delayed diagnosis and treatment. Neuromuscular ultrasound (NMUS), already established in the diagnosis of entrapment neuropathies, may offer another means of diagnosis and monitoring response to therapy. This review of current evidence discusses diffuse nerve hypertrophy in hereditary demyelinating neuropathies, multifocal nerve enlargement in acquired demyelinating PN and the lack of readily apparent structural change in axonal neuropathies. NMUS detection of fasciculations and muscular change in MND is also reviewed, along with the need for further research to better define the role of nerve imaging in patients with PN. Muscle Nerve 47: 790–804, 2013</p></div>
]]></content:encoded><description>

Current standards for diagnosing polyneuropathies (PN) and motor neuron disease (MND) sometimes lack early sensitivity and result in delayed diagnosis and treatment. Neuromuscular ultrasound (NMUS), already established in the diagnosis of entrapment neuropathies, may offer another means of diagnosis and monitoring response to therapy. This review of current evidence discusses diffuse nerve hypertrophy in hereditary demyelinating neuropathies, multifocal nerve enlargement in acquired demyelinating PN and the lack of readily apparent structural change in axonal neuropathies. NMUS detection of fasciculations and muscular change in MND is also reviewed, along with the need for further research to better define the role of nerve imaging in patients with PN. Muscle Nerve 47: 790–804, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23755" xmlns="http://purl.org/rss/1.0/"><title>Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia)</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23755</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperckemia)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nicholas J. Silvestri, Gil I. Wolfe</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-28T23:11:10.42504-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23755</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23755</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23755</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Invited Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">805</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">815</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Neuromuscular clinicians are frequently asked to evaluate patients referred for asymptomatic elevations in creatine kinase (CK), a catalytic enzyme that combines creatine and ATP to form phosphocreatine and ADP. This reaction is crucial for cellular energy generation and metabolism. This laboratory finding, often referred to in simplified lexicon as asymptomatic hyperCKemia, continues to generate controversy at several levels, including definition, the extent of evaluation, and the yield of diagnostic testing. In this review, we summarize the literature based on series of patients with asymptomatic hyperCKemia and provide a rational clinical approach to reveal identifiable underlying causes. Muscle Nerve 47: 805–815, 2013</p></div>
]]></content:encoded><description>

Neuromuscular clinicians are frequently asked to evaluate patients referred for asymptomatic elevations in creatine kinase (CK), a catalytic enzyme that combines creatine and ATP to form phosphocreatine and ADP. This reaction is crucial for cellular energy generation and metabolism. This laboratory finding, often referred to in simplified lexicon as asymptomatic hyperCKemia, continues to generate controversy at several levels, including definition, the extent of evaluation, and the yield of diagnostic testing. In this review, we summarize the literature based on series of patients with asymptomatic hyperCKemia and provide a rational clinical approach to reveal identifiable underlying causes. Muscle Nerve 47: 805–815, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23759" xmlns="http://purl.org/rss/1.0/"><title>An open trial of long-term testosterone suppression in spinal and bulbar muscular atrophy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23759</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">An open trial of long-term testosterone suppression in spinal and bulbar muscular atrophy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tomotaka Yamamoto, Kazuhiko Yokota, Rie Amao, Takashi Maeno, Nobuhiko Haga, Masataka Taguri, Hiroshi Ohtsu, Yaeko Ichikawa, Jun Goto, Shoji Tsuji</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T01:37:39.847934-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23759</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23759</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23759</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">816</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">822</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23759-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>We investigated the long-term effects of leuprorelin on leg-muscle strength in spinal and bulbar muscular atrophy (SBMA). We hypothesized that testosterone suppression by leuprorelin would prevent the progression of muscle weakness.</p></div></div>
<div class="section" id="mus23759-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>In a prospective, long duration, open trial, 16 SBMA patients underwent medical castration with leuprorelin for 3.5 years. Chlormadinone was coadministered initially to prevent a testosterone surge. The strength of knee extension and flexion were quantitated using a torque machine.</p></div></div>
<div class="section" id="mus23759-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Our hypothesis was rejected. The leg strength measures decreased significantly with the mean reduction of 22.3–27.8%. In a <em>post hoc</em> analysis, the leg strength of 4 patients with higher pretreatment baseline total testosterone levels and short disease duration of 1–6 years were stronger at baseline and decreased by only 12.3–15.7% after treatment.</p></div></div>
<div class="section" id="mus23759-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Leuprorelin was not effective in this small long-term treatment trial in SBMA. The possibility that earlier treatment might be beneficial may deserve further study. Muscle Nerve 47: 816–822, 2013</p></div></div>
]]></content:encoded><description>


Introduction
We investigated the long-term effects of leuprorelin on leg-muscle strength in spinal and bulbar muscular atrophy (SBMA). We hypothesized that testosterone suppression by leuprorelin would prevent the progression of muscle weakness.


Methods
In a prospective, long duration, open trial, 16 SBMA patients underwent medical castration with leuprorelin for 3.5 years. Chlormadinone was coadministered initially to prevent a testosterone surge. The strength of knee extension and flexion were quantitated using a torque machine.


Results
Our hypothesis was rejected. The leg strength measures decreased significantly with the mean reduction of 22.3–27.8%. In a post hoc analysis, the leg strength of 4 patients with higher pretreatment baseline total testosterone levels and short disease duration of 1–6 years were stronger at baseline and decreased by only 12.3–15.7% after treatment.


Conclusions
Leuprorelin was not effective in this small long-term treatment trial in SBMA. The possibility that earlier treatment might be beneficial may deserve further study. Muscle Nerve 47: 816–822, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23813" xmlns="http://purl.org/rss/1.0/"><title>Androgen receptors in muscle fibers induce rapid loss of force but not mass: Implications for spinal bulbar muscular atrophy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23813</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Androgen receptors in muscle fibers induce rapid loss of force but not mass: Implications for spinal bulbar muscular atrophy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kentaro Oki, Robert W. Wiseman, S. Marc Breedlove, Cynthia L. Jordan</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-30T01:32:02.739729-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23813</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23813</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23813</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">823</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">834</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23813-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Testosterone (T) induces motor dysfunction in transgenic (Tg) mice that overexpress wild-type androgen receptor (AR) in skeletal muscles. Because many genes implicated in motor neuron disease are expressed in skeletal muscle, mutant proteins may act in muscle to cause dysfunction in motor neuron disease.</p></div></div>
<div class="section" id="mus23813-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>We examined contractile properties of the extensor digitorum longus (EDL) and soleus (SOL) muscles <em>in vitro</em> after 5 and 3 days of T treatment in motor-impaired Tg female mice.</p></div></div>
<div class="section" id="mus23813-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Both muscles showed deficits in tetanic force after 5 days of T treatment, without losses in muscle mass, protein content, or fiber number. After 3 days of T treatment, only SOL showed a deficit in tetanic force comparable to that of 5 days of treatment. In both treatments, EDL showed slowed twitch kinetics, whereas SOL showed deficits in the twitch/tetanus ratio.</p></div></div>
<div class="section" id="mus23813-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>These results suggest calcium-handling mechanisms in muscle fibers are defective in motor-impaired mice. Muscle Nerve 47: 823–834, 2013</p></div></div>
]]></content:encoded><description>


Introduction
Testosterone (T) induces motor dysfunction in transgenic (Tg) mice that overexpress wild-type androgen receptor (AR) in skeletal muscles. Because many genes implicated in motor neuron disease are expressed in skeletal muscle, mutant proteins may act in muscle to cause dysfunction in motor neuron disease.


Methods
We examined contractile properties of the extensor digitorum longus (EDL) and soleus (SOL) muscles in vitro after 5 and 3 days of T treatment in motor-impaired Tg female mice.


Results
Both muscles showed deficits in tetanic force after 5 days of T treatment, without losses in muscle mass, protein content, or fiber number. After 3 days of T treatment, only SOL showed a deficit in tetanic force comparable to that of 5 days of treatment. In both treatments, EDL showed slowed twitch kinetics, whereas SOL showed deficits in the twitch/tetanus ratio.


Conclusions
These results suggest calcium-handling mechanisms in muscle fibers are defective in motor-impaired mice. Muscle Nerve 47: 823–834, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23697" xmlns="http://purl.org/rss/1.0/"><title>Role of repeat skeletal muscle biopsy: How useful is it?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23697</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Role of repeat skeletal muscle biopsy: How useful is it?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Stephen A. Goutman, Richard A. Prayson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-21T22:45:50.783508-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23697</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23697</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23697</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">835</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">839</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: The role of skeletal muscle biopsy is established; however, to our knowledge, no study has systematically evaluated the utility of a repeat biopsy. <em>Methods</em>: This study was a retrospective clinicopathologic review of 66 patients (mean age 38.1 years, 39 men) with at least 1 repeat muscle biopsy obtained between February 1992 and November 2011. Clinical data determined how results of the subsequent biopsy impacted patient management. <em>Results</em>: Repeat biopsy yielded a definitive diagnosis in 16 of 66 patients (24%). In the remaining patients, a repeat study provided clinically useful information or directly answered the clinical question (<em>n</em> = 30, 45%) by excluding a differential consideration (<em>n</em> = 19), supporting treatment continuation (<em>n</em> = 8), prompting treatment change (<em>n</em> = 1), confirming the original diagnosis (<em>n</em> = 1), or establishing a likely diagnosis (<em>n</em> = 1). <em>Conclusion</em>: Repeat muscle biopsy plays a role in the evaluation of patients with suspected myopathy in certain clinical circumstances. Muscle Nerve 47: 835–839, 2013</p></div>
]]></content:encoded><description>
Introduction: The role of skeletal muscle biopsy is established; however, to our knowledge, no study has systematically evaluated the utility of a repeat biopsy. Methods: This study was a retrospective clinicopathologic review of 66 patients (mean age 38.1 years, 39 men) with at least 1 repeat muscle biopsy obtained between February 1992 and November 2011. Clinical data determined how results of the subsequent biopsy impacted patient management. Results: Repeat biopsy yielded a definitive diagnosis in 16 of 66 patients (24%). In the remaining patients, a repeat study provided clinically useful information or directly answered the clinical question (n = 30, 45%) by excluding a differential consideration (n = 19), supporting treatment continuation (n = 8), prompting treatment change (n = 1), confirming the original diagnosis (n = 1), or establishing a likely diagnosis (n = 1). Conclusion: Repeat muscle biopsy plays a role in the evaluation of patients with suspected myopathy in certain clinical circumstances. Muscle Nerve 47: 835–839, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23707" xmlns="http://purl.org/rss/1.0/"><title>Safety of repetitive nerve stimulation in patients with cardiac implantable electronic devices</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23707</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Safety of repetitive nerve stimulation in patients with cardiac implantable electronic devices</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Edmond M. Cronin, Jennifer Gray, Bernard Abi-Saleh, Bruce L. Wilkoff, Kerry H. Levin</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-21T22:50:28.627884-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23707</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23707</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23707</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">840</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">844</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Pacemakers and implantable cardioverter-defibrillators (ICDs) are vulnerable to inappropriate sensing of electromagnetic interference (EMI), such as from nerve conduction studies. We conducted a prospective study to assess the safety of repetitive nerve stimulation (RNS). Methods: Fourteen patients undergoing insertion of 10 ICDs and 4 pacemakers under general anesthesia received RNS of the median, axillary, and spinal accessory nerves at 2 H<span class="smallCaps">Z</span> and 50 H<span class="smallCaps">Z</span>. We recorded detection of EMI and whether or not this resulted in an arrhythmia diagnosis or change in pacing output. Results: EMI was visible in 2 ICDs, without spurious tachyarrhythmia detection. EMI was observed in 3 of the 4 pacemakers, which led to pacing inhibition and a pause in 2, both of which were programmed to a unipolar sensing configuration. Conclusions: RNS is safe in patients with ICDs. In pacemaker patients, RNS appears safe during bipolar sensing, but caution is recommended in pacemaker patients with unipolar sensing. Muscle Nerve 47: 840–844, 2013</p></div>
]]></content:encoded><description>
Introduction: Pacemakers and implantable cardioverter-defibrillators (ICDs) are vulnerable to inappropriate sensing of electromagnetic interference (EMI), such as from nerve conduction studies. We conducted a prospective study to assess the safety of repetitive nerve stimulation (RNS). Methods: Fourteen patients undergoing insertion of 10 ICDs and 4 pacemakers under general anesthesia received RNS of the median, axillary, and spinal accessory nerves at 2 HZ and 50 HZ. We recorded detection of EMI and whether or not this resulted in an arrhythmia diagnosis or change in pacing output. Results: EMI was visible in 2 ICDs, without spurious tachyarrhythmia detection. EMI was observed in 3 of the 4 pacemakers, which led to pacing inhibition and a pause in 2, both of which were programmed to a unipolar sensing configuration. Conclusions: RNS is safe in patients with ICDs. In pacemaker patients, RNS appears safe during bipolar sensing, but caution is recommended in pacemaker patients with unipolar sensing. Muscle Nerve 47: 840–844, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23716" xmlns="http://purl.org/rss/1.0/"><title>Diagnostic impact of myotonic discharges in myofibrillar myopathies</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23716</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Diagnostic impact of myotonic discharges in myofibrillar myopathies</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Frank Hanisch, Torsten Kraya, Malte Kornhuber, Stephan Zierz</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-21T22:50:45.324393-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23716</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23716</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23716</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">845</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">848</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: In patients with myofibrillar myopathies (MFM), myotonic discharges have occasionally been detected by needle electromyography (EMG). Nevertheless, this peculiar type of spontaneous repetitive discharge has not attracted special interest in the genetically heterogeneous MFMs. <em>Methods</em>: EMG features were analyzed in 6 patients with genetically confirmed MFM (n = 1 <em>MYOT</em>, n = 1 <em>DES</em>, n = 2 <em>ZASP</em>, n = 2 <em>FLNC</em>). <em>Results</em>: Fibrillation potentials, positive sharp waves, and myotonic discharges were found in all 6 patients, and complex repetitive discharges were found in 5. Myotonic discharges were detected in approximately 50% of the analyzed muscles independent of the site, including distal (3/6), proximal limb (4/6), and paravertebral muscles (3/6). Clinical myotonia could not be elicited in any patient. <em>Conclusions</em>: Myotonic discharges appear to be part of the electrodiagnostic characteristics of myofibrillar myopathy. Along with other appropriate clinical and histological findings, the presence of myotonic discharges supports the diagnosis of myofibrillar myopathy. Muscle Nerve 47: 845–848, 2013</p></div>
]]></content:encoded><description>
Introduction: In patients with myofibrillar myopathies (MFM), myotonic discharges have occasionally been detected by needle electromyography (EMG). Nevertheless, this peculiar type of spontaneous repetitive discharge has not attracted special interest in the genetically heterogeneous MFMs. Methods: EMG features were analyzed in 6 patients with genetically confirmed MFM (n = 1 MYOT, n = 1 DES, n = 2 ZASP, n = 2 FLNC). Results: Fibrillation potentials, positive sharp waves, and myotonic discharges were found in all 6 patients, and complex repetitive discharges were found in 5. Myotonic discharges were detected in approximately 50% of the analyzed muscles independent of the site, including distal (3/6), proximal limb (4/6), and paravertebral muscles (3/6). Clinical myotonia could not be elicited in any patient. Conclusions: Myotonic discharges appear to be part of the electrodiagnostic characteristics of myofibrillar myopathy. Along with other appropriate clinical and histological findings, the presence of myotonic discharges supports the diagnosis of myofibrillar myopathy. Muscle Nerve 47: 845–848, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23715" xmlns="http://purl.org/rss/1.0/"><title>Sonographic incidence of ulnar nerve (sub)luxation and its associated clinical and electrodiagnostic characteristics</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23715</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Sonographic incidence of ulnar nerve (sub)luxation and its associated clinical and electrodiagnostic characteristics</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Petronella J. Den Berg, Sander M. Pompe, Roy Beekman, Leo H. Visser</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-28T23:10:21.750713-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23715</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23715</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23715</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">849</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">855</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: The aim of this study was to assess the presence of (sub)luxation of the ulnar nerve in patients with ulnar neuropathy at the elbow (UNE) compared with healthy controls (HC). We assessed its clinical patterns, electrodiagnostic, and sonographic characteristics. <em>Methods</em>: Using high-resolution sonography, we studied the incidence of (sub)luxation in a cohort of 342 patients and 70 HC. <em>Results</em>: Subluxation occurred in 14% and luxation in 6.7% of the UNE patients versus 5.7% and 5.7%, respectively, in HC (no significant differences). Pain at the elbow occurred more often in patients with (sub)luxation (<em>P</em> = 0.007). Electrodiagnostic and sonographic findings did not differ between patients with or without (sub)luxation. <em>Conclusions</em>: The incidence of ulnar nerve (sub)luxation between patients with UNE and HC does not differ. UNE patients with (sub)luxation do not have specific clinical or electrodiagnostic findings, apart from experiencing pain at the elbow more often. Muscle Nerve 47: 849–855, 2013</p></div>
]]></content:encoded><description>
Introduction: The aim of this study was to assess the presence of (sub)luxation of the ulnar nerve in patients with ulnar neuropathy at the elbow (UNE) compared with healthy controls (HC). We assessed its clinical patterns, electrodiagnostic, and sonographic characteristics. Methods: Using high-resolution sonography, we studied the incidence of (sub)luxation in a cohort of 342 patients and 70 HC. Results: Subluxation occurred in 14% and luxation in 6.7% of the UNE patients versus 5.7% and 5.7%, respectively, in HC (no significant differences). Pain at the elbow occurred more often in patients with (sub)luxation (P = 0.007). Electrodiagnostic and sonographic findings did not differ between patients with or without (sub)luxation. Conclusions: The incidence of ulnar nerve (sub)luxation between patients with UNE and HC does not differ. UNE patients with (sub)luxation do not have specific clinical or electrodiagnostic findings, apart from experiencing pain at the elbow more often. Muscle Nerve 47: 849–855, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23690" xmlns="http://purl.org/rss/1.0/"><title>Quantitative muscle ultrasound and muscle force in healthy children: A 4-year follow-up study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23690</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Quantitative muscle ultrasound and muscle force in healthy children: A 4-year follow-up study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Joost Jacobs, Merel Jansen, Henny Janssen, Wilma Raijmann, Nens Alfen, Sigrid Pillen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T23:50:00.169856-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23690</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23690</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23690</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">856</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">863</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="section" id="mus23690-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>No longitudinal data on the normal development of muscle thickness (MT), quantitative muscle ultrasound echo intensity (EI), and muscle force (MF) in healthy children are yet available.</p></div></div>
<div class="section" id="mus23690-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Reference values of MT, EI, and MF of 4 muscles from infancy to age 16 years were established during a 4-year follow-up period and correlated with age and growth.</p></div></div>
<div class="section" id="mus23690-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>For most muscles, MT and MF correlated with growth and aging, with almost equal influences of weight and height. EI increased only slightly (1% per year) with height, weight, and age.</p></div></div>
<div class="section" id="mus23690-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>To use these reference values for repeated measurements, MF and MT can be corrected for either weight or height. It does not seem necessary to correct EI for these factors during follow-up of a few years. These results provide a basis for more precise detection of changes in muscle structure or force in neuromuscular disorders. Muscle Nerve 47: 856–863, 2013</p></div></div>
]]></content:encoded><description>

Introduction
No longitudinal data on the normal development of muscle thickness (MT), quantitative muscle ultrasound echo intensity (EI), and muscle force (MF) in healthy children are yet available.


Methods
Reference values of MT, EI, and MF of 4 muscles from infancy to age 16 years were established during a 4-year follow-up period and correlated with age and growth.


Results
For most muscles, MT and MF correlated with growth and aging, with almost equal influences of weight and height. EI increased only slightly (1% per year) with height, weight, and age.


Conclusions
To use these reference values for repeated measurements, MF and MT can be corrected for either weight or height. It does not seem necessary to correct EI for these factors during follow-up of a few years. These results provide a basis for more precise detection of changes in muscle structure or force in neuromuscular disorders. Muscle Nerve 47: 856–863, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23691" xmlns="http://purl.org/rss/1.0/"><title>Reference values for nerve ultrasonography in the upper extremity</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23691</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Reference values for nerve ultrasonography in the upper extremity</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sun Jae Won, Byung-Jo Kim, Kyung Seok Park, Joon Shik Yoon, Hyuk Choi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-28T23:10:26.581849-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23691</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23691</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23691</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">864</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">871</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="section" id="mus23691-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>The aims of this study were to identify factors affecting the measurement of nerve cross-sectional area (CSA) and to establish normal reference values for nerve ultrasonography of the upper extremity.</p></div></div>
<div class="section" id="mus23691-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Ninety-seven age-matched, healthy individuals were enrolled. Ultrasonographic tests were performed by tracing nerves from the axilla to the distal arm. CSA was measured at the following locations: median nerve (carpal tunnel inlet, forearm, antecubital fossa, midhumerus); ulnar nerve (wrist, 2 cm proximal to the wrist, forearm, cubital tunnel outlet and inlet, midhumerus); radial nerve (spiral groove, antecubital fossa); and musculocutaneous nerve (proximal humerus).</p></div></div>
<div class="section" id="mus23691-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The CSA reference values differed between the measured points along the path of each nerve. Nerve CSA correlated significantly with weight, body mass index, height, and gender; however, the CSA ratio (distal/proximal) did not correlate with demographic factors.</p></div></div>
<div class="section" id="mus23691-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>The normal reference values may be helpful in diagnosis of pathologies involving these nerves. Muscle Nerve 47: 864–871, 2013</p></div></div>
]]></content:encoded><description>

Introduction
The aims of this study were to identify factors affecting the measurement of nerve cross-sectional area (CSA) and to establish normal reference values for nerve ultrasonography of the upper extremity.


Methods
Ninety-seven age-matched, healthy individuals were enrolled. Ultrasonographic tests were performed by tracing nerves from the axilla to the distal arm. CSA was measured at the following locations: median nerve (carpal tunnel inlet, forearm, antecubital fossa, midhumerus); ulnar nerve (wrist, 2 cm proximal to the wrist, forearm, cubital tunnel outlet and inlet, midhumerus); radial nerve (spiral groove, antecubital fossa); and musculocutaneous nerve (proximal humerus).


Results
The CSA reference values differed between the measured points along the path of each nerve. Nerve CSA correlated significantly with weight, body mass index, height, and gender; however, the CSA ratio (distal/proximal) did not correlate with demographic factors.


Conclusions
The normal reference values may be helpful in diagnosis of pathologies involving these nerves. Muscle Nerve 47: 864–871, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23672" xmlns="http://purl.org/rss/1.0/"><title>Increased pulse wave velocity and carotid intima–media thickness in patients with carpal tunnel syndrome</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23672</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Increased pulse wave velocity and carotid intima–media thickness in patients with carpal tunnel syndrome</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Murtaza Emre Durakoğlugil, Yüksel Çiçek, Sinan Altan Kocaman, Mehmet Sabri Balik, Serkan Kirbaş, Mustafa Çetin, Turan Erdoğan, Aytun Çanga</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T23:54:38.565518-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23672</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23672</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23672</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">872</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">877</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Carpal tunnel syndrome (CTS) is associated with cardiovascular risk factors. The aim of our study was to determine whether carotid intima–media thickness (CIMT) and carotid–femoral pulse wave velocity (cf-PWV), as surrogates of cardiovascular disease and arterial stiffness, are increased in patients with carpal tunnel syndrome. Methods: Forty patients with CTS and 40 gender- and age-matched controls underwent cf-PWV assessment, CIMT measurement, and nerve conduction study. Results: CIMT and cf-PWV were increased significantly in patients with CTS. They correlated positively with median sensory and motor nerve distal latency. Whereas both CIMT and PWV related to CTS, only CIMT independently predicted CTS. Conclusions: There is both increased pulse wave velocity and CIMT and a positive correlation between these parameters and median nerve sensory distal latency in patients with CTS. CTS appears to be associated with arterial stiffness and atherosclerotic burden, but the underlying mechanisms require further study. Muscle Nerve 47: 872–877, 2013</p></div>
]]></content:encoded><description>
Introduction: Carpal tunnel syndrome (CTS) is associated with cardiovascular risk factors. The aim of our study was to determine whether carotid intima–media thickness (CIMT) and carotid–femoral pulse wave velocity (cf-PWV), as surrogates of cardiovascular disease and arterial stiffness, are increased in patients with carpal tunnel syndrome. Methods: Forty patients with CTS and 40 gender- and age-matched controls underwent cf-PWV assessment, CIMT measurement, and nerve conduction study. Results: CIMT and cf-PWV were increased significantly in patients with CTS. They correlated positively with median sensory and motor nerve distal latency. Whereas both CIMT and PWV related to CTS, only CIMT independently predicted CTS. Conclusions: There is both increased pulse wave velocity and CIMT and a positive correlation between these parameters and median nerve sensory distal latency in patients with CTS. CTS appears to be associated with arterial stiffness and atherosclerotic burden, but the underlying mechanisms require further study. Muscle Nerve 47: 872–877, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23693" xmlns="http://purl.org/rss/1.0/"><title>Quantitative ultrasonography of facial muscles</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23693</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Quantitative ultrasonography of facial muscles</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gerd Fabian Volk, Nadja Wystub, Martin Pohlmann, Mira Finkensieper, Heather J. Chalmers, Orlando Guntinas-Lichius</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T23:56:31.986769-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23693</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23693</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23693</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">878</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">883</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: There is no standardized method for examination of facial muscles with ultrasound. The purpose of this study was to identify those facial muscles accessible for reliable identification and to provide reference data. Methods: In healthy subjects all facial muscles were screened for visibility, separation from adjacent muscles, and reliability of landmarks. Bilateral scans of reliable muscles were performed in 40 adult volunteers. Results: Six facial muscles were clearly demarcated with ultrasound. These were: frontalis, orbicularis oculi, orbicularis oris, depressor anguli oris, depressor labii inferioris, and mentalis muscles. Cross-sectional area and muscle thickness showed gender differences and were independently related to age for some muscles. A significant left–right side difference was only seen for the orbicularis oculi muscle in women. Conclusions: These data demonstrate the usefulness of ultrasonography to assess facial muscles and provide reference values that can be applied in the clinical setting. Muscle Nerve 47: 878–883, 2013</p></div>
]]></content:encoded><description>
Introduction: There is no standardized method for examination of facial muscles with ultrasound. The purpose of this study was to identify those facial muscles accessible for reliable identification and to provide reference data. Methods: In healthy subjects all facial muscles were screened for visibility, separation from adjacent muscles, and reliability of landmarks. Bilateral scans of reliable muscles were performed in 40 adult volunteers. Results: Six facial muscles were clearly demarcated with ultrasound. These were: frontalis, orbicularis oculi, orbicularis oris, depressor anguli oris, depressor labii inferioris, and mentalis muscles. Cross-sectional area and muscle thickness showed gender differences and were independently related to age for some muscles. A significant left–right side difference was only seen for the orbicularis oculi muscle in women. Conclusions: These data demonstrate the usefulness of ultrasonography to assess facial muscles and provide reference values that can be applied in the clinical setting. Muscle Nerve 47: 878–883, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23702" xmlns="http://purl.org/rss/1.0/"><title>Two-dimensional ultrasound imaging of the diaphragm: Quantitative values in normal subjects</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23702</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Two-dimensional ultrasound imaging of the diaphragm: Quantitative values in normal subjects</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Andrea J. Boon, Caitlin J. Harper, Leili Shahgholi Ghahfarokhi, Jeffrey A. Strommen, James C. Watson, Eric J. Sorenson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-28T23:10:32.224699-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23702</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23702</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23702</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">884</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">889</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: Real time ultrasound imaging of the diaphragm is an under-used tool in the evaluation of patients with unexplained dyspnea or respiratory failure. <em>Methods</em>: We measured diaphragm thickness and the change in thickness that occurs with maximal inspiration in 150 normal subjects, with results stratified for age, gender, body mass index, and smoking history. <em>Results</em>: The lower limit of normal diaphragm thickness at end expiration or functional residual capacity is 0.15 cm, and an increase of at least 20% in diaphragm thickness from functional residual capacity to total lung capacity is normal. A side to side difference in thickness at end expiration of &gt; 0.33 cm is abnormal. Diaphragm thickness and contractility are minimally affected by age, gender, body habitus, or smoking history. <em>Conclusions</em>: This study confirms previous findings in much smaller groups of normal controls for quantitative ultrasound of the diaphragm and provides data that can be applied widely to the general population. Muscle Nerve 47: 884–889, 2013</p></div>
]]></content:encoded><description>
Introduction: Real time ultrasound imaging of the diaphragm is an under-used tool in the evaluation of patients with unexplained dyspnea or respiratory failure. Methods: We measured diaphragm thickness and the change in thickness that occurs with maximal inspiration in 150 normal subjects, with results stratified for age, gender, body mass index, and smoking history. Results: The lower limit of normal diaphragm thickness at end expiration or functional residual capacity is 0.15 cm, and an increase of at least 20% in diaphragm thickness from functional residual capacity to total lung capacity is normal. A side to side difference in thickness at end expiration of &gt; 0.33 cm is abnormal. Diaphragm thickness and contractility are minimally affected by age, gender, body habitus, or smoking history. Conclusions: This study confirms previous findings in much smaller groups of normal controls for quantitative ultrasound of the diaphragm and provides data that can be applied widely to the general population. Muscle Nerve 47: 884–889, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23718" xmlns="http://purl.org/rss/1.0/"><title>Nerve cross-sectional area in extremes of age</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23718</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Nerve cross-sectional area in extremes of age</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Michael S. Cartwright, David R. Mayans, Natalie A. Gillson, Leah P. Griffin, Francis O. Walker</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-14T06:06:03.278412-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23718</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23718</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23718</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">890</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">893</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: Nerve cross-sectional area reference values have been reported for many nerves, but there have been few studies in pediatric and geriatric populations. This study was conducted to determine the influence of age on nerve cross-sectional area. <em>Methods</em>: Thirty-two children (3 months to 16 years) and 20 geriatric adults (67–92 years) without known neurologic conditions underwent bilateral ultrasound to measure the area of the following nerves: median at the wrist and forearm; ulnar at the wrist and elbow; radial in the spiral groove; sciatic in the distal thigh; fibular at the knee; tibial at the knee and ankle; and sural at the ankle. <em>Results</em>: In general, nerve cross-sectional area increased with age. Nerve size correlated most closely with age, but a correlation was also seen with body mass index. <em>Conclusions</em>: Nerve cross-sectional area increases with age, which is important to note when using ultrasound to evaluate children and geriatric patients. Muscle Nerve 47: 890–893, 2013</p></div>
]]></content:encoded><description>
Introduction: Nerve cross-sectional area reference values have been reported for many nerves, but there have been few studies in pediatric and geriatric populations. This study was conducted to determine the influence of age on nerve cross-sectional area. Methods: Thirty-two children (3 months to 16 years) and 20 geriatric adults (67–92 years) without known neurologic conditions underwent bilateral ultrasound to measure the area of the following nerves: median at the wrist and forearm; ulnar at the wrist and elbow; radial in the spiral groove; sciatic in the distal thigh; fibular at the knee; tibial at the knee and ankle; and sural at the ankle. Results: In general, nerve cross-sectional area increased with age. Nerve size correlated most closely with age, but a correlation was also seen with body mass index. Conclusions: Nerve cross-sectional area increases with age, which is important to note when using ultrasound to evaluate children and geriatric patients. Muscle Nerve 47: 890–893, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23674" xmlns="http://purl.org/rss/1.0/"><title>Possibility of intrinsic muscle contractile properties in force summation and postactivation potentiation as indices of maximal muscle strength and muscle fatigue</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23674</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Possibility of intrinsic muscle contractile properties in force summation and postactivation potentiation as indices of maximal muscle strength and muscle fatigue</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yoichi Ohta, Kyohei Takahashi, Takeo Matsubayashi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T01:37:22.877279-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23674</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23674</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23674</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">894</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">902</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="section" id="mus23674-sec-0001" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>We investigated whether intrinsic muscle contractile properties in force summation and postactivation potentiation (PAP) can be used as indices of maximal muscle strength and muscle fatigue.</p></div></div>
<div class="section" id="mus23674-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Twelve men participated in this study. The maximum voluntary contraction torque (MVC), torque evoked by several stimulations in the tibialis anterior (TA) muscle, force summation parameters, and PAP were evaluated with the progression of fatigue. The force summation parameters were evaluated with respect to responses of single, double, and triple stimulations.</p></div></div>
<div class="section" id="mus23674-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The percent decreases in the evoked torque parameters with or without PAP were greater than those during MVC. Force summation parameters were significantly related to MVC and fatigue resistance.</p></div></div>
<div class="section" id="mus23674-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Intrinsic muscle contractile properties with or without PAP in the TA overestimate fatigue during MVC. However, force summation parameters can be used as indices of maximal muscle strength with or without fatigue and fatigue resistance capacity. Muscle Nerve 47: 894–902, 2013</p></div></div>
]]></content:encoded><description>

Introduction
We investigated whether intrinsic muscle contractile properties in force summation and postactivation potentiation (PAP) can be used as indices of maximal muscle strength and muscle fatigue.


Methods
Twelve men participated in this study. The maximum voluntary contraction torque (MVC), torque evoked by several stimulations in the tibialis anterior (TA) muscle, force summation parameters, and PAP were evaluated with the progression of fatigue. The force summation parameters were evaluated with respect to responses of single, double, and triple stimulations.


Results
The percent decreases in the evoked torque parameters with or without PAP were greater than those during MVC. Force summation parameters were significantly related to MVC and fatigue resistance.


Conclusions
Intrinsic muscle contractile properties with or without PAP in the TA overestimate fatigue during MVC. However, force summation parameters can be used as indices of maximal muscle strength with or without fatigue and fatigue resistance capacity. Muscle Nerve 47: 894–902, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23678" xmlns="http://purl.org/rss/1.0/"><title>A possible clinical tool to depict muscle elasticity mapping using magnetic resonance elastography</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23678</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A possible clinical tool to depict muscle elasticity mapping using magnetic resonance elastography</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Laëtitia Debernard, Ludovic Robert, Fabrice Charleux, Sabine F. Bensamoun</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T01:37:27.657998-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23678</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23678</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23678</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">903</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">908</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="section" id="mus23678-sec-0015" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Characterization of muscle elasticity will improve the diagnosis and treatment of muscle disorders. The purpose is to compare the use of magnetic resonance elastography (MRE) and ultrasound elastography (USE) techniques to elucidate the MRE cartography of thigh muscles.</p></div></div>
<div class="section" id="mus23678-sec-0016" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Both elastography techniques were performed on 5 children and 7 adults. Quantitative (MRE) and qualitative (USE) cartographies of muscle elasticity, as a function of muscle state and age, were obtained with shear waves and manual compression of the ultrasound probe, respectively.</p></div></div>
<div class="section" id="mus23678-sec-0017" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Similar cartographies of muscle elasticity were obtained with the 2 methods. The combination of both imaging techniques results in an improved depiction of the physiological changes associated with muscle state and age.</p></div></div>
<div class="section" id="mus23678-sec-0018" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>This study demonstrates the feasibility of MRE for use as a clinical tool in the characterization of neuromuscular pathologies and for assessing the efficacy of specific treatments for muscle related diseases. Muscle Nerve 47: 903–908, 2013</p></div></div>
]]></content:encoded><description>

Introduction
Characterization of muscle elasticity will improve the diagnosis and treatment of muscle disorders. The purpose is to compare the use of magnetic resonance elastography (MRE) and ultrasound elastography (USE) techniques to elucidate the MRE cartography of thigh muscles.


Methods
Both elastography techniques were performed on 5 children and 7 adults. Quantitative (MRE) and qualitative (USE) cartographies of muscle elasticity, as a function of muscle state and age, were obtained with shear waves and manual compression of the ultrasound probe, respectively.


Results
Similar cartographies of muscle elasticity were obtained with the 2 methods. The combination of both imaging techniques results in an improved depiction of the physiological changes associated with muscle state and age.


Conclusions
This study demonstrates the feasibility of MRE for use as a clinical tool in the characterization of neuromuscular pathologies and for assessing the efficacy of specific treatments for muscle related diseases. Muscle Nerve 47: 903–908, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23689" xmlns="http://purl.org/rss/1.0/"><title>Growth-associated protein-43 expression in cocultures of dorsal root ganglion neurons and skeletal muscle cells with different neurotrophins</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23689</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Growth-associated protein-43 expression in cocultures of dorsal root ganglion neurons and skeletal muscle cells with different neurotrophins</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Weiwei Zhang, Yajun Miao, Ziying Xing, Hao Li, Huangxiang Liu, Zhenzhong Li</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T23:18:41.13533-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23689</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23689</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23689</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">909</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">915</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Introduction: Both target skeletal muscle (SKM) cells and neurotrophins (NTs) are essential for the maintenance of neuronal function and nerve–muscle communication. The effects of different NTs and SKM cells on growth-associated protein-43 (GAP-43) expression in dorsal root ganglion (DRG) neurons have not been clarified. Methods: The morphological relationship between DRG neurons and SKM cells in neuromuscular cocultures was observed by scanning electron microscopy. The levels of GAP-43 and its mRNA were determined after administration of different NTs. Results: DRG neurons demonstrated dense neurite outgrowth in the presence of NTs. Distinct NTs promoted GAP-43 and its mRNA expression in neuromuscular cocultures of DRG neurons and SKM cells. Conclusions: These results offer new clues for a better understanding of the effects of distinct NTs on GAP-43 expression in DRG sensory neurons in the presence of target SKM cells and implicate NTs and target SKM cells in DRG neuronal regeneration. Muscle Nerve 47: 909–915, 2013</p></div>
]]></content:encoded><description>
Introduction: Both target skeletal muscle (SKM) cells and neurotrophins (NTs) are essential for the maintenance of neuronal function and nerve–muscle communication. The effects of different NTs and SKM cells on growth-associated protein-43 (GAP-43) expression in dorsal root ganglion (DRG) neurons have not been clarified. Methods: The morphological relationship between DRG neurons and SKM cells in neuromuscular cocultures was observed by scanning electron microscopy. The levels of GAP-43 and its mRNA were determined after administration of different NTs. Results: DRG neurons demonstrated dense neurite outgrowth in the presence of NTs. Distinct NTs promoted GAP-43 and its mRNA expression in neuromuscular cocultures of DRG neurons and SKM cells. Conclusions: These results offer new clues for a better understanding of the effects of distinct NTs on GAP-43 expression in DRG sensory neurons in the presence of target SKM cells and implicate NTs and target SKM cells in DRG neuronal regeneration. Muscle Nerve 47: 909–915, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23696" xmlns="http://purl.org/rss/1.0/"><title>Optical inhibition of motor nerve and muscle activity in vivo</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23696</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Optical inhibition of motor nerve and muscle activity in vivo</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Holly Liske, Chris Towne, Polina Anikeeva, Shengli Zhao, Guoping Feng, Karl Deisseroth, Scott Delp</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-30T01:31:09.566017-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23696</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23696</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23696</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">916</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">921</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: There is no therapeutic approach that provides precise and rapidly reversible inhibition of motor nerve and muscle activity for treatment of spastic hypertonia. <em>Methods</em>: We used optogenetics to demonstrate precise and rapidly reversible light-mediated inhibition of motor nerve and muscle activity <em>in vivo</em> in transgenic <em>Thy1::eNpHR2.0</em> mice. <em>Results</em>: We found optical inhibition of motor nerve and muscle activity to be effective at all muscle force amplitudes and determined that muscle activity can be modulated by changing light pulse duration and light power density. <em>Conclusions</em>: This demonstration of optical inhibition of motor nerves is an important advancement toward novel optogenetics-based therapies for spastic hypertonia. Muscle Nerve 47: 916–921, 2013</p></div>
]]></content:encoded><description>

Introduction: There is no therapeutic approach that provides precise and rapidly reversible inhibition of motor nerve and muscle activity for treatment of spastic hypertonia. Methods: We used optogenetics to demonstrate precise and rapidly reversible light-mediated inhibition of motor nerve and muscle activity in vivo in transgenic Thy1::eNpHR2.0 mice. Results: We found optical inhibition of motor nerve and muscle activity to be effective at all muscle force amplitudes and determined that muscle activity can be modulated by changing light pulse duration and light power density. Conclusions: This demonstration of optical inhibition of motor nerves is an important advancement toward novel optogenetics-based therapies for spastic hypertonia. Muscle Nerve 47: 916–921, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23743" xmlns="http://purl.org/rss/1.0/"><title>Re-analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23743</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Re-analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rabia Chaudhry, Aditi Kidambi, Megan Hwa Brewer, Anthony Antonellis, Katherine Mathews, Garth Nicholson, Marina Kennerson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-28T23:41:06.422664-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23743</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23743</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23743</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">922</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">924</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23743-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Charcot–Marie–Tooth (CMT) disease is a group of peripheral neuropathies affecting both motor and sensory nerves. CMTX3 is an X-linked CMT locus, which maps to chromosome Xq26.3–q27.3. Initially, CMTX3 was mapped to a 31.2-Mb region in 2 American families. We have reexamined 1 of the original families (US-PED2) by next generation sequencing.</p></div></div>
<div class="section" id="mus23743-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Three members of the family underwent exome sequencing. Candidate variants were validated by PCR and Sanger sequencing analysis.</p></div></div>
<div class="section" id="mus23743-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>No pathogenic coding variants localizing to the CMTX3 region were identified. However, exome sequencing identified a known <em>BSCL2</em> mutation (N88S). This study demonstrates the power of exome sequencing as a tool to identify gene mutations for a small family in the absence of statistically significant linkage data. Muscle Nerve 47: 922–924, 2013</p></div></div>
]]></content:encoded><description>


Introduction
Charcot–Marie–Tooth (CMT) disease is a group of peripheral neuropathies affecting both motor and sensory nerves. CMTX3 is an X-linked CMT locus, which maps to chromosome Xq26.3–q27.3. Initially, CMTX3 was mapped to a 31.2-Mb region in 2 American families. We have reexamined 1 of the original families (US-PED2) by next generation sequencing.


Methods
Three members of the family underwent exome sequencing. Candidate variants were validated by PCR and Sanger sequencing analysis.


Conclusion
No pathogenic coding variants localizing to the CMTX3 region were identified. However, exome sequencing identified a known BSCL2 mutation (N88S). This study demonstrates the power of exome sequencing as a tool to identify gene mutations for a small family in the absence of statistically significant linkage data. Muscle Nerve 47: 922–924, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23754" xmlns="http://purl.org/rss/1.0/"><title>Seasonal variation in prevalence of carpal tunnel syndrome</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23754</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Seasonal variation in prevalence of carpal tunnel syndrome</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Renata Siciliani Scalco, Franciane Pietroski, Luiz Felippe S. Celli, Irenio Gomes, Jefferson Becker</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-20T23:57:08.144085-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23754</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23754</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23754</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">925</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">927</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p><em>Introduction</em>: The influence of cold temperatures on neuropathies has been reported previously, but its impact on carpal tunnel syndrome (CTS) is not well analyzed. <em>Methods</em>: We analyzed the frequency of CTS among neurophysiological evaluations according to seasonal variation in 9574 consecutive patients (4260 with CTS). <em>Results</em>: A higher frequency of CTS was found in the winter (50.8%), and the lowest number for CTS diagnosis was found in the summer (38.9%). In both autumn and spring the prevalence remained stable at an intermediate level between summer and winter at 42.8% and 43.5%, respectively. <em>Conclusion</em>: CTS frequency was much higher in winter in this center. Muscle Nerve 47: 925–927, 2013</p></div>
]]></content:encoded><description>

Introduction: The influence of cold temperatures on neuropathies has been reported previously, but its impact on carpal tunnel syndrome (CTS) is not well analyzed. Methods: We analyzed the frequency of CTS among neurophysiological evaluations according to seasonal variation in 9574 consecutive patients (4260 with CTS). Results: A higher frequency of CTS was found in the winter (50.8%), and the lowest number for CTS diagnosis was found in the summer (38.9%). In both autumn and spring the prevalence remained stable at an intermediate level between summer and winter at 42.8% and 43.5%, respectively. Conclusion: CTS frequency was much higher in winter in this center. Muscle Nerve 47: 925–927, 2013
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23751" xmlns="http://purl.org/rss/1.0/"><title>Exacerbation of myasthenia gravis with voriconazole</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23751</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Exacerbation of myasthenia gravis with voriconazole</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Raed Azzam, Aasef G. Shaikh, Alessandro Serra, Bashar Katirji</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T23:40:26.148984-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23751</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23751</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23751</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Cases of the Month</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">928</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">930</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23751-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>We describe a patient with stable generalized myasthenia gravis who presented with new onset severe ophthalmoplegia and ptosis after initiation of voriconazole for aspergillosis.</p></div></div>
<div class="section" id="mus23751-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Ligand-protein docking software was used to simulate the interaction of voriconazole with the acetylcholine receptor (AChR). We tested voriconazole binding to AChR in comparison to high affinity and neutral compounds.</p></div></div>
<div class="section" id="mus23751-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>There was no clinical improvement after intravenous immunoglobulin infusion and plasmapheresis. However, the patient improved slowly after withdrawal of voriconazole. Based on our results, voriconazole binds favorably to AChR and may putatively block muscle nicotinic AChRs. Other theoretical explanations include blocking potassium channels and reducing their intracellular trafficking.</p></div></div>
<div class="section" id="mus23751-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>The mechanisms involved in ocular exacerbation may be multi-factorial, reflecting the intricate dynamics of the neuromuscular junction. It is important to consider medications that harbor pyridine or pyrimidine moieties as potential causes of exacerbation in myasthenic patients, especially those who present with ocular symptoms. Muscle Nerve 47: 928–930, 2013</p></div></div>
]]></content:encoded><description>


Introduction
We describe a patient with stable generalized myasthenia gravis who presented with new onset severe ophthalmoplegia and ptosis after initiation of voriconazole for aspergillosis.


Methods
Ligand-protein docking software was used to simulate the interaction of voriconazole with the acetylcholine receptor (AChR). We tested voriconazole binding to AChR in comparison to high affinity and neutral compounds.


Results
There was no clinical improvement after intravenous immunoglobulin infusion and plasmapheresis. However, the patient improved slowly after withdrawal of voriconazole. Based on our results, voriconazole binds favorably to AChR and may putatively block muscle nicotinic AChRs. Other theoretical explanations include blocking potassium channels and reducing their intracellular trafficking.


Conclusions
The mechanisms involved in ocular exacerbation may be multi-factorial, reflecting the intricate dynamics of the neuromuscular junction. It is important to consider medications that harbor pyridine or pyrimidine moieties as potential causes of exacerbation in myasthenic patients, especially those who present with ocular symptoms. Muscle Nerve 47: 928–930, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23763" xmlns="http://purl.org/rss/1.0/"><title>Ancestral founder mutations in calpain-3 in the Indian Agarwal community: Historical, clinical, and molecular perspective</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23763</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Ancestral founder mutations in calpain-3 in the Indian Agarwal community: Historical, clinical, and molecular perspective</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Arunkanth Ankala, Jordan N. Kohn, Rashna Dastur, Pradnya Gaitonde, Satish V. Khadilkar, Madhuri R. Hegde</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T23:18:44.801596-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23763</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23763</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23763</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Case of the Month</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">931</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">937</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">ABSTRACT</h3>
<div class="section" id="mus23763-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Introduction</h4><div class="para"><p>Clinical heterogeneity of limb-girdle muscular dystrophies (LGMDs, 24 known subtypes), which includes overlapping phenotypes and varying ages of onset and morbidity, adds complexity to clinical and molecular diagnoses.</p></div></div>
<div class="section" id="mus23763-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>To diagnose LGMD subtype, protein analysis, using immunohistochemistry (IHC) and immunoblotting, was followed by gene sequencing through a panel approach (simultaneous sequencing of known LGMD genes) in 9 patients from unrelated families of the Indian Agarwal community. Haplotype studies were performed by targeted SNP genotyping to establish mutation segregation.</p></div></div>
<div class="section" id="mus23763-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>We identified 2 founder mutations in <em>CAPN3</em>, a missense (c.2338G&gt;C; p.D780H) and a splice-site (c.2099-1G&gt;T) mutation, on 2 different haplotype backgrounds. The patients were either heterozygous for both or homozygous for either of these mutations.</p></div></div>
<div class="section" id="mus23763-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Founder mutations have immediate clinical application, at least in selected population groups. Clinically available gene panels may provide a definitive molecular diagnosis for heterogeneous disorders such as LGMD. Muscle Nerve 47: 931–937, 2013</p></div></div>
]]></content:encoded><description>


Introduction
Clinical heterogeneity of limb-girdle muscular dystrophies (LGMDs, 24 known subtypes), which includes overlapping phenotypes and varying ages of onset and morbidity, adds complexity to clinical and molecular diagnoses.


Methods
To diagnose LGMD subtype, protein analysis, using immunohistochemistry (IHC) and immunoblotting, was followed by gene sequencing through a panel approach (simultaneous sequencing of known LGMD genes) in 9 patients from unrelated families of the Indian Agarwal community. Haplotype studies were performed by targeted SNP genotyping to establish mutation segregation.


Results
We identified 2 founder mutations in CAPN3, a missense (c.2338G&gt;C; p.D780H) and a splice-site (c.2099-1G&gt;T) mutation, on 2 different haplotype backgrounds. The patients were either heterozygous for both or homozygous for either of these mutations.


Conclusions
Founder mutations have immediate clinical application, at least in selected population groups. Clinically available gene panels may provide a definitive molecular diagnosis for heterogeneous disorders such as LGMD. Muscle Nerve 47: 931–937, 2013

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23706" xmlns="http://purl.org/rss/1.0/"><title>Stiff person syndrome improvement with chemotherapy in a patient with cutaneous t cell lymphoma</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23706</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Stiff person syndrome improvement with chemotherapy in a patient with cutaneous t cell lymphoma</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Goran Rakocevic, Aamir Hussain</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-21T22:45:54.725139-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23706</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23706</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23706</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">938</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">939</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23796" xmlns="http://purl.org/rss/1.0/"><title>Flexor hallucis brevis spasm</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23796</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Flexor hallucis brevis spasm</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Rickie Patani, Nizar Muhammed, Abhijit Chaudhuri</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-26T05:12:47.540189-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23796</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23796</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23796</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">939</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">939</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23572" xmlns="http://purl.org/rss/1.0/"><title>Calendar of events</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23572</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Calendar of events</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-23T23:26:58.197863-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23572</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23572</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23572</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">AANEM Calendar of Events</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">940</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">940</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23573" xmlns="http://purl.org/rss/1.0/"><title>News &amp; Comments</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23573</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">News &amp; Comments</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-23T23:26:58.197863-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23573</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23573</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23573</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">News &amp; Comments</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">941</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">949</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23574" xmlns="http://purl.org/rss/1.0/"><title>AANEM Application</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23574</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">AANEM Application</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-23T23:26:58.197863-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/mus.23574</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/mus.23574</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1002%2Fmus.23574</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">AANEM Application</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">950</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">951</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item></rdf:RDF>